<!DOCTYPE html>

<html lang="en">


<!doctype html>
<html lang="en" class="no-js">
  <head>
    
      <meta charset="utf-8">
      <meta name="viewport" content="width=device-width,initial-scale=1">
      
      
      
      
        <link rel="prev" href="../Immunology/">
      
      
      
      <link rel="icon" href="../assets/images/favicon.png">
      <meta name="generator" content="mkdocs-1.5.3, mkdocs-material-9.5.12">
    
    
<title>Literature Survey (VPE)</title>

    
      <link rel="stylesheet" href="../assets/stylesheets/main.7e359304.min.css">
      
        
        <link rel="stylesheet" href="../assets/stylesheets/palette.06af60db.min.css">
      
      


    
    
  <!-- Add scripts that need to run before here -->
  <!-- Add jquery script -->
  <script src="https://code.jquery.com/jquery-3.7.1.js"></script>
  <!-- Add data table libraries -->
  <script src="https://cdn.datatables.net/2.0.1/js/dataTables.js"></script>
  <link rel="stylesheet" href="https://cdn.datatables.net/2.0.1/css/dataTables.dataTables.css">
  <!-- Load plotly.js into the DOM -->
	<script src='https://cdn.plot.ly/plotly-2.29.1.min.js'></script>
  <link rel="stylesheet" href="https://cdn.datatables.net/buttons/3.0.1/css/buttons.dataTables.css">
  <!-- fixedColumns -->
  <script src="https://cdn.datatables.net/fixedcolumns/5.0.0/js/dataTables.fixedColumns.js"></script>
  <script src="https://cdn.datatables.net/fixedcolumns/5.0.0/js/fixedColumns.dataTables.js"></script>
  <link rel="stylesheet" href="https://cdn.datatables.net/fixedcolumns/5.0.0/css/fixedColumns.dataTables.css">
  <!-- Already specified in mkdocs.yml -->
  <!-- <link rel="stylesheet" href="../docs/custom.css"> -->
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/dataTables.buttons.js"></script>
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/buttons.dataTables.js"></script>
  <script src="https://cdnjs.cloudflare.com/ajax/libs/jszip/3.10.1/jszip.min.js"></script>
  <script src="https://cdnjs.cloudflare.com/ajax/libs/pdfmake/0.2.7/pdfmake.min.js"></script>
  <script src="https://cdnjs.cloudflare.com/ajax/libs/pdfmake/0.2.7/vfs_fonts.js"></script>
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/buttons.html5.min.js"></script>
  <script src="https://cdn.datatables.net/buttons/3.0.1/js/buttons.print.min.js"></script>
  <!-- Google fonts -->
  <link rel="stylesheet" href="https://fonts.googleapis.com/icon?family=Material+Icons">
  <!-- Intro.js -->
  <script src="https://cdn.jsdelivr.net/npm/intro.js@7.2.0/intro.min.js"></script>
  <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/intro.js@7.2.0/minified/introjs.min.css">


  <!-- 
      
     -->
  <!-- Add scripts that need to run afterwards here -->

    
      
        
        
        <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
        <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:300,300i,400,400i,700,700i%7CRoboto+Mono:400,400i,700,700i&display=fallback">
        <style>:root{--md-text-font:"Roboto";--md-code-font:"Roboto Mono"}</style>
      
    
    
      <link rel="stylesheet" href="../assets/_mkdocstrings.css">
    
      <link rel="stylesheet" href="../custom.css">
    
    <script>__md_scope=new URL("..",location),__md_hash=e=>[...e].reduce((e,_)=>(e<<5)-e+_.charCodeAt(0),0),__md_get=(e,_=localStorage,t=__md_scope)=>JSON.parse(_.getItem(t.pathname+"."+e)),__md_set=(e,_,t=localStorage,a=__md_scope)=>{try{t.setItem(a.pathname+"."+e,JSON.stringify(_))}catch(e){}}</script>
    
      

    
    
    
  </head>
  
  
    
    
      
    
    
    
    
    <body dir="ltr" data-md-color-scheme="default" data-md-color-primary="white" data-md-color-accent="black">
  
    
    <input class="md-toggle" data-md-toggle="drawer" type="checkbox" id="__drawer" autocomplete="off">
    <input class="md-toggle" data-md-toggle="search" type="checkbox" id="__search" autocomplete="off">
    <label class="md-overlay" for="__drawer"></label>
    <div data-md-component="skip">
      
    </div>
    <div data-md-component="announce">
      
    </div>
    
    
      

<header class="md-header" data-md-component="header">
  <nav class="md-header__inner md-grid" aria-label="Header">
    <a href=".." title="Literature Survey for Swathi" class="md-header__button md-logo" aria-label="Literature Survey for Swathi" data-md-component="logo">
      
  <img src="../assets/VPE.png" alt="logo">

    </a>
    <label class="md-header__button md-icon" for="__drawer">
      
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M3 6h18v2H3V6m0 5h18v2H3v-2m0 5h18v2H3v-2Z"/></svg>
    </label>
    <div class="md-header__title" data-md-component="header-title">
      <div class="md-header__ellipsis">
        <div class="md-header__topic">
          <span class="md-ellipsis">
            Literature Survey for Swathi
          </span>
        </div>
        <div class="md-header__topic" data-md-component="header-topic">
          <span class="md-ellipsis">
            
              Oncology
            
          </span>
        </div>
      </div>
    </div>
    
      
        <form class="md-header__option" data-md-component="palette">
  
    
    
    
    <input class="md-option" data-md-color-media="" data-md-color-scheme="default" data-md-color-primary="white" data-md-color-accent="black"  aria-label="Switch to dark mode"  type="radio" name="__palette" id="__palette_0">
    
      <label class="md-header__button md-icon" title="Switch to dark mode" for="__palette_1" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M17 6H7c-3.31 0-6 2.69-6 6s2.69 6 6 6h10c3.31 0 6-2.69 6-6s-2.69-6-6-6zm0 10H7c-2.21 0-4-1.79-4-4s1.79-4 4-4h10c2.21 0 4 1.79 4 4s-1.79 4-4 4zM7 9c-1.66 0-3 1.34-3 3s1.34 3 3 3 3-1.34 3-3-1.34-3-3-3z"/></svg>
      </label>
    
  
    
    
    
    <input class="md-option" data-md-color-media="" data-md-color-scheme="slate" data-md-color-primary="white" data-md-color-accent="black"  aria-label="Switch to light mode"  type="radio" name="__palette" id="__palette_1">
    
      <label class="md-header__button md-icon" title="Switch to light mode" for="__palette_0" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M17 7H7a5 5 0 0 0-5 5 5 5 0 0 0 5 5h10a5 5 0 0 0 5-5 5 5 0 0 0-5-5m0 8a3 3 0 0 1-3-3 3 3 0 0 1 3-3 3 3 0 0 1 3 3 3 3 0 0 1-3 3Z"/></svg>
      </label>
    
  
</form>
      
    
    
      <script>var media,input,key,value,palette=__md_get("__palette");if(palette&&palette.color){"(prefers-color-scheme)"===palette.color.media&&(media=matchMedia("(prefers-color-scheme: light)"),input=document.querySelector(media.matches?"[data-md-color-media='(prefers-color-scheme: light)']":"[data-md-color-media='(prefers-color-scheme: dark)']"),palette.color.media=input.getAttribute("data-md-color-media"),palette.color.scheme=input.getAttribute("data-md-color-scheme"),palette.color.primary=input.getAttribute("data-md-color-primary"),palette.color.accent=input.getAttribute("data-md-color-accent"));for([key,value]of Object.entries(palette.color))document.body.setAttribute("data-md-color-"+key,value)}</script>
    
    
    
      <label class="md-header__button md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.516 6.516 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5Z"/></svg>
      </label>
      <div class="md-search" data-md-component="search" role="dialog">
  <label class="md-search__overlay" for="__search"></label>
  <div class="md-search__inner" role="search">
    <form class="md-search__form" name="search">
      <input type="text" class="md-search__input" name="query" aria-label="Search" placeholder="Search" autocapitalize="off" autocorrect="off" autocomplete="off" spellcheck="false" data-md-component="search-query" required>
      <label class="md-search__icon md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.516 6.516 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5Z"/></svg>
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M20 11v2H8l5.5 5.5-1.42 1.42L4.16 12l7.92-7.92L13.5 5.5 8 11h12Z"/></svg>
      </label>
      <nav class="md-search__options" aria-label="Search">
        
        <button type="reset" class="md-search__icon md-icon" title="Clear" aria-label="Clear" tabindex="-1">
          
          <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M19 6.41 17.59 5 12 10.59 6.41 5 5 6.41 10.59 12 5 17.59 6.41 19 12 13.41 17.59 19 19 17.59 13.41 12 19 6.41Z"/></svg>
        </button>
      </nav>
      
    </form>
    <div class="md-search__output">
      <div class="md-search__scrollwrap" data-md-scrollfix>
        <div class="md-search-result" data-md-component="search-result">
          <div class="md-search-result__meta">
            Initializing search
          </div>
          <ol class="md-search-result__list" role="presentation"></ol>
        </div>
      </div>
    </div>
  </div>
</div>
    
    
      <div class="md-header__source">
        <a href="https://github.com/VirtualPatientEngine/literatureSurvey" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 496 512"><!--! Font Awesome Free 6.5.1 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2023 Fonticons, Inc.--><path d="M165.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6zm-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3zm44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9zM244.8 8C106.1 8 0 113.3 0 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C428.2 457.8 496 362.9 496 252 496 113.3 383.5 8 244.8 8zM97.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1zm-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7zm32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1zm-11.4-14.7c-1.6 1-1.6 3.6 0 5.9 1.6 2.3 4.3 3.3 5.6 2.3 1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2z"/></svg>
  </div>
  <div class="md-source__repository">
    VPE/LiteratureSurvey
  </div>
</a>
      </div>
    
  </nav>
  
</header>
    
    <div class="md-container" data-md-component="container">
      
      
        
          
            
<nav class="md-tabs" aria-label="Tabs" data-md-component="tabs">
  <div class="md-grid">
    <ul class="md-tabs__list">
      
        
  
  
  
    <li class="md-tabs__item">
      <a href=".." class="md-tabs__link">
        
  
    
  
  Home

      </a>
    </li>
  

      
        
  
  
  
    <li class="md-tabs__item">
      <a href="../Immunology/" class="md-tabs__link">
        
  
    
  
  Immunology

      </a>
    </li>
  

      
        
  
  
    
  
  
    <li class="md-tabs__item md-tabs__item--active">
      <a href="./" class="md-tabs__link">
        
  
    
  
  Oncology

      </a>
    </li>
  

      
    </ul>
  </div>
</nav>
          
        
      
      <main class="md-main" data-md-component="main">
        <div class="md-main__inner md-grid">
          
            
              
                
              
              <div class="md-sidebar md-sidebar--primary" data-md-component="sidebar" data-md-type="navigation" hidden>
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    


  


<nav class="md-nav md-nav--primary md-nav--lifted" aria-label="Navigation" data-md-level="0">
  <label class="md-nav__title" for="__drawer">
    <a href=".." title="Literature Survey for Swathi" class="md-nav__button md-logo" aria-label="Literature Survey for Swathi" data-md-component="logo">
      
  <img src="../assets/VPE.png" alt="logo">

    </a>
    Literature Survey for Swathi
  </label>
  
    <div class="md-nav__source">
      <a href="https://github.com/VirtualPatientEngine/literatureSurvey" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 496 512"><!--! Font Awesome Free 6.5.1 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2023 Fonticons, Inc.--><path d="M165.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6zm-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3zm44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9zM244.8 8C106.1 8 0 113.3 0 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C428.2 457.8 496 362.9 496 252 496 113.3 383.5 8 244.8 8zM97.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1zm-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7zm32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1zm-11.4-14.7c-1.6 1-1.6 3.6 0 5.9 1.6 2.3 4.3 3.3 5.6 2.3 1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2z"/></svg>
  </div>
  <div class="md-source__repository">
    VPE/LiteratureSurvey
  </div>
</a>
    </div>
  
  <ul class="md-nav__list" data-md-scrollfix>
    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href=".." class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Home
  </span>
  

      </a>
    </li>
  

    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href="../Immunology/" class="md-nav__link">
        
  
  <span class="md-ellipsis">
    Immunology
  </span>
  

      </a>
    </li>
  

    
      
      
  
  
    
  
  
  
    <li class="md-nav__item md-nav__item--active">
      
      <input class="md-nav__toggle md-toggle" type="checkbox" id="__toc">
      
      
      
      <a href="./" class="md-nav__link md-nav__link--active">
        
  
  <span class="md-ellipsis">
    Oncology
  </span>
  

      </a>
      
    </li>
  

    
  </ul>
</nav>
                  </div>
                </div>
              </div>
            
            
              
                
              
              <div class="md-sidebar md-sidebar--secondary" data-md-component="sidebar" data-md-type="toc" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    

<nav class="md-nav md-nav--secondary" aria-label="Table of contents">
  
  
  
  
</nav>
                  </div>
                </div>
              </div>
            
          
          
            <div class="md-content" data-md-component="content">
              <article class="md-content__inner md-typeset">
                
                  

  
  


  <h1>Oncology</h1>

<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
</head>

<body>
  <p>
  <i class="footer">This page was last updated on 2025-12-08 09:21:04 UTC</i>
  </p>

  <div class="note info" onclick="startIntro()">
    <p>
      <button type="button" class="buttons">
        <div style="display: flex; align-items: center;">
        Click here for a quick intro of the page! <i class="material-icons">help</i>
        </div>
      </button>
    </p>
  </div>

  <!--
  <div data-intro='Table of contents'>
    <p>
    <h3>Table of Contents</h3>
      <a href="#plot1">1. Citations over time on Oncology</a><br>
      <a href="#manually_curated_articles">2. Manually curated articles on Oncology</a><br>
      <a href="#recommended_articles">3. Recommended articles on Oncology</a><br>
    <p>
  </div>

  <div data-intro='Plot displaying number of citations over time 
                  on the given topic based on recommended articles'>
    <p>
    <h3 id="plot1">1. Citations over time on Oncology</h3>
      <div id='myDiv1'>
      </div>
    </p>
  </div>
  -->

  <div data-intro='Manually curated articles on the given topic'>
    <p>
    <h3 id="manually_curated_articles">Manually curated articles on <i>Oncology</i></h3>
    <table id="table1" class="display" style="width:100%">
    <thead>
      <tr>
          <th data-intro='Click to view the abstract (if available)'>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/ Conference</th>
          <th>Citation count</th>
          <th data-intro='Highest h-index among the authors'>Highest h-index</th>
          <th data-intro='Recommended articles extracted by considering
                          only the given article'>
              View recommendations
              </th>
      </tr>
    </thead>
    <tbody>

        <tr id="Sustained smouldering, or low-grade activation, of myeloid cells is a common hallmark of several chronic neurological diseases, including multiple sclerosis1. Distinct metabolic and mitochondrial features guide the activation and the diverse functional states of myeloid cells2. However, how these metabolic features act to perpetuate inflammation of the central nervous system is unclear. Here, using a multiomics approach, we identify a molecular signature that sustains the activation of microglia through mitochondrial complex I activity driving reverse electron transport and the production of reactive oxygen species. Mechanistically, blocking complex I in pro-inflammatory microglia protects the central nervous system against neurotoxic damage and improves functional outcomes in an animal disease model in vivo. Complex I activity in microglia is a potential therapeutic target to foster neuroprotection in chronic inflammatory disorders of the central nervous system3. Blocking mitochondrial complex I in pro-inflammatory microglia protects the central nervous system against neurotoxic damage and improves functional outcomes in vivo in an animal disease model.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/21fcaf99ddc745b1c9ce7be98fe589c812c89ddf" target='_blank'>
                Mitochondrial complex I activity in microglia sustains neuroinflammation
                </a>
              </td>
          <td>
            L. Peruzzotti-Jametti, C. Willis, G. Krzak, R. Hamel, L. Pirvan, Rosana-Bristena Ionescu, J. Reisz, H. Prag, M. E. Garcia-Segura, V. Wu, Y. Xiang, B. Barlas, A. Casey, A. van den Bosch, A. Nicaise, L. Roth, G. R. Bates, H. Huang, P. Prasad, A. E. Vincent, C. Frezza, C. Viscomi, G. Balmus, Z. Takáts, J. Marioni, A. D'alessandro, M. P. Murphy, I. Mohorianu, S. Pluchino
          </td>
          <td>2024-03-13</td>
          <td>Nature</td>
          <td>127</td>
          <td>31</td>

            <td><a href='../recommendations/21fcaf99ddc745b1c9ce7be98fe589c812c89ddf' target='_blank'>
              <i class="material-icons">open_in_new</i></a>
            </td>

        </tr>

        <tr id="The COVID-19 pandemic is an ongoing global health threat, yet our understanding of the dynamics of early cellular responses to this disease remains limited1. Here in our SARS-CoV-2 human challenge study, we used single-cell multi-omics profiling of nasopharyngeal swabs and blood to temporally resolve abortive, transient and sustained infections in seronegative individuals challenged with pre-Alpha SARS-CoV-2. Our analyses revealed rapid changes in cell-type proportions and dozens of highly dynamic cellular response states in epithelial and immune cells associated with specific time points and infection status. We observed that the interferon response in blood preceded the nasopharyngeal response. Moreover, nasopharyngeal immune infiltration occurred early in samples from individuals with only transient infection and later in samples from individuals with sustained infection. High expression of HLA-DQA2 before inoculation was associated with preventing sustained infection. Ciliated cells showed multiple immune responses and were most permissive for viral replication, whereas nasopharyngeal T cells and macrophages were infected non-productively. We resolved 54 T cell states, including acutely activated T cells that clonally expanded while carrying convergent SARS-CoV-2 motifs. Our new computational pipeline Cell2TCR identifies activated antigen-responding T cells based on a gene expression signature and clusters these into clonotype groups and motifs. Overall, our detailed time series data can serve as a Rosetta stone for epithelial and immune cell responses and reveals early dynamic responses associated with protection against infection. A human SARS-CoV-2 challenge study in individuals without previous exposure to the virus or vaccines provides detailed profiles of local and systemic epithelial and immune cell response dynamics over time and infection status.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/380489b0c6f9106219184f0c5fe6612e0b4e165a" target='_blank'>
                Human SARS-CoV-2 challenge uncovers local and systemic response dynamics
                </a>
              </td>
          <td>
            Rik G. H. Lindeboom, Kaylee B. Worlock, L. Dratva, M. Yoshida, David Scobie, Helen R. Wagstaffe, Laura Richardson, A. Wilbrey-Clark, Josephine L. Barnes, Lorenz Kretschmer, K. Polański, J. Allen-Hyttinen, Puja Mehta, D. Sumanaweera, J. M. Boccacino, W. Sungnak, R. Elmentaite, Ni Huang, L. Mamanova, R. Kapuge, L. Bolt, E. Prigmore, B. Killingley, M. Kalinova, Maria Mayer, A. Boyers, Alex J. Mann, Leo Swadling, M. Woodall, Samuel Ellis, Claire M. Smith, V. Teixeira, Sam M. Janes, R. Chambers, M. Haniffa, A. Catchpole, R. Heyderman, M. Noursadeghi, Benjamin M. Chain, Andreas Mayer, Kerstin B. Meyer, Christopher Chiu, Marko Z. Nikolić, Sarah A. Teichmann
          </td>
          <td>2024-06-19</td>
          <td>Nature</td>
          <td>73</td>
          <td>75</td>

            <td><a href='../recommendations/380489b0c6f9106219184f0c5fe6612e0b4e165a' target='_blank'>
              <i class="material-icons">open_in_new</i></a>
            </td>

        </tr>

    </tbody>
    <tfoot>
      <tr>
          <th>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/ Conference</th>
          <th>Citation count</th>
          <th>Highest h-index</th>
          <th>View recommendations</th>
      </tr>
    </tfoot>
    </table>
    </p>
  </div>

  <div data-intro='Recommended articles extracted by contrasting
                  articles that are relevant against not relevant for Oncology'>
    <p>
    <h3 id="recommended_articles">Recommended articles on <i>Oncology</i></h3>
    <table id="table2" class="display" style="width:100%">
    <thead>
      <tr>
          <th>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/Conference</th>
          <th>Citation count</th>
          <th>Highest h-index</th>
      </tr>
    </thead>
    <tbody>

        <tr id="While males are more likely to suffer severe outcomes during acute COVID-19, a greater proportion of females develop post-acute sequalae of COVID-19 (PASC) despite similar rates of infection. To identify mechanisms of PASC, mice were infected with SARS-CoV-2 and viral, inflammatory, and behavioral outcomes were evaluated through 84 days post infection. Sex differences were not observed in virus replication or persistence of viral RNA in pulmonary or extrapulmonary tissues in acute or PASC phases. Following recovery from infection, female mice exhibited persistent neurocognitive and behavioral impairments, along with greater frequencies of inflammatory myeloid subsets, neuroinflammation, and dysregulated T cell subsets, including Tregs. Sex differences in inflammation and cognitive phenotypes during PASC were mediated by the presence of two X chromosomes. XX animals independent of chromosome Y presented with neuroinflammation and PASC along with infection-induced upregulation of the X-linked genes Xist and Tlr7 that regulate inflammation and chronic disease outcomes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/79890359565389b73c061b8b182c8a9f91a90fcd" target='_blank'>
              Mechanisms of sex differences in acute and long COVID sequelae in mice
              </a>
            </td>
          <td>
            Jennifer A. Liu, Sabal Chaulagain, Patrick S. Creisher, Weizhi Zhong, Tianle Zhang, Maraake Taddese, Karly Shi, Han-sol Park, Haley Hcnir, Arthur P. Arnold, Ralph S. Baric, Natasha B Barahona, Elizabeth Engler-Chiurazzi, Kevin J. Zwezdaryk, Chloe L. Thio, A. Balagopal, J.R. Harkema, Elizabeth A. Thompson, A. Pekosz, Andrea L. Cox, S. Klein
          </td>
          <td>2025-10-14</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="Cytomegalovirus is the leading viral cause of congenital infection with neurological sequelae. Effective medical treatments are limited due to an inadequate understanding of the underlying pathogenesis. Here, we applied single-cell transcriptomics to analyze neonatal mouse brains with congenital cytomegalovirus infection (cCMV). We profiled cCMV in 22 cell types and identified neural progenitor cells (NPCs) and monocyte-derived macrophages (MDMs) as the most commonly infected cells. Infected NPCs exhibited dysregulated neurodevelopment-associated signaling pathways, correlating with viral transcript levels that indicate viral replication levels. Genes associated with phagocytosis and antigen presentation were downregulated exclusively in infected MDMs but remained largely unaffected in microglia and barrier-associated macrophages regardless of infection status. Analysis of intrinsic and induced interferon-stimulated gene expression revealed great heterogeneity across cell types but no direct correlation with cCMV susceptibility. Furthermore, our findings indicate that interferon type II is crucial for the control of cCMV and consequent cortical damage and calcification in the neonatal brain. This study advances our understanding of cCMV tropism and the molecular details of cCMV-induced neurodevelopmental impairment, cerebral immune response, and brain pathology.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/37e868bb50c4bf02ba4bc61b84aaec7d5968b07e" target='_blank'>
              Molecular features of congenital cytomegalovirus infection in neonatal mouse brain at single-cell resolution
              </a>
            </td>
          <td>
            Meng-Jie Mei, Yue-Peng Zhou, Yu-Ting Pan, Jin-yan Sun, , Tong Wu, M. McVoy, William J. Britt, Wen Zhou, Bo Yang, Xuan Jiang, Simon Rayner, Han Cheng, Min-Hua Luo
          </td>
          <td>2025-11-17</td>
          <td>Acta Neuropathologica Communications</td>
          <td>0</td>
          <td>34</td>
        </tr>

        <tr id="Aberrant and sustained activation of microglia is implicated in the progression and severity of multiple sclerosis (MS). However, whether intrinsic alterations in microglial function impact the pathogenesis of this disease remains unclear. We conducted transcriptomic and functional analyses of microglia-like cells (iMGLs) differentiated from induced pluripotent stem cells (iPSCs) from patients with MS (pwMS) to answer this question. We generated iPSCs from six pwMS showing increased microglial activity via translocator protein (TSPO)-PET imaging. We demonstrated that the differentiated iMGL transcriptional profile resembled the microglial signature found in MS lesions. Importantly, compared with healthy controls, MS iMGLs presented cell-autonomous differences in their regulation of inflammation, both in the basal state and following inflammatory lipopolysaccharide challenge. Through transcriptomic profiling, we showed that MS iMGLs display increased expression of genes known to be upregulated in MS microglia. Furthermore, upregulated genes in MS iMGLs were associated with immune receptor activation, antigen presentation, and the complement system, with known MS implications. Finally, functional analyses indicated that the transcriptional changes in MS iMGLs corresponded with alterations in the secretion of inflammatory cytokines and chemokines and increased phagocytosis. Together, our results provide evidence of putative cell-autonomous microglial activation in pwMS and identify transcriptomic and functional changes that recapitulate the phenotypes observed in vivo in microglia from pwMS. These findings indicate that MS disease-specific iPSCs are valuable tools for studying disease-specific microglial activation in vitro and highlight microglia as potential therapeutic targets in MS.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ce483627b1620ca8e2ea90bf499e8cad452ba523" target='_blank'>
              Microglia from patients with multiple sclerosis display a cell-autonomous immune activation state
              </a>
            </td>
          <td>
            Tanja Hyvärinen, J. Lotila, Luca Giudice, Iisa Tujula, M. Nylund, S. Ohtonen, Flavia Scoyni, Henna Jäntti, Sara Pihlava, H. Skottman, Susanna Narkilahti, L. Airas, T. Malm, S. Hagman
          </td>
          <td>2024-12-11</td>
          <td>Journal of Neuroinflammation</td>
          <td>2</td>
          <td>47</td>
        </tr>

        <tr id="Severe SARS-CoV-2 infection is characterized by lung hyperinflammation, impaired interferon responses, and defective T-cell activation, yet the molecular drivers of these immune dysregulations remain incompletely understood. Caspase-11 (CASP11), a key mediator of the non-canonical inflammasome, has been shown to mediate an innate hyperinflammatory response and cytokine release in a non-severe, non-lethal SARS-CoV-2 infection model. However, the role played by CASP11 in severe SARS-CoV-2 disease and how it impacts adaptive immunity is not identified. Here, we newly discover that CASP11 exacerbates severe SARS-CoV-2 pathogenesis by amplifying early innate immune responses while concurrently impairing antiviral CD8 T-cell immunity. Using global knockouts, reciprocal bone marrow chimeras, and phagocyte-monocyte system (PMS) cell-specific CASP11 deletion models, we show that CASP11 deletion in monocyte-derived cells reduces lung inflammation, enhances type I and II interferon signaling, and promotes robust virus-specific effector CD8⁺ T-cell response. This was associated with enhanced viral clearance and improved survival, even under lethal infection conditions. Importantly, CASP11 KO mice also exhibited faster resolution of post-viral inflammation, suggesting a role in long-term immune remodeling. These findings position CASP11 as a promising immunomodulatory target for acute and delayed manifestations of severe SARS-CoV-2.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fa0d09c722147bd759ef9cedc307b8c6a5fb7718" target='_blank'>
              Caspase-11 Mediated Hyperinflammation Impairs CD8⁺ T Cell Immunity and Viral Clearance in Severe SARS-CoV-2 Infection
              </a>
            </td>
          <td>
            Mostafa Eltobgy, Mohamed M. Shamseldin, Owen Whitham, Heba M Amer, Jeffery Atkinson, Asmaa Badr, Jesse Hall, Jihad Omran, Gauruv A. Gupta, Yara Hassan, Rabab Abdelaleem, Richard Perez, Sarah Faber, Maciej Pietrzak, Amy Webb, Xiaoli Zhang, A. Kenney, Destiny Bissel, Shady Z K Estfanous, Kylene P. Daily, Andrew Mcnamara, K. Mahesh, M. Peeples, Emily A. Hemann, Shahid M. Nimjee, E. Cormet-Boyaka, Jianrong Li, P. Boyaka, Jacob S. Yount, Benjamin M. Segal, Purnima Dubey, Amal O Amer
          </td>
          <td>2025-11-03</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>43</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/22393b9ffca1a3471e0c12f80fd5127144012755" target='_blank'>
              A Human Alveolus-on-Chip Recapitulates SARS-CoV-2-mediated Lung Injury in an Organ-relevant Context for Pre-clinical Applications
              </a>
            </td>
          <td>
            M. Kiener, Lea Lara De Maddalena, Nuria Roldan, P. Chouvardas, L. Froment, M. De Menna, Thomas Geiser, J. Stucki, Nina Hobi, Marianna Kruithof-de Julio
          </td>
          <td>2025-10-20</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>13</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e1f062d3d912692ad94fd023b7389eaa8ae74fd9" target='_blank'>
              Temporal Dynamics of Antigen-Specific T Cell Expansion in Primary SARS-CoV-2 Infection
              </a>
            </td>
          <td>
            Andrew Pyo, Adlina Chan, J. Rosenheim, Clare Thakker, Lucy Bell, Gayathrie Nageswaran, Suzanne Byrne, Ben Killingley, David Scobie, M. Kalinova, A. Boyers, A. Catchpole, Alex J. Mann, Rik G. H. Lindeboom, Marko Z. Nikolić, Sarah A. Teichmann, H. Wagstaffe, M. Noursadeghi, Christopher Chiu, Curtis G. Callan, Andreas Tiffeau-Mayer, N. Wingreen, Benjamin M. Chain
          </td>
          <td>2025-11-05</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>80</td>
        </tr>

        <tr id="Abstract After severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, a minority of patients experience persistent or emerging symptoms, termed ‘long coronavirus disease (COVID)’ or post-acute sequelae of COVID-19. The molecular causes of long COVID remain unclear, but disrupted immune functions, such as inflammation and immune deficit, have been posited as factors. In this retrospective cohort study, we measured markers of immune function in a group of patients with long COVID up to 40 months post infection. As proxies for immune function, we measured serum antibody levels, antibody neutralizing capability and production of IFN gamma (IFN-γ) and IL-2 against SARS-CoV-2 and other viral peptides. As expected, serum antibody levels increased over time with vaccinations and reinfections with later variants of SARS-CoV-2. Patients also showed corresponding increasing SARS-CoV-2-specific IL-2 responses and stable IFN-γ responses. We observed no significant differences in immune responses among patients with ongoing long COVID, those who had recovered from it or individuals who recovered from acute COVID-19. Overall, we found no indication of a reduction in these aspects of immune function after SARS-CoV-2 infection. This study provides a valuable foundation for further research aimed at understanding the causes of long COVID.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/dd9f2a9af816e4527bff007fe6bd487c949ce190" target='_blank'>
              Robust antibody and T cell responses tracked longitudinally in patients with long COVID
              </a>
            </td>
          <td>
            M. Metaxaki, Ranjana Ram, Marianne Perera, Mark Wills, Ben Krishna, N. Sithole
          </td>
          <td>2025-12-01</td>
          <td>The Journal of General Virology</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="Chronically inflamed, reactive microglia represent a prominent feature of secondary progressive multiple sclerosis (SPMS). Especially their interplay with encephalitogenic T cells promotes neuroaxonal damage associated with disease progression. In our study, we aimed to explore the potential of siponimod, a sphingosine-1-phosphate modulator approved for the treatment of active SPMS, to inhibit disease-associated T cell-microglia interactions using a chronic murine experimental autoimmune encephalomyelitis (EAE) model of MS. We found that therapeutic siponimod treatment of chronic EAE improved clinical severity accompanied by reduced demyelination and neuroaxonal damage, diminished CNS T cell infiltration and altered proinflammatory microglia responses. This effect was partly attributed to a direct effect on microglia, as siponimod pretreatment inhibited interferon-γ-elicited responses of primary mouse microglia in vitro and limited their ability to induce T cell activation and proliferation in T cell-microglia co-cultures. Additionally, we observed reduced peripheral T cell numbers in our EAE model, with a pronounced shift to immunosenescent and regulatory T cell subsets, a pattern which we similarly detected in a cohort of SPMS patients following siponimod treatment. These findings indicate that siponimod dampens compartmentalized CNS inflammation by disrupting detrimental interactions between T cells and microglia through a dual central and peripheral mechanism of action.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/83f2db773998fbd7481c31e492b0b69aae1f4480" target='_blank'>
              Siponimod inhibits disease-associated microglia-T cell interactions in chronic experimental autoimmune encephalomyelitis
              </a>
            </td>
          <td>
            Leila Husseini, Anastasia Geladaris, Marlene C. J. Steinleitner, Darius Häusler, Martin S. Weber
          </td>
          <td>2025-12-01</td>
          <td>Acta Neuropathologica Communications</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="Tuberculosis (TB), caused by Mycobacterium tuberculosis, remains a leading cause of global morbidity and mortality. Although gamma-delta (γδ) T cells have increasingly been suggested to contribute to the TB immune response, quantitative and qualitative differences in this immune cell compartment between healthy and TB diseased individuals are not well-characterized. In this study, we used single-cell RNA sequencing to provide a high-resolution characterization of CD4-CD8- γδ T cells in peripheral blood across healthy Mtb-non-sensitized, healthy Mtb-sensitized, and TB disease pre-/post-treatment cohorts. We found upregulation of an activated and cytotoxic gene signature in γδ T cells of TB disease compared to both healthy cohorts. Strikingly, these differences persisted through one year following diagnosis of TB disease (corresponding to six months after completion of anti-TB therapy). We found that these transcriptomic differences were largely mediated by an NK-like cytotoxic Vδ1 and Vδ3 subset that was enriched in TB disease, with a unique Vδ3 TCR gene usage. Our findings suggest long-lasting changes in the CD4-CD8- γδ T cell compartment and highlight Vδ3 cells, a previously underappreciated γδ T cell subset, as potentially important in TB.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/bfebb60d4d4f02fb39194b81fd4a071f887608f9" target='_blank'>
              Enrichment of a CD4 - CD8 - NK-like cytotoxic Vδ1/3 T cell subset in tuberculosis disease
              </a>
            </td>
          <td>
            Kendall Kearns, R. Tippalagama, Ashu Chawla, Jason A. Greenbaum, A. D. de Silva, Wathsala Gunasinghe, Judy Perera, Hansani Gunasekera, Darsha D Senevirathne, Thomas J. Scriba, Julie G. Burel, C. L. Lindestam Arlehamn, Bjoern Peters
          </td>
          <td>2025-11-13</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>37</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c559472c33293babdbbd5dda4f528462a56a71a7" target='_blank'>
              Meningeal γδ T cells facilitate bacterial entry into the brain in neonatal meningitis and trigger long-term behavioural sequelae
              </a>
            </td>
          <td>
            Inês Lorga, Joana Soares, Joana Bravo, Pedro Mesquita, Nuno Ribeiro, João Rodrigues, Ahmed Hassan, Morgana Mesquita, Bruno Cavadas, Hristo Georgiev, Ana Magalhães, T. Summavielle, Manuel Vilanova, J. Ribot, Elva Bonifácio Andrade
          </td>
          <td>2025-11-09</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>26</td>
        </tr>

        <tr id="Intracerebral hemorrhage (ICH) is a severe neurological disease with limited treatment options. Microglia, the primary immune cells of the brain, contribute significantly to secondary injury following ICH, exhibiting heterogeneity in response across different stages of ICH. However, the exact mechanisms regulating this process remain incompletely elucidated. In this study, we utilized single-nucleus RNA sequencing (snRNA-seq) in conjunction with the ICH model of mice to establish a comprehensive single-nucleus transcriptomic atlas for ICH and further elucidate its pathogenesis to identify potential therapeutic targets. We identified five principal brain clusters with cell-type specific gene expression patterns. Focused on microglia and inflammation-associated subgroup, we identified 8 distinct microglia subtypes and the key transcription factors (TFs) involved in the inflammatory response of microglia following ICH, including Stat2, Stat1, Irf7, Nfkb1, Etv6, Cebpb, Batf, and Bach1. Notably, Stat2 and Stat1 were identified as the most central TFs. In vitro experiments revealed that inhibiting Stat2 and Stat1 can attenuate the inflammatory response in microglia after ICH. Overall, our findings enhance the understanding of cell responses in ICH and highlight potential therapeutic targets, specifically suggesting that inhibiting STAT1 and STAT2 could mitigate microglial-mediated inflammation in ICH.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3656b9b2cf60fce5d6a414f852d3b6e8b7436a9c" target='_blank'>
              snRNA-seq reveals key transcription factors in the inflammatory response of microglia after intracerebral hemorrhage
              </a>
            </td>
          <td>
            Zhuojin Wu, Danyang Chen, Shiling Chen, Ge Zhang, Xuan Wu, Kai Shu, Chao Pan, Zhouping Tang
          </td>
          <td>2025-11-20</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="Traumatic brain injury (TBI) remains a leading cause of chronic neurological impairment, yet the cellular mechanisms underlying long-term neurodegeneration in TBI remain incompletely understood. Astrocytes, the most abundant glial cell type, are central to maintaining neuroglial and neurovascular homeostasis. Following TBI, however, astrocytic activation contributes to sustained inflammation and neurotoxicity. In this study, we employed immunohistochemistry and RNA sequencing to longitudinally profile astrocyte morphology and transcriptional states at acute (2 days), subacute (2 weeks), and chronic (1 year) stages after controlled cortical impact in mice. We identified a temporally evolving astrocyte response—beginning with a pro-inflammatory profile acutely, transitioning through a profile suggestive of mixed inflammatory and neurodegenerative signatures subacutely, and culminating in a chronic state marked generally by expression of Alzheimer’s and Parkinson’s disease-associated genes. Notably, a subset of astrocyte-derived progenitor cells also was found up to one-year post-injury, expressing markers associated with neurogenesis. These findings reveal that astrocyte activation is not transient but persists chronically, undergoing a dynamic shift from inflammation to degeneration. The observed parallels between astrocyte states in chronic TBI and neurodegenerative disorders underscore their potential role in post-traumatic cognitive decline and highlight astrocyte-targeted interventions as a promising avenue for therapeutic development. Transcriptomic analysis of astrocytes in the acute, subacute, and chronic phases after traumatic brain injury reveal an evolving dynamic shift from neuroinflammation to neurodegeneration, and to a limited extent, regeneration.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0c70e1566bf8218bb883f7cd7c00852baff7513e" target='_blank'>
              Astrocyte activation persists one year after TBI: a dynamic shift from inflammation to neurodegeneration
              </a>
            </td>
          <td>
            Hadi Abou-El-Hassan, Taha Yahya, Benjamin E. Zusman, Omar Albastaki, Harm T. Imkamp, Jessica J. Ye, Francesca Percopo, Jonathan R Christenson, Maryam H. Al Mansi, , Galina Gabriely, Bruna K. Tatematsu, K. Habashy, Juliana R Lopes, A. Maghzi, R. M. Rezende, F. Quintana, Howard L. Weiner, Saef Izzy
          </td>
          <td>2025-12-01</td>
          <td>Communications Biology</td>
          <td>0</td>
          <td>29</td>
        </tr>

        <tr id="Multiple sclerosis (MS) is a progressive, chronic, and highly disabling neuroinflammatory disorder characterized by demyelination and T cell–driven inflammation. Pathogenic T cells play a central role in MS, but effective therapeutic targeting remains challenging. Here, we identified ankyrin repeat domain–containing protein 55 (ANKRD55) as a key regulator of T cell function by single-cell transcriptomic analysis of cerebrospinal fluid and blood from MS patients. ANKRD55 was predominantly expressed in CD4+ T cells in both compartments. Genetic ablation of Ankrd55 led to a robustly reduced disease severity and neuroinflammation in experimental autoimmune encephalomyelitis (EAE), a widely used animal model for MS. Furthermore, T cell–specific deficiency of Ankrd55 significantly impaired Th1 polarization and Th17 differentiation, reducing EAE pathogenicity. Mechanistically, we found that Ankrd55 deficiency disrupted T cell receptor (TCR) signaling integrity. We demonstrated that ANKRD55 regulates the formation of the immune synapse, an essential prerequisite for TCR activation, by interacting with subunits of the chaperonin-containing TCP1 (CCT) complex and modulating its activity, enhancing its assembly by competing with CCT5 for binding to TCP1, CCT3, and CCT6. This facilitates proper microtubule organization and TCR activation. These findings establish ANKRD55 as a critical regulator of TCR signaling and highlight its therapeutic potential in pathogenic T cell–driven autoimmune diseases.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/865b26367cf4f5ce2ee12fb7cd224a9d528add57" target='_blank'>
              ANKRD55 is a key regulator of T cell inflammation in multiple sclerosis
              </a>
            </td>
          <td>
            Chuyu Wu, Mei-Ling Jiang, Xue Yang, Yixuan Liu, Bin Huang, Yi Guo, Runjing Cao, Zhihui Cui, Guozhen Deng, Weiyan Wang, Mengdi Guo, Zhiyong Lin, Jiahui Fan, Lin-ming Zhang, L. di Cesare Mannelli, Tao Pang, Chenhui Wang, Cun-Jin Zhang
          </td>
          <td>2025-10-15</td>
          <td>The Journal of Clinical Investigation</td>
          <td>0</td>
          <td>46</td>
        </tr>

        <tr id="Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has caused a global health crisis, marked by high transmissibility and virulence. Despite widespread vaccination efforts, effective treatments for COVID-19, particularly for severe cases leading to Acute Respiratory Distress Syndrome (ARDS), remain limited. This study investigates the efficacy of KVX-053, a protein tyrosine phosphatase type IVA (PTP4A3) small molecule inhibitor, in modulating SARS-CoV-2-induced inflammation and lung injury using in vitro cell models and in vivo K18-hACE2 transgenic mice. KVX-053 reduced in vitro pro-inflammatory cytokine expression, including TNFα, CXCL10, and CXCL11, without impacting viral replication or cell viability. K18-hACE2 mice treated with KVX-053 demonstrated marked improvement in clinical scores and reduced histological evidence of lung injury compared to untreated SARS-CoV-2-infected controls. KVX-053 mitigated the activation of key inflammatory mediators in the lung, including NLRP3 inflammasomes, IL-6, and phosphorylated STAT3, effectively curbing the “cytokine storm” associated with severe COVID-19. Importantly, treatment preserved lung parenchymal integrity, reduced edema, and minimized macrophage infiltration. Our findings highlight PTP4A3 as a potential critical regulator of the inflammatory response during SARS-CoV-2 infection. KVX-053, a potent and selective PTP4A3 inhibitor, emerges as a promising host-directed therapeutic strategy for mitigating ARDS and inflammation-driven lung injury in SARS-CoV-2 and potentially other respiratory viral infections. Future studies are required to optimize dosing strategies, elucidate precise molecular mechanisms, and validate these findings in clinical settings.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/20ae8d61209d49d0e74feaa9c96947aababae586" target='_blank'>
              The PTP4A3 inhibitor KVX-053 reduces Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virulence, inflammation, and development of acute lung injury in K18-hACE2 mice
              </a>
            </td>
          <td>
            Ruben M. L. Colunga-Biancatelli, P. Solopov, Caitlin M Woodson, I. Allen, I. Akhrymuk, Maryna Akhrymuk, Brittany N. Heath, Hannah M. Ivester, T. Day, Dan E. Austin, K. Kehn-Hall, John S. Lazo, E. Sharlow, J. Catravas
          </td>
          <td>2025-10-28</td>
          <td>Respiratory Research</td>
          <td>0</td>
          <td>35</td>
        </tr>

        <tr id="Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections worldwide, particularly affecting infants, older adults, and immunocompromised individuals. Understanding the cellular immune response to RSV infection is essential for developing effective treatments for infection and its complications. In this study, we investigated the susceptibility of blood-derived primary monocytes and monocytic THP-1 cells to infection with a contemporary RSV A-ON1 strain and characterized the subsequent cytokine and chemokine secretion, as well as the expression of surface markers involved in antigen presentation. Our findings demonstrate that primary monocytes and related THP-1 cells are permissive to abortive infection by RSV, leading to increased expression of proinflammatory cytokines and chemokines, including IP-10, IL-6, and CCL2. Furthermore, primary monocytes expressed CD80, CD86, and HLA-DR upon direct infection or through potential paracrine stimulation. Collectively, these findings demonstrate the activation of monocytes by RSV infection, suggesting their contributory role in orchestrating early immune responses during infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e0a13235925d18993e167d01b4f6d405002e8701" target='_blank'>
              A contemporary strain of RSV activates primary human monocytes after abortive infection
              </a>
            </td>
          <td>
            Ayse Agac, M. Ludlow, Marie-Christin Knittler, C. K. Prajeeth, G. Saletti, A. Osterhaus, Robert Meineke, G. Rimmelzwaan
          </td>
          <td>2025-11-07</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>96</td>
        </tr>

        <tr id="Chronic activation of innate immune responses in the brain is increasingly recognized as a contributor to neurodegenerative diseases, including Alzheimer's disease (AD). AD remains a major global health challenge due to the inefficacy of current therapies to modify disease progression. In AD, hyperactivated microglia, the brain’s resident macrophages, play a central role by responding to amyloid-beta peptides (Aβ) through activation of the NLRP3 inflammasome, a key innate immune sensor and a promising therapeutic target. Leishmania infantum, a protozoan parasite causing visceral leishmaniasis, is known to employ sophisticated mechanisms to subvert inflammatory responses in macrophages, including modulation of the NLRP3 inflammasome, thus representing a potential natural model for counteracting microglia-related inflammation. However, microglia-Leishmania interactions remain unexplored, particularly the parasite’s ability to modulate microglial NLRP3 activation. Here, we demonstrate that L. infantum invades and persists in microglia without inducing cell activation, indicating an immunologically silent entry. Aβ-stimulated NLRP3 activation was suppressed by Leishmania infection, as evidenced by a significant reduction in key pro-inflammatory mediators, including IL-1β, IL-18, TNF-α, and neurotoxic nitric oxide. Mechanistically, L. infantum disrupted NLRP3 priming by interfering with NF-κB signaling and upregulating the negative regulator A20. Additionally, L. infantum limited ASC speck formation, caspase-1 activation and ROS production while preserving lysosomal integrity. These findings reveal, for the first time, an unrecognized inhibitory effect of L. infantum on the microglial NLRP3/NF-κB axis and provide mechanistic insights into the parasite’s immune subversion in Aβ-activated microglia. Deciphering the molecular pathways exploited by L. infantum and the specific parasitic effectors involved could offer novel therapeutic targets and bioinspired strategies to mitigate microglial inflammatory responses in the context of AD.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5d4274589a2e9af8d7c8bc822e827f06747927ea" target='_blank'>
              Immune subversion by Leishmania infantum parasites suppresses NLRP3-driven inflammatory responses in amyloid-β-activated microglia
              </a>
            </td>
          <td>
            Estefanía Calvo Alvarez, Chiara Sfogliarini, F. La Rosa, M. Saresella, M. Dolci, Elisabetta Vegeto, D. Taramelli, N. Basilico, Mario Clerici
          </td>
          <td>2025-10-29</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>46</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/69df5fd6672a630864c6251428da30e869ad36a2" target='_blank'>
              Neuronal activity promotes repair by microglial reprogramming following demyelination
              </a>
            </td>
          <td>
            C. Perrot, R. Ronzano, Z. Li, M.S. Aigrot, V. Pantazou, P. Stheneur, FX Lejeune, B. Zalc, F. Quintana, B. Stankoff, C. Lubetzki, A. Desmazières
          </td>
          <td>2025-12-02</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="


 Caspase 11 is a critical component of the noncanonical inflammasome with multifaceted roles in the innate immune response, contributing to host defense against pathogens. We demonstrated that Casp11 deletion improved disease outcomes in SARS-CoV-2 infection by modulating the innate inflammatory response. However, its role in shaping adaptive immune responses after SARS-CoV-2 infection remains unclear. We found that Casp11-/- MA10 infected mice exhibited higher numbers of activated lung resident memory T cells at Day 7 post-infection compared to wild-type (WT) controls, independent of lung viral load. Ex vivo stimulation of lung-resident T cells with SARS-CoV-2 peptides and tetramer staining revealed that T cells from Casp11-/- mice retained their activation status, antigen specificity, and phenotype. This suggests that Casp11 deletion promotes the expansion and activation of lung resident T cells without impairing their functionality. Using Casp11-/- bone marrow chimera and Casp11-/- Cre-flox mouse models, we identified that the enhanced adaptive immune response was mediated by Casp11 in peripheral immune cells, particularly myeloid cells. These findings indicate that Casp11 deletion leads to a more robust lung-resident adaptive immune response by modulating the early innate immune response. This enhanced adaptive immunity contributed to more effective viral clearance, improved infection control, and reduced progression to severe disease in a P30 severe infection model.



 NIH 1P01AI175399-01A1 NIH 5R01HL168501-02



 Viral Immunology (VIR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f4123fdbf56086c0c4d68d79c27fddbd6c198d90" target='_blank'>
              Caspase11 modulates the adaptive immune response in SARS-CoV-2 infection through innate immune regulation 4503
              </a>
            </td>
          <td>
            Mostafa Eltobgy, Benjamin Segal, Eugene M. Oltz, Jacob Yount, Shahid M. Nimjee, Purnima Dubey, Amal O Amer
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="The COVID-19 pandemic, caused by SARS-CoV-2, represents one of the most profound global public health challenges in modern history. While T cell immunity is crucial for viral clearance, the dynamics of the T cell receptor (TCR) repertoire during reinfection remain poorly understood. This study sought to characterize the TCR repertoire in peripheral blood T cells from healthy convalescent individuals (HC), patients with primary SARS-CoV-2 infection (PI), and reinfected individuals (RI), aiming to identify distinct TCR signatures linked to susceptibility or protection against reinfection. We enrolled 48 age- and sex-matched participants (18 PI, 18 RI, 12 HC), collecting blood samples during acute infection (PI/RI) or convalescence (HC). Deep TCRα/β sequencing was performed using the SMARTer Human TCR Profiling Kit with unique molecular identifiers (UMIs), followed by analysis of TCR repertoire diversity, clonal expansion, V(D)J gene usage, and CDR3 characteristics. Compared to HC, both PI and RI groups exhibited significantly reduced TCR diversity (p< 0.001), though no significant differences were observed between PI and RI. COVID-19 patients displayed skewed TCR repertoires dominated by expanded clones (>1%), whereas HC primarily harbored small clones (≤ 0.1%). RI patients demonstrated intermediate clonality, suggesting partial memory recall. Group-specific V(D)J pairings were identified, including TRAV27/TRAJ42 in RI, TRAV24/TRAJ42 in PI, and TRAV35/TRAJ42 in HC, while TRBV6-4/TRBD2/TRBJ2–3 was conserved across all groups. Additionally, HC-enriched and RI-exclusive CDR3 clusters were detected. Our findings indicate that SARS-CoV-2 reinfection is associated with impaired TCR diversity and distinct clonal expansion patterns, underscoring the role of T cell immunity in reinfection susceptibility. HC-enriched TCR clusters may represent protective memory responses, whereas RI-specific signatures suggest compromised immunity. These results offer valuable insights for vaccine design and risk stratification, though further functional validation of the identified TCRs is necessary.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2d977242eab98e457279671a381065b9ee003f60" target='_blank'>
              Distinct characteristics of T cell receptor repertoire associated with the SARS-CoV-2 reinfection
              </a>
            </td>
          <td>
            Li Zeng, Li Liu, Baolin Ren, Bing Feng, Xudong Lai, Xunxi Lai, Zhimin Chen, Yihui Huang, Wenxin Hong
          </td>
          <td>2025-10-23</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="COVID-19 causes a wide range of complications in the central nervous system, including encephalitis and other neurological symptoms such as memory problems, psychological disorders, depression, and anxiety. We present comprehensive data on the changes in gene expression levels in astrocytes infected with the Delta or Omicron variants of SARS-CoV-2. In RNA-seq data, we found 346 genes that were significantly evoked (197 up- and 149 down-regulated) in astrocytes challenged with the Omicron variant, compared to 341 evoked genes (215 up- and 126 down-regulated) in the Delta variant. A surprisingly large number of genes were exclusively evoked by Delta (82 up- and 48 downregulated) and Omicron variants (65 up and 60 downregulated). Numerous pathways, including those pertaining to the neuronal system, metabolism, response to viral infection, signal transduction, cytokine signaling, and homeostasis, were dysregulated in infected astrocytes. In this report we have dissected major pathways that are related to pathogen recognition, integrity of the BBB and glia limitans, and neurological disorders that could lead to neurological symptoms listed above. Our findings also reveal dysregulation of a large number of non-coding RNAs. The data presented here may help us better understand the role of astrocytes in the neurological disorders seen in COVID-19 patients.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c339992734ddc6d228d9b0178084b42909087023" target='_blank'>
              Comprehensive mapping of the signaling events evoked by SARS-CoV-2 variants delta and omicron in human astrocytes
              </a>
            </td>
          <td>
            K. Bhide, M. Sláviková, Lea Talpašová, Katarína Kucková, Boris Klempa, Punit Tyagi, Mangesh Bhide
          </td>
          <td>2025-10-22</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="Influenza A virus (IAV) infection is a significant cause of morbidity and mortality for patients worldwide. Alveolar type 2 (AT2) cells are the preferential target of IAV as part of the pathogenesis of viral pneumonia and acute respiratory distress syndrome (ARDS). Early IAV infection of alveolar cells has been challenging to model both in vitro and in vivo. To address this challenge, we used a combination of murine and human primary alveolar organoids to define methods for robust IAV infection and evaluated cell-autonomous consequences of IAV using a temporal series of multiome paired single nuclei RNA/ATAC sequencing. Infected AT2 cells undergo conserved changes defined by early loss of surfactant secretion, decreased lipid biogenesis, a rapid burst of antiviral response, and late viral-mediated suppression. Surprisingly, uninfected AT2 cells undergo substantial transcriptional and epigenomic changes in IAV-treated cultures, leading to transition to damage-associated cell states within hours via a process driven by the inflammatory milieu of murine organoids. Together, these data provide new methods for high-fidelity modeling of IAV infection in alveolar cells and define a conserved AT2 cell response signature to IAV with implications for ARDS pathogenesis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b1d0d64915e039a05df492a9420be5b6930184b1" target='_blank'>
              Early cell autonomous and niche-mediated alveolar epithelial response to influenza infection in primary lung organoids
              </a>
            </td>
          <td>
            Amber Elitz, Sharlene Fernandes, K. Cook, H. Warheit-Niemi, Barbara Zhao, Andrea Toth, Amanda L. Zacharias, William J. Zacharias
          </td>
          <td>2025-10-25</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="


 The reasons for varied SARS-CoV-2 transmission risk among infected individuals remain unclear. In this study, we identify cellular immune signatures associated with the speed of viral clearance in individuals with acute SARS-CoV-2 infection. We utilized mass cytometry (CyTOF) on peripheral blood mononuclear cells (PBMCs) from 34 vaccinated and unvaccinated individuals sampled during acute SARS-CoV-2 infection (4-6 days post-symptom onset), with uninfected controls for comparison (n = 5). Amongst unvaccinated participants, greater activation of non-naïve CD8+ T cells, plasmablasts, Th1 CD4+ T cells, and γδ T cells correlated significantly with faster viral clearance (Spearman’s p_adj < 0.05). In addition, coordinated activation between 297 pairs of innate and/or adaptive immune cell features was observed uniquely in infected and not in uninfected individuals (Spearman’s p_adj < 0.05, r > |0.65|). Finally, vaccinated individuals had a cellular immune signature during acute SARS-CoV-2 infection that was similar to uninfected participants, and showed significantly less immune activation across broad cell types (T/B/NK cells and monocytes) compared to unvaccinated individuals with similar duration of viral shedding (p_adj < 0.05, Kruskal-Wallis test). Our findings provide crucial insight into early immune signatures associated with the speed of clearance of infectious SARS-CoV-2 and could inform future vaccine strategies and therapeutic approaches to reduce transmission.



 Supported by the Centers for Disease Control and Prevention Broad Agency Announcement (contract 75D30120C08009)



 Viral Immunology (VIR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/90fd04a5d1a5966484b843aab431d168630f313d" target='_blank'>
              Cellular immune signatures associated with fast versus slow clearance of infectious SARS-CoV-2 4227
              </a>
            </td>
          <td>
            L. Zemelko, Rafael Tibúrcio, Yen Y. Wang, Christian M. Constantz, G. Borgo, M. Spitzer, K. Anglin, Jeffrey N. Martin, M. Peluso, J. Kelly, A. Deitchman, R. Rutishauser
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>23</td>
        </tr>

        <tr id="Sterile alpha motif and HD domain-containing protein 1 (SAMHD1) restricts a board spectrum of viruses through multifaceted mechanisms. It also limits spontaneous- and virus-induced innate immune responses by suppressing proinflammatory cytokine and type-I interferon (IFN-I) production. Some viruses escape SAMHD1 restriction by utilizing SAMHD1-mediated innate immune suppression to establish effective infection through viral antagonism. Our previous studies showed that SAMHD1 is a proviral factor facilitating replication of severe acute respiratory syndrome coronavirus (SARS-CoV-2) in human macrophages, monocytic THP-1 and epithelial-like HEK293T cell lines by suppressing IFN responses. However, it is unclear about the function of SAMHD1 in lung epithelial cells during SARS-CoV-2 infection. Here, we report that SAMHD1 facilitates SARS-CoV-2 replication in lung epithelial Calu-3 cells by enhancing endogenous expression of the viral receptor angiotensin-converting enzyme 2 (ACE2) via hepatocyte nuclear factor 1-alpha (HNF1α) and HNF1β. Using pseudotyped SARS-CoV-2 and lentiviral vectors, we found that SARS-CoV-2 spike protein-mediated viral entry was suppressed in Calu-3 cells with SAMHD1 knockout (KO). SAMHD1 KO repressed ACE2 expression in Calu-3 cells at mRNA and protein levels. Functional analyses revealed that HNF1α and HNF1β were crucial for the endogenous ACE2 expression in Calu-3 cells. Additionally, SAMHD1 KO led to a reduction in the expression levels and ACE2-promoting function of HNF1α and HNF1β. Inhibition of IFN antiviral response by baricitinib, a Janus kinase 1 and 2 (JAK 1/2) inhibitor, did not revert the suppression of SARS-CoV-2 in SAMHD1 KO Calu-3 cells. Our findings demonstrate that SAMHD1 facilitates HNF1-mediated ACE2 expression and SARS-CoV-2 replication in Calu-3 cells via a novel mechanism beyond its IFN-suppressive function. Author Summary During viral infection, SAMHD1 acts as a viral restriction factor and a suppressor of the innate immune system, controlling viral replication while also ensuring immune homeostasis. The innate immune suppressive function of SAMHD1 can be proviral for some viruses. SAMHD1 has been shown to facilitate SARS-CoV-2 infection in human macrophages, THP-1 and HEK293T cell lines by promoting IFN antagonism, but its role in lung epithelial cells is unclear. Here, we demonstrated that SAMHD1 promotes SARS-CoV-2 replication in human lung epithelial Calu-3 cells by enhancing expression of the major viral receptor ACE2. We found that SAMHD1 facilitated HNF1-medaited ACE2 expression that was required for spike protein-mediated SARS-CoV-2 entry. However, inhibiting IFN signaling in SAMHD1 KO Calu-3 cells was not sufficient to revert SARS-CoV-2 replication. Our findings shed light on the differential proviral function of SAMHD1 in ACE2 expressing cells and suggest that SAMHD1 can facilitate SARS-CoV-2 infection beyond enhancing IFN antagonism.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1adb144859e1add4bf4fcfba4fbb11e22fcf1d31" target='_blank'>
              SAMHD1 promotes SARS-CoV-2 infection by enhancing HNF1-dependent ACE2 expression in lung epithelial cells
              </a>
            </td>
          <td>
            Pak-Hin Hinson Cheung, Pearl Chan, Hua Yang, Shravya Honne, Baek Kim, Stanley Perlman, Li Wu
          </td>
          <td>2025-10-26</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="Background COVID-19, including its post-acute sequelae (Long COVID), is increasingly recognized as involving persistent immune dysregulation and chronic inflammation. Severe and prolonged disease states are often accompanied by sustained cytokine release, immune cell exhaustion, and ongoing cell-cell communication that shapes the inflammatory milieu. Among immune subsets, CD8+ T cells play a central role in antiviral defense, yet the molecular mechanisms linking their dysfunction to prolonged inflammation remain incompletely understood. Methods We analyzed 73,110 peripheral blood mononuclear cells (PBMCs) from individuals across four disease states (Healthy, Exposed, Infected, and Hospitalized) using single-cell RNA sequencing. Immune cell subsets were annotated, and T cell heterogeneity was profiled. Cytokine and inflammatory scores were calculated to assess immune activation. Differentially expressed genes (DEGs) underwent Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis. Cell-cell communication was evaluated to map ligand-receptor networks. Additionally, nine machine learning models were trained on a bulk RNA-seq cohort, and the SHapley Additive exPlanations (SHAP) framework was applied to interpret key predictive genes. Results Progressive disease severity was associated with a decline in T cell proportions, enrichment of pro-inflammatory myeloid cells, and elevated cytokine expression, particularly IL-32. Memory CD8+ T cells showed increased exhaustion and inflammatory scores while maintaining a central position in MHC-I-mediated communication networks. Persistent activation of immune and metabolic pathways, including antigen presentation and oxidative phosphorylation, was observed in prolonged disease states. Seven genes (RPS26, RPS29, RPL36, RPL39, RPS28, RPS21, and CD3E) were identified as strong predictors of chronic immune dysregulation, with the XGBoost model achieving the highest AUC. SHAP analysis confirmed their contributions to disease classification. Conclusion This study maps the immune landscape of COVID-19 and Long COVID at single-cell resolution, revealing that persistent immune cell communication, particularly involving memory CD8+ T cells, may sustain chronic inflammation beyond the acute phase. The identified molecular signatures offer potential biomarkers and therapeutic targets for mitigating post-viral inflammatory syndromes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/536000d345ef1e6f7663efc28145b0e979e70e7b" target='_blank'>
              Immune cell communication networks and memory CD8+ T cell signatures sustaining chronic inflammation in COVID-19 and Long COVID
              </a>
            </td>
          <td>
            Hengrui Liu, Zewen Xu, Ilayda Karsidag, Panpan Wang, Jieling Weng
          </td>
          <td>2025-10-22</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="Human NK cells exhibit functional heterogeneity, yet the clinical conditions and cellular processes driving this diversity remain insufficiently understood. Here, we report that NK cell diversity emerges during peripheral development, influenced by the divergence of adaptive NK cells from various stages of canonical NK cell maturation during the resolution phase of severe COVID-19. Using scRNA-seq, we analyzed blood NK cells from patients with severe COVID-19 (acute phase and post-intensive care), individuals vaccinated with the SARS-CoV-2 mRNA vaccine (BNT162b2), and healthy donors. The frequencies of immature CD56bright and proliferating NK cells increased following BNT162b2 vaccination. In contrast, the frequency of adaptive CD56dim cells was markedly elevated in patients recovering from severe COVID-19, alongside clonal expansion and enhanced mitochondrial oxidative phosphorylation. Trajectory analysis revealed a bifurcation in peripheral NK cell development, with CD56bright cells diverging into canonical and adaptive CD56dim subsets during the course of severe COVID-19. Notably, adaptive NK differentiation exhibited transcriptional and signaling profiles analogous to those of T-cell activation. Thus, NK cell diversity is shaped by the induction of an intrinsic adaptive program. These findings uncover the mechanisms underlying NK cell heterogeneity and have implications for medical applications, including the development of immunotherapies that leverage adaptive NK cell functions.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1a0a71ca475b9bbf9d2f431483da1cc2babd0b42" target='_blank'>
              Mapping NK cell diversity in response to COVID-19 and mRNA vaccination
              </a>
            </td>
          <td>
            Yosuke Kishi, Yu-chen Liu, Masakazu Ishikawa, Maika Yamashita, Hisatake Matsumoto, Hiroshi Ogura, Shuhei Sakakibara, Daisuke Okuzaki
          </td>
          <td>2025-10-28</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="SARS-CoV-2 infection is associated with long-lasting neuropsychiatric and cognitive symptoms, collectively referred to as neuro-PASC. Emerging studies indicates that accelerate brain aging and cellular senescence in COVID brain could lead to altered neuroimmune responses and neurodegenerative outcomes. However, little is known about how cellular senescence is development in neuro-PASC. Here, we examined the role of spike protein subunit S1, a persistent viral antigen, in driving the development of cellular senescence in primary human astrocytes. We have demonstrated that S1 enters endolysosomes and induces endolysosome dysfunction and cellular senescence. Moreover, the multibasic motif is critical for such S1-induced damaging effects. Importantly, we identified Toll-like receptor 7 (TLR7), an endolysosome-resident pattern recognition receptor, as a critical mediator of S1-induced damaging effects. Mechanistically, S1 interacts with TLR7 at the site of the endolysosome lumen and activates p38 MAPK signaling of downstream of TLR7, which drive the development of cellular senescence. Together, these findings suggest that TLR7 mediates S1-induced endolysosome dysfunction and cellular senescence, and that TLR7 represents a therapeutic target for mitigating neuro-PASC.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8ee07e08edc89cce8e4214928941b26b2316b896" target='_blank'>
              SARS-CoV-2 spike triggers TLR7-dependent endolysosome dysfunction and senescence in human astrocytes
              </a>
            </td>
          <td>
            Wendie A. Hasler, Emily McKay, Gaurav Datta, Samantha Johnson, Neda Rezagholizadeh, Xuesong Chen
          </td>
          <td>2025-10-31</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="Significance SARS-CoV-2 infection of the respiratory tract continues to be a health risk even among immunized individuals suggesting that localized factors could maintain viral infection and transmission. Here, we show that although the locally produced innate immune-surveillance molecule collectin-11 (CL-11) is bound by SARS-CoV-2 to trigger complement activation, the virus is resistant to complement lysis offering a means of immune escape. Moreover, we reveal CL-11 binding enhances SARS-CoV-2 infectivity of respiratory epithelial cells (RECs) by a complement-independent mechanism affording highly transmissible variants of SARS-CoV-2 a survival advantage. Additionally, SARS-CoV-2-infected RECs are vulnerable to membrane injury by self-generated CL-11 and complement. These insights provide a strong rationale for CL-11 blockade to reduce SARS-CoV-2 infection and injury of the respiratory tract.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/770c499cd02634b3a9ade6f8f24779629ad4fcd0" target='_blank'>
              Glycan recognition by collectin-11 drives SARS-CoV-2 infectivity and membrane injury of respiratory epithelial cells
              </a>
            </td>
          <td>
            Anastasia Polycarpou, Tara Wagner-Gamble, Roseanna Greenlaw, Lauren O'Neill, Varsha Kanabar, Alanoud Alrehaili, Yusun Jeon, Jonathan Baker, Mona Bafadhel, H. Khan, M. Malim, Marco Romano, C. Farrar, Dorota Smolarek, R. Martinez-Nunez, K. Doores, Russell Wallis, Linda S. Klavinskis, Steven H Sacks
          </td>
          <td>2025-10-24</td>
          <td>Proceedings of the National Academy of Sciences of the United States of America</td>
          <td>0</td>
          <td>91</td>
        </tr>

        <tr id="Pediatric acute-onset neuropsychiatric syndrome (PANS) is characterized by the sudden onset of obsessive-compulsive symptoms alongside a constellation of neuropsychiatric and somatic features. Disease progression typically includes flare and recovery states, with some patients exhibiting a persistent disease course (> 12 months of flare). We characterized circulating monocyte subsets during flare and recovery in pediatric patients with PANS, uncovering disease-state–dependent shifts in polarization and trafficking phenotypes. Inflammatory M1-like monocytes and monocyte-derived dendritic cells were elevated during flare, while anti-inflammatory M2-like monocytes were enriched in recovery. We also identified a circulating subset with a surface phenotype consistent with central nervous system (CNS) homing, which was reduced during flare and restored in recovery. These cells were detectable in the cerebrospinal fluid (CSF) of new-onset patients but not in persistent cases, suggesting differential compartmentalization during disease progression. Notably, monocyte phenotypes, including M2 polarization (monocytosis) and circulating CNS-homing profiles, exhibited striking sex-associated differences, particularly during recovery, with several subsets enriched in males but not females. Plasma from flare-phase patients modestly induced CNS-homing markers in monocytes from healthy donors, indicating the presence of circulating modulators. Together, these findings support a model in which distinct myeloid phenotypes—including sex-biased patterns—may contribute to both the pathogenesis and resolution of neuroinflammation in PANS.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ab805830c315ccc3f7c69d468623a69aa039f03c" target='_blank'>
              Sex-associated and disease state-dependent monocyte polarization and CNS-trafficking phenotypes in pediatric acute-onset neuropsychiatric syndrome (PANS)
              </a>
            </td>
          <td>
            Shamma S. Rahman, Noor Hussein, Silvia Giulia Galfrè, Fabian Gaertner, Claudia Macaubas, Avis L. Chan, Laurie Columbo, Jaynelle Gao, Samira Galehdari, Batuhan Bayram, Meiqian Ma, C. Manko, Kate Miles, B. Farhadian, M. Silverman, M. Thienemann, Noga Or-Geva, Keith Van Haren, Kari C. Nadeau, Lu Tian, Jennifer Frankovich, Elizabeth D. Mellins
          </td>
          <td>2025-11-18</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>19</td>
        </tr>

        <tr id="Neurocognitive symptoms have emerged as notable sequelae of SARS-CoV-2 infection (COVID-19). Although primarily a respiratory virus, SARS-CoV-2 has been associated with central nervous system (CNS) changes observed in both clinical and experimental settings. To better understand these effects and their pathological mechanisms, we conducted a systematic literature search of published studies and employed a qualitative, analytical approach to identify and synthesize key findings from peer-reviewed studies, including large-scale retrospective clinical cohorts, human autopsy reports, animal models (murine, non-human primate), and in vitro brain organoid systems. While viral components were detected in post mortem central nervous system tissues, COVID-19 neuropathology appears to stem primarily from immune-mediated inflammation and vascular injury rather than direct CNS infection. Persistent glial activation and BBB disruption may underlie the long-term neurological symptoms reported in long COVID-19. Although animal models offer mechanistic insight, species-specific differences necessitate cautious extrapolation to human pathology. Further investigation into the chronic effects of SARS-CoV-2 on the brain is essential to guide long-term clinical management and therapeutic development.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/80dbd9c5ebe55dfb43d42e081dfaadab6e430c79" target='_blank'>
              Neurological Manifestations of SARS-CoV-2
              </a>
            </td>
          <td>
            Jasmine Miftahof, Blake Bernauer, Chen Sabrina Tan
          </td>
          <td>2025-10-28</td>
          <td>Viruses</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="Subjects with Long COVID, also known as post-acute sequelae of SARS-CoV-2 infection (PASC), experience a wide range of symptoms, including fatigue and respiratory disturbances, affecting their quality of life. Despite the increasing prevalence of Long COVID, the underlying pathogenic mechanisms remain poorly understood. Extracellular vesicles (EVs) are known to be involved in various processes, such as tissue repair and the transmission of viral particles. However, the specific characteristics and functional roles of EVs derived- from patients with Long COVID (LC-EVs) are poorly characterized. To uncover systemic mechanisms underlying Long COVID, we performed a comprehensive characterization of patient-derived extracellular vesicles (EVs) via Nanoparticle Tracking analysis (NTA), Atomic Force Microscopy (AFM), Transmission Electron Microscope (TEM) and flow cytometry. These EVs were applied to lung cells, Mesenchymal Stem Cell (MSCs), Human Umbilical Vein Endothelial Cells (HUVECs) and Aortic Smooth Muscle Cells (ASMCs), revealing stress responses through SESN1, SESN2, and p53 activation. We further assessed mitochondrial respiration to evaluate metabolic dysfunction, and conducted targeted transfection experiments to dissect the molecular pathways involved, shedding light on EV-driven cellular reprogramming. Thus, we observed that Long COVID (LC) patients experienced breathlessness and leg discomfort during exertion. Our data highlighted that LC-EVs induce aberrant RUNX2 expression and activate the p53/p21 pathway in lung cells as well stress responses. Additionally, LC-EVs impair mitochondrial function and cellular adaptability under metabolic stress, reducing maximal respiration and ATP production at high cell densities. Protein interaction analysis showed RUNX2 involvement in key biological processes and post-transcriptional regulation by hsa-miR-204-5p was identified. Finally, LC-EVs also activated stress pathways and increased RUNX2, SESN, p53, and p21 levels in endothelial cells, aortic smooth muscle cells, and mesenchymal stem cells. In conclusions, these findings provide new insights into the role of extracellular vesicles in Long COVID, revealing their involvement in cellular stress and impaired mitochondrial function.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4d9f706bfa4303fba5e18198656479afdf7b243a" target='_blank'>
              Extracellular vesicles from long COVID patients promote RUNX2-mediated cellular stress via dysregulated miR-204 and p53 pathway activation
              </a>
            </td>
          <td>
            Luca Dalle Carbonare, Arianna Minoia, Sharazed Zouari, Michele Braggio, M. Cominacini, S. Gaglio, Francesca Cristiana Piritore, Pamela Lorenzi, Mirko Meneghel, Kevin Dervishi, Andrea Corsi, A. Pedrinolla, G. Giuriato, Alessandra Fiore, Adriana Celesia, Laura Guerricchio, M. Venturelli, Federico Schena, M. Donadelli, M. Mottes, Maria Grazia Romanelli, M. Perduca, Daniele Guardavaccaro, Ernesto Crisafulli, D. Zipeto, Lucio Barile, M. Valenti
          </td>
          <td>2025-11-26</td>
          <td>Cell Communication and Signaling : CCS</td>
          <td>0</td>
          <td>29</td>
        </tr>

        <tr id="Neuroinflammation plays a central role in a wide spectrum of neurological diseases, driven generally by reactive microglia and astrocytes. Inflammatory stimulation of microglia and astrocytes leads to a metabolic shift from oxidative phosphorylation (OXPHOS) to glycolysis, which is required to support pro-inflammatory effector functions. This metabolic reprogramming is associated with impaired mitochondrial dynamics, including reduced biogenesis, increased fragmentation, and loss of membrane potential. Targeting microglia and astrocyte metabolism may offer a novel therapeutic approach for modulating neuroinflammation and restoring homeostatic immune functions. Here, we examined the potential of 2-Deoxy-D-Glucose (2DG), a glycolysis inhibitor, to attenuate neuroinflammation by restoring mitochondrial dynamics. In BV2 and primary glial cultures, low-dose 2DG reversed LPS-induced metabolic reprogramming, restoring OXPHOS, reducing mitochondrial fragmentation, and enhancing biogenesis. In vivo, it preserved spare respiratory capacity and increased complex-V activity in brain mitochondria from LPS-treated mice without affecting oxidative stress. At a mechanistic level, 2DG restored activation of AMP-activated protein kinase, a master regulator of mitochondrial dynamics. In conjunction with these metabolic effects, 2DG suppressed LPS-induced pro-inflammatory gene expression while enhancing markers associated with the resolution of inflammation and tissue repair. Critically, systemic low-dose 2DG reduced neuroinflammation and restored immune homeostasis in two LPS-induced mouse models, highlighting its therapeutic potential in neurological disorders.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/df23e47245588eca6bc8cbd6d462a83f41867576" target='_blank'>
              2-Deoxy-D-Glucose restores glial cell mitochondrial function and attenuates neuroinflammation
              </a>
            </td>
          <td>
            P. Gharibani, Yu Guo, Shruthi Shanmukha, Judy J Lee, Katherine Kopp, Paul M Kim, M. Kornberg
          </td>
          <td>2025-11-06</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="The COVID-19 pandemic has left a lasting imprint on immune function, particularly in the elderly—a population already vulnerable to immunosenescence. While acute and long-COVID immune responses have been widely studied, the long-term apoptotic behavior of peripheral blood mononuclear cells (PBMCs) remains underexplored. This study aims to investigate the legacy of SARS-CoV-2 on PBMC apoptosis in elderly individuals during the post-COVID era, shedding light on potential persistent immune dysregulation. In this cross-sectional study, PBMCs were isolated from peripheral blood samples of elderly individuals (> 65 years old) with a documented history of COVID-19 infection at least six months prior. Using multiparametric flow cytometry, we quantified early and late apoptosis markers (Annexin V/PI), mitochondrial membrane potential disruption (ΔΨm), and expression of pro-apoptotic (Bax, Caspase-3) and anti-apoptotic (Bcl-2) proteins. Statistical analyses were performed to assess intergroup differences and correlations with clinical history. This study was conducted in 2025. Elderly post-COVID individuals exhibited a significantly elevated proportion of apoptotic PBMCs compared to controls (p < 0.01), particularly within the CD4 + and CD8 + T-cell subsets. Mitochondrial depolarization and increased Bax/Bcl-2 ratios indicated a shift toward intrinsic apoptotic pathways. Caspase-3 activation was also heightened in the post-COVID group. Notably, apoptotic burden correlated with time since infection and severity of initial illness. Our findings suggest a prolonged apoptotic signature in the immune cells of elderly individuals following recovery from COVID-19. These alterations may reflect a sustained immune exhaustion or maladaptive remodeling of lymphocyte populations, potentially contributing to impaired immunosurveillance and increased vulnerability to secondary infections or chronic inflammatory conditions. COVID-19 may cast a long immunological shadow in the elderly, with persistent PBMC apoptosis representing a novel facet of post-viral immune dysregulation. Flow cytometry reveals a unique apoptotic phenotype that could serve as a biomarker for long-term immune health and guide post-pandemic clinical management strategies for aging populations.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/096a986d262753a585b2bfff92537948a29f8c5b" target='_blank'>
              Investigating apoptosis in peripheral blood mononuclear cells among the elderly in the post-COVID-19 era
              </a>
            </td>
          <td>
            Elaheh Abiri, Najmeh Hemmatian
          </td>
          <td>2025-10-31</td>
          <td>BMC Immunology</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="Post-COVID syndrome (PCS) affects approximately 3-17% of individuals following acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and poses a potential global health burden. While improved assessment strategies are emerging, mechanistic insights and treatment options remain limited. This study investigates molecular mechanisms underlying PCS using single-cell RNA (scRNA) transcriptomics combined with in vitro validation. scRNA analysis is performed on nasal biopsies from 25 patients with moderate or severe PCS to investigate differential cell types, signalling pathways, and cell-cell communication. Air-liquid interface cultures are used to validate findings, focusing on the TNFα-TGFβ axis. Severe PCS shows reduced numbers of ciliated cells, increased immune cell infiltration, and heightened inflammatory signaling that drives TGFβ and TNFα upregulation, in the absence of a detectable viral load. These changes trigger epithelial-mesenchymal transition, basal cell expansion and a mis-stratified nasal epithelium. In vitro experiments confirm TGFβ and TNFα as causal cytokines promoting ciliated cell loss and increased basal cell abundance. These findings indicate a sustained severe PCS is not driven by ongoing viral load but by immune cell activity and chronic cytokine production. Targeting the TNFα-TGFβ axis may mitigate immune-mediated nasal tissue damage and support epithelium restoration, offering a potential therapeutic strategy for PCS. In this work, authors apply single-cell transcriptomics to nasal biopsies from post-COVID syndrome patients, revealing chronic inflammation driven by TNFα and TGFβ, alongside persistent airway epithelial remodelling in the absence of viral load.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f11cef8e6987c6f7f18c86a6ad021d44e359f249" target='_blank'>
              scRNA-seq reveals persistent aberrant differentiation of nasal epithelium driven by TNFα and TGFβ in post-COVID syndrome
              </a>
            </td>
          <td>
            K. Reddy, Y. Maluje, F. Ott, R. Saurabh, A. Schaaf, A. Bohnhorst, S. Biedermann, J. Pierstorf, S. Winkelmann, B. Voss, M. Laudien, T. Bahmer, J. Heyckendorf, F. Brinkmann, S. Schreiber, W. Lieb, C. Jakwerth, C. Schmidt‐Weber, G. Hansen, E. von Mutius, K. F. Rabe, A. Dittrich, N. Maison, B. Schaub, M. Kopp, H. Busch, M. Weckmann, A. Fähnrich
          </td>
          <td>2025-10-28</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>14</td>
        </tr>

        <tr id="Microglia have emerged as key regulators in Alzheimer’s disease (AD), yet the molecular factors driving their dysfunction remain unclear. Through integrative transcriptomic and proteomic analyses, we identified PLXDC2, a transmembrane receptor, as a protein consistently upregulated in the AD brain and cerebrospinal fluid. Single-nucleus RNA-seq confirmed its microglia-specific enrichment, particularly in lipid-processing, phagocytic, and inflammatory subclusters. Functional assays revealed that PLXDC2 overexpression in BV2 microglial cells impaired Aβ uptake and suppressed pro-inflammatory cytokines Il-6 and Il-1β, without altering lipid droplet formation. These findings indicate that PLXDC2 plays a regulatory role in critical microglial functions and may drive AD pathogenesis by disrupting phagocytic activity and immune responses.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/dd2e059e5a9336779ce01698e78cf73cb3fa681f" target='_blank'>
              Microglial PLXDC2 Modulates Aβ Phagocytosis and Inflammatory Responses
              </a>
            </td>
          <td>
            Yoonah R. Oh, Se Eun Park, Hee Kyung Kim, Hyungseok Seo, Min-Kyoo Shin
          </td>
          <td>2025-10-23</td>
          <td>Biomolecules & Therapeutics</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="Background Acute rejection is a significant cause of impaired graft survival in the early post-transplantation period, and the early-stage immune cell dynamics with local intercellular communication during this process require further elucidation. Methods We performed single-cell RNA sequencing (scRNA-seq) on CD45+ immune cells isolated from rat renal allografts during the early phase of acute rejection (days 0, 1, 3, and 7). Using unsupervised clustering, functional enrichment analysis, cellular trajectory inference, and intercellular communication network mapping, we delineated the immune cell dynamics and local communication networks at single-cell resolution. Our findings were subsequently validated through multiplex immunofluorescence and therapeutic intervention experiments. Results Macrophages constituted the dominant immune population during acute rejection. Sub-clustering analysis revealed a rapid expansion of the Isg15+Mac subset by post-transplant day 1, which persisted at elevated levels thereafter. Functional enrichment and trajectory inference demonstrated the pro-inflammatory properties of Isg15+Mac, implicating this subset in acute rejection. Cell-cell communication analysis identified Ccl3-Ccr5 ligand-receptor interactions between Isg15+Mac and T cells. Multiplex immunofluorescence confirmed abundance of Isg15+Mac within the allografts. Moreover, the acute rejection after kidney transplantation was alleviated by the FDA-approved Ccr5 blocker Maraviroc. Conclusions Our study establishes an in-depth, early-stage immune landscape of renal transplantation, revealed that the Isg15+Mac subset activates T cells via the Ccl3–Ccr5 axis and thereby serves as a critical driver of acute rejection. And indicating that Maraviroc may potentially be a therapeutic candidate for transplant rejection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0e9d767fb56923b15a4ac52a99263c253eebc577" target='_blank'>
              Single-cell transcriptomics unravels the early immune landscape of renal allograft rejection and nominates Ccl3-Ccr5 as a therapeutic target
              </a>
            </td>
          <td>
            Fanchao Wei, Zhaoxiang Wang, Ruochen Qi, Jingliang Zhang, Shichao Han, Changhong Shi, Tong Lu, Zhite Zhao, Zhengxuan Li, Lang Li, Weijun Qin, Shuaijun Ma, Lijun Yang
          </td>
          <td>2025-10-22</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="Abstract Multiple sclerosis (MS) is an autoimmune demyelinating disease of the central nervous system (CNS) characterized by multifocal inflammation and axonal degeneration, driven by innate and adaptive immune cells. The Janus Kinase (JAK)/Signal Transducers and Activators of Transcription (STAT)/Suppressors Of Cytokine Signaling (SOCS) pathway regulates immune cell activity, with SOCS proteins functioning as negative regulators. Using the Experimental Autoimmune Encephalomyelitis (EAE) model of MS, our prior work demonstrated that mice lacking Socs3 in myeloid cells ( Socs3 ΔLysM ) developed severe, brain-targeted EAE (btEAE), with increased cerebellar infiltration of activated neutrophils. To define neutrophil-specific roles, we generated mice with Socs3 deletion restricted to neutrophils ( Socs3 ΔLy6G ). Following MOG-induced EAE, these mice exhibited clinical features identical to Socs3 ΔLysM mice, including severe cerebellar demyelination, increased cerebellar infiltration of activated neutrophils and CD4 + T-cells, and clinical symptoms of both btEAE and classical EAE (cEAE), the latter involving the spinal cord (SC). Cerebellar neutrophils from Socs3 ΔLy6G mice exhibited a primed, inflammatory phenotype with elevated reactive oxygen species, neutrophil extracellular traps (NETs) and heightened production of pro-inflammatory cytokines/chemokines. Neutrophil depletion alleviated btEAE, confirming their pathogenic role. Single-cell RNA Sequencing (scRNA-Seq) of cerebellum (CB) and SC neutrophils revealed five clusters in naïve and EAE mice, with expansion of two clusters (Neu2 and Neu4) in Socs3 ΔLy6G mice with EAE. Neu2, Neu3 and Neu4 clusters showed high expression of Saa3 , Il1b and Cxcl2 , with Neu4 enriched in cytokine signaling pathways and inflammatory responses. Strikingly, Saa3 mRNA and protein expression were markedly increased in the CB and SC of Socs3 ΔLy6G mice with EAE compared to controls. Translationally, the human orthologue SAA1 was significantly elevated in plasma from MS patients relative to healthy controls. Collectively, these findings demonstrate that Socs3 deficiency unleashes pathogenic neutrophil activity in Socs3 ΔLy6G mice with EAE. They further reveal neutrophil heterogeneity within the inflamed CNS, define inflammatory transcriptional states and identify Saa3/SAA1 as potential biomarkers and therapeutic targets to attenuate autoimmune neuroinflammation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fe5a2480e246a352587ff976b7ff5324d95b8c9e" target='_blank'>
              Single-Cell RNA Sequencing Uncovers Neutrophil Clusters Associated with Autoimmune Neuroinflammation
              </a>
            </td>
          <td>
            Yong Wang, William Turbitt, Lianna Zhou, Zhaoqi Yan, Sweta B Patel, Wei Yang, Zhang Li, Jessica A. Buckley, R. Welner, William R. Meador, Chander Raman, H. Qin, Etty N. Benveniste
          </td>
          <td>2025-11-19</td>
          <td>Research Square</td>
          <td>0</td>
          <td>43</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0f99bb18019cd4b39bd05d6d11bec440e5d21593" target='_blank'>
              B cell transcriptomics reveals lasting dysregulation and rapid decline of protective immune memory after chronic hepatitis C cure
              </a>
            </td>
          <td>
            Fang Chen, E. Giang, Padmaja Natarajan, Tony S. Mondala, Steven R. Head, Sing Chau Lau, Aishwarya Sundaresan, Liudmila Kulakova, Xiaohe Lin, Jasneet Aneja, R. Andrabi, Yun Zhang, Richard H. Scheuermann, Eric A. Toth, Thomas R. Fuerst, Lia Lewis-Ximenez, Arthur Y Kim, Paul Pockros, Georg M Lauer, M. Law
          </td>
          <td>2025-10-24</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>40</td>
        </tr>

        <tr id="The COVID-19 pandemic, which began in 2019 due to SARS-CoV-2, remains a global health crisis, especially as new variants emerge that could trigger widespread outbreaks again. While various aspects of SARS-CoV-2 infection warrant attention, the antiviral innate immune response is a crucial area of focus. Understanding how viruses evade host defenses is vital for developing effective vaccines and therapies. SARS-CoV-2 targets key components of the innate immune system for its survival, and this interference with the host immune system is central to the virus's ability to cause disease. However, the specific mechanisms by which the innate immune response counteracts SARS-CoV-2 infection have not been fully clarified. This review examines key elements of the antiviral innate immune response to SARS-CoV-2 infection, concentrating on viral evasion strategies and potential therapeutic targets.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2283fdb7927a9966d77a4f3f180d82163d69d72b" target='_blank'>
              Host’s innate immune response to SARS-CoV-2 infection—Current understanding and trends
              </a>
            </td>
          <td>
            Nitin Saksena
          </td>
          <td>2025-11-08</td>
          <td>Journal of Cellular and Molecular Immunology</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="The mechanisms by which Enterovirus D68 (EV-D68) infection leads to acute flaccid myelitis (AFM), a severe neurological condition characterized by sudden muscle weakness and paralysis, remain poorly understood. To investigate the cellular tropism and infection dynamics of EV-D68, we profiled naive and EV-D68-infected human spinal cord organoids (hSCOs) derived from induced pluripotent stem cells (iPSCs) using single-cell RNA sequencing (scRNA-seq). Examining the cellular composition of healthy hSCOs, we found that hSCOs include diverse cell types, including neurons, astrocytes, oligodendrocyte progenitor cells (OPCs), and multipotent glial progenitor cells (mGPCs). Upon infection with 2 EV-D68 strains, US/IL/14-18952 (a B2 strain) and US/MA/18-23089 (a B3 strain), we observed distinct viral tropism and host transcriptional responses. Notably, US/IL/14-18952 showed a significant preference for neurons, while US/MA/18-23089 exhibited higher rates of infection in cycling astrocytes and OPCs. These findings provide novel insights into the host cell tropism of EV-D68 in the spinal cord, offering insight into the potential mechanisms underlying AFM pathogenesis. Understanding the dynamics of infection at single-cell resolution will inform future therapeutic strategies aimed at mitigating the neurological impact of enterovirus infections.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fb54cf51aa995a2705a7d71cb812e43393ceb04a" target='_blank'>
              Strain-specific tropism and transcriptional responses of enterovirus D68 infection in human spinal cord organoids
              </a>
            </td>
          <td>
            Nathânia Dábilla, Sarah Maya, Colton McNinch, Taylor Eddens, Patrick T. Dolan, M. Freeman
          </td>
          <td>2025-11-19</td>
          <td>Frontiers in Microbiology</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/083cd9665e2adce6c636caf445e71437ffb29674" target='_blank'>
              Astrocytes control the Neuroinflammation and ILC2 response through IL-33/ST2 signaling, during protection against Cerebral Malaria in Toxoplasma-P. berghei coinfected Mice
              </a>
            </td>
          <td>
            Inès Leleu, Tarun Keswani, Fabien Herbert, Capucine Picavet, Manon Arnaud, Marion Sabrina, Corine Glineur, Pied Sylviane
          </td>
          <td>2025-10-25</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for coronavirus disease 2019 (COVID-19), uses the angiotensin-converting enzyme 2 (ACE2) receptor and transmembrane serine protease 2 (TMPRSS2) to enter host cells. Variability in gene expression of these entry factors has been hypothesized to influence susceptibility and disease severity. The present study aimed to evaluate the expression of ACE2 and TMPRSS2 in nasopharyngeal cells and their association with COVID-19 infection and clinical outcomes. Nasopharyngeal samples from 491 individuals (aged 18-80 years) treated in public hospitals in Brazil during 2020 were analyzed. Patients were categorized based on SARS-CoV-2 reverse transcription-quantitative polymerase chain reaction (RT-qPCR) results and disease severity (including intensive care unit admission). Gene expression levels of ACE2 and TMPRSS2 were quantified using RT-qPCR, and statistical analyses assessed associations with infection status, age, sex, and disease severity. The findings revealed that infected individuals were significantly older (P=0.0010) and predominantly male (52.9%). ACE2 expression was significantly reduced in SARS-CoV-2-positive individuals compared with negative individuals (P<0.001), but no association with severity or sex was observed. By contrast, high ACE2 levels were found in moderately symptomatic SARS-CoV-2-negative individuals. TMPRSS2 expression did not significantly differ by infection status or disease severity. In summary, ACE2 downregulation appeared to be associated with SARS-CoV-2 infection, potentially reflecting viral evasion mechanisms. However, neither ACE2 nor TMPRSS2 gene expression in the nasopharynx served as a reliable biomarker for predicting COVID-19 severity. These findings underscore the need for multifactorial models integrating host, viral, and clinical factors to improve our understanding disease progression.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/601d43aad8b2e595606c7bb8e092bf4ba6f19a85" target='_blank'>
              Expression of ACE2 and TMPRSS2 and the severity of COVID-19.
              </a>
            </td>
          <td>
            Samantha Sanches de Carvalho, Anna Carolina Blanco Capassi Santos, Marcos Yuji Shiroma Graziano, Marina Cristina Peres, Renan Sousa Silva, Isabella Trufelli, Glaucia Luciano da Veiga, F. L. A. Fonseca, Beatriz da Costa Aguiar Alves
          </td>
          <td>2025-10-10</td>
          <td>Biomedical reports</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="The nucleocapsid (N) protein of SARS‐CoV‐2 is critical for viral replication and genome packaging. However, whether it induces inflammation through endothelial cell and monocyte activation remains controversial. One aspect that has been overlooked is the consideration of residual endotoxins in recombinant proteins when conducting immune response studies. We aimed to assess whether N‐protein induces an inflammatory response in mouse and human microvascular endothelial cells (MEC and HMEC) and THP‐1 cells, independent of endotoxin contamination. MEC, HMEC, and THP‐1 cells were treated with vehicle, lipopolysaccharide (LPS), or recombinant N‐protein in the presence or absence of the LPS‐neutralizing agent polymyxin B. The inflammatory response was assessed through quantification of mRNA and protein levels of inflammatory markers and monocyte adhesion to endothelial cells. In MEC, treatment with N‐protein resulted in at least a 15‐fold increase in inflammatory marker levels. Similarly, in THP‐1 cells, N‐protein caused a significant increase in mRNA inflammatory marker levels, which were brought back to control levels with polymyxin B. LPS or N‐protein alone resulted in a tripling of monocyte adhesion to MEC, and this was reduced to control levels with polymyxin B. In addition, in HMEC, endotoxin‐depleted N‐protein did not cause a significant increase in inflammatory marker levels. In conclusion, our data show that N‐protein does not induce inflammation in endothelial cells or monocytes. Some of its observed inflammatory effects may be due to endotoxin contamination, suggesting that it does not directly induce inflammation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/092d82591b24f35578b8fb78c9b6f81f7b0f0b51" target='_blank'>
              SARS‐CoV‐2 Nucleocapsid Protein Does Not Induce Inflammation in Endothelial Cells or Monocytes
              </a>
            </td>
          <td>
            Mehreen Tufail, Xiangru Lu, Stephen D Barr, Nica M. Borradaile, Qingping Feng
          </td>
          <td>2025-10-22</td>
          <td>The FASEB Journal</td>
          <td>0</td>
          <td>34</td>
        </tr>

        <tr id="ABSTRACT Avian coronavirus infectious bronchitis virus (IBV) induces severe renal inflammation and urate deposition in chickens, but the underlying mechanisms remain incompletely understood. Here, we used both in vivo chicken infection models and in vitro primary renal epithelial cell cultures and found that IBV activates the NLRP3 (NOD-like receptor family, pyrin domain containing 3) inflammasome, leading to the maturation and secretion of IL-1β (interleukin-1 beta). Pharmacological inhibition of NLRP3 in an in vivo chicken model alleviates renal pathology without affecting viral replication, implicating host inflammatory responses in disease progression. These findings indicate that host inflammasome activation, rather than direct viral replication or cytotoxicity, plays a central role in IBV-associated renal pathology. Notably, we observed that NLRP3 is predominantly expressed in the renal collecting duct, primarily within AQP2 (Aquaporin-2)-positive epithelial cells—an anatomic localization of inflammasome activity not previously reported. Single-cell transcriptomic profiling further revealed that IBV infection reprograms collecting duct cells from an electrolyte-regulating phenotype into a pro-inflammatory state, accompanied by disrupted urate metabolism and impaired ion transport. These findings identify collecting duct-targeted NLRP3 activation as a central mechanism of IBV-induced nephropathy and provide a theoretical foundation for developing targeted anti-inflammatory therapies. IMPORTANCE In vivo studies in chickens demonstrate that the activation of the NLRP3 inflammasome is a key driver of renal injury during infectious bronchitis virus (IBV) infection. Pharmacological inhibition of NLRP3 significantly alleviates renal inflammation and tissue damage without affecting viral replication, highlighting the central role of host inflammatory responses in disease progression. Importantly, we report for the first time that NLRP3 activation is predominantly localized to AQP2-positive collecting ducts, a nephron segment essential for uric acid excretion and electrolyte balance. IBV infection reprograms these epithelial cells into a pro-inflammatory, metabolically dysregulated state, promoting urate crystal formation and amplifying tissue injury. These findings reveal a spatially confined epithelial-immune axis of coronavirus-induced renal pathology and suggest new avenues for targeted intervention. In vivo studies in chickens demonstrate that the activation of the NLRP3 inflammasome is a key driver of renal injury during infectious bronchitis virus (IBV) infection. Pharmacological inhibition of NLRP3 significantly alleviates renal inflammation and tissue damage without affecting viral replication, highlighting the central role of host inflammatory responses in disease progression. Importantly, we report for the first time that NLRP3 activation is predominantly localized to AQP2-positive collecting ducts, a nephron segment essential for uric acid excretion and electrolyte balance. IBV infection reprograms these epithelial cells into a pro-inflammatory, metabolically dysregulated state, promoting urate crystal formation and amplifying tissue injury. These findings reveal a spatially confined epithelial-immune axis of coronavirus-induced renal pathology and suggest new avenues for targeted intervention.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/baa28b1eb0fbf6fb53108019955f2aeab6f74090" target='_blank'>
              Avian coronavirus IBV-induced activation of the NLRP3–Caspase-1–IL-1β axis in renal collecting ducts contributes to nephropathogenesis
              </a>
            </td>
          <td>
            Min Huang, Chengyin Liukang, Rong Liang, Yingfei Li, Ruihua Yang, Mingwei Zhang, Ye Zhao, Jing Zhao, Guozhen Zhang
          </td>
          <td>2025-12-03</td>
          <td>Journal of Virology</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="


 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a single-stranded positive sense RNA virus that is responsible for the COVID-19 pandemic. While most patients can mount proper immune responses to control the viral infection, a small percentage of the population develop severe disease symptoms which results in dysregulated immune activation that leads to injury of the lung and other organs. Severe COVID-19 patients have an increased recruitment and accumulation of CCR10+ antibody-secreting plasma cells (IgA-ASCs) in the lungs compared to healthy and mild patients, suggesting a role of CCR10-regulated mucosal IgA responses in SARS-CoV-2 infection. CCR10 is a chemokine receptor that can regulate localization and maintenance of IgA-ASCs through interaction with its ligand CCL28, which is highly expressed in mucosal tissues. We investigated how CCR10-regulated mucosal IgA responses are involved in clearance of SARS-CoV-2 viral infection versus immunopathological development using CCR10-knockout (KO) mice. Compared to CCR10-sufficent mice, SARS-CoV-2 infected CCR10-KO mice developed more severe lung pathology associated with impaired localization of IgA+ plasma cells and reduced antigen-specific IgA responses in lungs. On the hand, CCR10-KO mice were still able to control SARS-CoV-2 infections. Our findings revealed a primary role of CCR10-regulated mucosal IgA responses in protection against over-active immune pathological damage to the lung by the viral infection.



 Supported by NIH R21 AI169430; R01 AI174181-01A1S1



 Mucosal and Regional Immunology (MUC)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5b36d2329f917c0cde84acfcdf02e5a273326d7a" target='_blank'>
              Roles of CCR10-regulated mucosal IgA responses in lung SARS-CoV-2 infection clearance and pathogenesis 3261
              </a>
            </td>
          <td>
            Juan Garcia, Na Xiong
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="Peripheral immune cell infiltration plays a key role in the excessive intracranial inflammatory response during sepsis, contributing to cognitive dysfunction and increased mortality. This study aims to elucidate the immune inflammatory status of hippocampal tissue in septic mice, providing potential targets for treatment and prevention. Male C57BL/6J mice underwent cecal ligation and puncture (CLP) or sham surgery. Twenty‐four hours post‐surgery, hippocampal tissues were harvested for transcriptome sequencing and immunofluorescence analysis. Immune cell infiltration was assessed using the xCell package, and structural changes in brain microvessels were evaluated by transmission electron microscopy. Flow cytometry and immunofluorescence confirmed immune cell presence in the hippocampus. Hub genes related to immune responses were identified using protein–protein interaction networks, weighted gene co‐expression network analysis, and enrichment analysis of immune‐related biological processes. In CLP mice, microvessel endothelial cells were separated, with swelling and damage to tight junctions. Significant infiltration of myeloid immune cells, including dendritic cells, monocytes and neutrophils, was observed in the hippocampus. Seven immune‐related hub genes (Fcer1g, Fcgr2b, Fcgr3, Icam1, Itgb2, Ptprc and Slc11a1) play a pivotal role in mediating immune responses. Fcer1g, Fcgr2b and Slc11a1 were positively correlated with monocytes and neutrophils, suggesting their involvement in the recruitment of immune cells to the brain. This study enhances our understanding of peripheral immune cell infiltration in sepsis and provides novel insights into potential therapeutic targets for sepsis‐associated encephalopathy.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/245a88b1e684b6e2b4373d4be2ee46cd6cf621de" target='_blank'>
              Peripheral Immune Cell Infiltration in the Hippocampus of Sepsis Mice
              </a>
            </td>
          <td>
            Hui Zhang, Meixian Zhang, Yanan Gao, Qian Chen, Qiang Liu, Fanbing Meng, Xiaoxiao Sun, Miaomiao Fei, Cheng Li, Lize Xiong
          </td>
          <td>2025-10-31</td>
          <td>Journal of Cellular and Molecular Medicine</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="Since the onset of the COVID-19 pandemic, obesity has been consistently associated with worse clinical outcomes. In 2020, we hypothesized that adipose tissue (AT) might serve as a viral reservoir and amplifier of immune responses in SARS-CoV-2 infection. Five years on, accumulating evidence supports this hypothesis. Recent autopsy and in vitro studies support that SARS-CoV-2 disseminates to and may replicate within human adipocytes. While several studies have detected SARS-CoV-2 RNA and proteins in AT, the recovery of infectious virus from this tissue has not yet been demonstrated. This remains a critical gap in our understanding of SARS-CoV-2 viral tropism and replication within adipocytes. Viral entry is mediated via angiotensin-converting enzyme-2 and neuropilin-1 receptors. Infected AT exhibits immune cell infiltration and cytokine activation, implicating it in systemic inflammation. Persistent viral RNA in AT correlates with prolonged metabolic dysfunction. These findings highlight the dual role of AT as a potential viral reservoir and immunometabolic organ. Understanding these mechanisms is critical to mitigating the long-term impact of COVID-19 and guiding responses to future pandemics involving metabolically active tissues.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/77a113aee7203a484ecb443a20ff11990516bad4" target='_blank'>
              Adipose Tissue in SARS-CoV-2 Viral Tropism, Viral Replication, and the Concept of a Viral Reservoir: An Update.
              </a>
            </td>
          <td>
            Liam Charles Maher, Paul M. Ryan, Noel M. Caplice
          </td>
          <td>2025-11-24</td>
          <td>Obesity</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="COVID-19, caused by the SARS-CoV-2 virus, manifests with varying degrees of severity, affecting individuals worldwide. The spectrum of symptoms ranges from mild to severe, with respiratory failure being a leading cause of death. Immunological factors, particularly excessive cytokine production such as IL-18 and IL-1β, significantly contribute to disease severity. In this context, the NLRP3 inflammasome, a key component of the innate immune system, has influenced COVID-19 outcomes. This study investigated the association between single-nucleotide variants (SNVs) in the NLRP3 inflammasome and COVID-19 severity. A case-control study was conducted involving 800 adult participants infected with SARS-CoV-2, stratified into mild/moderate and severe/critical cases. Genetic associations were assessed through qPCR-based genotyping. While no association was found between SNVs in IL1B and CASP1 with COVID-19 severity, the multivariate analysis revealed that the gain-of-function SNV in the NLRP3 gene (rs35829419) was associated with a protective effect against COVID-19-related mortality. These findings suggest that genetic variations in the NLRP3 inflammasome may modulate the host response to SARS-CoV-2, highlighting potential biomarkers for disease prognosis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c3bc942541c2b74961a12f103de05cc6065fe633" target='_blank'>
              An NLRP3 Variant Protects Against Severe COVID-19: An Unexpected Contribution of Inflammasome Genetics in SARS-CoV-2 Infection.
              </a>
            </td>
          <td>
            L. M. Paulino, V. N. C. Leal, W. M. D. S. Santiago, Débora de Fátima Almeida Donanzam, Célio Roberto Siqueira Ledesma, Maria Fernanda Silva Bertelli, W. S. Fava, A. Latini, Alessandra Pontillo, James Venturini
          </td>
          <td>2025-10-27</td>
          <td>International journal of immunogenetics</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="Herpes simplex virus type 1 (HSV-1) is the most common cause of infectious blindness and is a major cause of acute retinal necrosis (ARN), a severe condition marked by rapid necrosis of the retina. Effective treatments for HSV-1 retinal infection are limited to general antiviral drugs, which do not specifically target the underlying pathophysiology. Here, we investigate the role of stimulator of interferon genes (STING), a key player in innate immunity, in HSV-1 retinal infections. STING knockout (KO) mice are highly susceptible to HSV-1 retinal infection, evidenced by impaired antiviral immune responses, increased ocular virus load and severe retinal necrosis. Mechanistically, STING is required for Z-DNA binding protein 1 (ZBP1)-mediated PANoptosis, an inflammatory programmed cell death pathway, in microglia and macrophages. STING forms a complex with ZBP1 and Z-form nuclei acid during HSV-1 infection. Further, activation of STING induced Z-form nuclei acid and subsequent activation of ZBP1. ZBP1 KO mice exhibited a similar defective antiviral phenotype as STING KO mice, whereas treatment with ZBP1 agonist Curaxin CBL0137 rescued the impaired antiviral response in STING-deficient microglia and macrophages and mitigates retinal necrosis in both WT and STING KO mice following HSV-1 infection. Together, our study revealed a STING-ZBP1-PANoptosis signal axis against HSV-1 infection in retina, which should provide new insights for the treatment of retinal virus infection such as ARN.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/13b5c00dbed3ab3d029b169faa417a52dd2a967c" target='_blank'>
              STING activates ZBP1-mediated PANoptosis to defend against HSV-1 retinal infection
              </a>
            </td>
          <td>
            Wei Liu, Haifeng Cui, Li Wang, Xiangyu Ge, Xingfei Zhu, Xingmiao Liang, Ziqing Chen, Yuwen Gan, Le Shi, Xuebin Hu, Xiaohu Ding, Zhengjie Xu, Xiaoling Liang, Lili Gong
          </td>
          <td>2025-10-27</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="Abstract Background Human T-lymphotropic virus type 1 (HTLV-1) infects up to ten million people worldwide, and causes severe diseases, including adult T-cell leukemia/lymphoma and HTLV-1–associated myelopathy/tropical spastic paraparesis (HAM/TSP). Individuals with HAM/TSP are prone to pulmonary complications (e.g., bronchiectasis). Their bronchoalveolar lavage fluid typically shows increased levels of inflammatory cytokines, chemokines and cell adhesion molecules contributing to chronic inflammation. Results This study assessed the impact of HTLV-1 infection on lung inflammation by analyzing the alveolar transcriptome of A549 epithelial cells following exposure to HTLV-1. Co-culture with HTLV-1-infected MT-2 cells caused transcriptomic changes related to viral response, NF-κB activation, and inflammation. RT-qPCR confirmed elevated expression of the chemokine monocyte chemotactic protein-1 (MCP-1/CCL2) and colony stimulating factor 1 (CSF-1) in A549 MT-2 co-cultures. Increased CSF-1 expression was mechanistically linked to NF-κB signaling, using CRISPR/Cas9 RELA knockout. Supernatant from A549 MT-2 co-cultures triggered chemotaxis and macrophage differentiation of THP-1 and primary monocytes. Systems biology analysis revealed enrichment in pathways associated with monocyte infiltration and bronchiectasis. Finally, we validate the in vivo relevance of our in vitro model through multi-cohort multi-omics analysis combining bulk and single-cell transcriptomics, viral interactomics and multi-ancestry GWAS. Conclusions We describe an in vitro co-culture model that recapitulates HTLV-1-triggered lung inflammation, through RELA/NF-kB-dependent release of pro-inflammatory cytokines and chemokines resulting in monocyte chemotaxis, activation and differentiation. Integrated multi-omics analysis confirmed the in vivo relevance of our in vitro model.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f2fcc915bbd12bb88b05e375c5c2d91f60fb7f15" target='_blank'>
              Deciphering HTLV-1-associated Lung Pathology through Integrated in vitro and Multi-cohort Multi-omics Analysis: Inflammation, Monocyte Recruitment and Differentiation Triggered by HTLV-1-exposed Alveolar Epithelial Cells
              </a>
            </td>
          <td>
            Clément J F Heymann, Mieke Gouwy, Robin Hermans, J. Twizere, Tatiana Assone, Jorge Casseb, Isaac Racine, Isabelle Cleynen, Edward L. Murphy, Roberta Bruhn, Dominique Schols, E. Vanderlinden, J. V. Weyenbergh
          </td>
          <td>2025-11-24</td>
          <td>Research Square</td>
          <td>0</td>
          <td>29</td>
        </tr>

        <tr id="Respiratory virus infections have been presenting significant global public health challenges. The virulence of SARS-CoV-2 and seasonal influenza largely relies on triggering abnormal host immune responses, particularly the production of a cytokine storm, which is notably increased in elderly patients. However, as the mechanisms underlying this age-associated exacerbation remain unclear, we investigated the role of the aging tissue microenvironment in promoting inflammation associated with viral infection. Our research, based on clinical samples, cellular experiments, and mouse models, provides evidence that the aging lung microenvironment induces severe inflammatory responses and leads to tissue damage, with senescent cells playing a crucial role in this process. Further mechanistic insights reveal that elevated levels of downstream inflammatory factors result from a significant and robust activation of the NF-κB pathway. This increase is attributed to the accumulation of reactive oxygen species in senescent cells and subsequent reduced expression of PDLIM2, an E3 ubiquitin ligase regulating P65 degradation. Finally, restoring PDLIM2 significantly inhibits viral infection-mediated inflammatory responses and organ damage in the aging body. Therefore, this study offers a novel perspective by elucidating the molecular mechanism and exploring the therapeutic potential behind viral infection-related inflammatory responses, particularly the mechanism accelerating inflammatory storms in elderly patients post-infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e07f24dbbacd6b1011804f10fdf4109e7d35e755" target='_blank'>
              Senescent cells promote viral infection-associated inflammation and tissue damage through a robust NF-κB pathway
              </a>
            </td>
          <td>
            Mingfu Tian, June Ma, Zhiqiang Li, Chenglin Ye, Xianghua Cui, Guolei Wang, Siyu Liu, Muhammad Suhaib Qudus, Uzair Afaq, Hong Fan, Jiali Xiong, Guangli Li, Chuanjin Luo, Zhen Wang, Zhengjiang Jin, Ming Guo, Xin Wang, Zhixiang Huang, Fang Zheng, Kailang Wu, Chengliang Zhu
          </td>
          <td>2025-10-28</td>
          <td>Cell Communication and Signaling : CCS</td>
          <td>0</td>
          <td>38</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/68a61536fdb213f77defcf43b41942dda2c2a3d0" target='_blank'>
              SARS-CoV-2 Variant-Dependent Alterations in Nasopharyngeal Microbiota and Host Inflammatory Response
              </a>
            </td>
          <td>
            Mario Maulen, Ignacio Pezoa-Soto, Daniel León, Ela M. Dominguez, Alberto J. M. Martin, W. Díaz-Vásquez
          </td>
          <td>2025-10-30</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>13</td>
        </tr>

        <tr id="Viral infections impose a substantial threat to human health, characterized by a wide range of pathogens, clinical manifestations, and complex immune responses. Single-cell multi-omics technologies have revolutionized the study of antiviral immunity by resolving cellular heterogeneity, transcriptional reprogramming, and clonal dynamics. However, no resource has yet comprehensively integrated such datasets in the context of viral infections. Here, we present scMOVIR, a single-cell multi-omics database for human viral infections and immune responses. The database systematically integrates transcriptomic, proteomic, and immune receptor repertoire profiles at single-cell resolution, compiling 8532 human samples across 114 viral species, subtypes, and strains. These datasets span 59 well-defined disease states, including acute and chronic infections, virus-associated malignancies, and immune-related disorders, and extend across >30 tissue types. In addition, these datasets incorporate vaccination cohorts, therapeutic interventions, and time-course models of infection. To ensure consistency and interoperability, all datasets undergo standardized preprocessing, including batch correction and unified cell-type annotation, with metadata harmonized using authoritative ontologies. scMOVIR provides user-friendly interfaces for dataset exploration and interactive visualization of cellular dynamics and molecular profiles, offering a high-resolution reference for investigating virus-host immune interactions and supporting antiviral research. The database is freely accessible at https://pgx.zju.edu.cn/scmovir.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/130c5b82f9725db7d1697918120f36ba3e49fd02" target='_blank'>
              scMOVIR: a single-cell multi-omics database for human viral infections and immune responses.
              </a>
            </td>
          <td>
            Xue Zhang, Shounan Yang, Xiaobin Xu, Yitao Lin, Huaicheng Sun, Bangyu Zhu, Wenyi Zhao, Binbin Zhou, Yan Lou, Xinyu Wang, Shuqing Chen, Qiaojun He, Feng Zhu, Zhan Zhou
          </td>
          <td>2025-11-13</td>
          <td>Nucleic acids research</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="Patients with femur fractures who are concurrently infected with COVID‐19 face a threefold increase in mortality, likely due to a compounded inflammatory response. Furthermore, sex‐specific differences in immune responses to COVID‐19 are well documented, implicating biological sex as a factor that can modulate disease severity in these comorbid conditions. Understanding the inflammatory interplay underlying this association is critical for the development of effective, targeted therapies to mitigate mortality. In this study, we investigated the systemic, sex‐specific inflammatory response in mice that sustain a fracture while infected with a murine coronavirus (MHV), which belongs to the same genus as SARS‐CoV‐2. The combined inflammatory insults of MHV infection and fracture (MHV + FX) disrupted systemic immunity in both females and males, producing immune dysregulation characterized by altered cell recruitment and a perturbed inflammatory cascade. In the MHV + FX group, females showed recovery toward a cytotoxic T cell dominant profile by Day 7, whereas males exhibited persistent cytotoxic T cell suppression with relatively higher T helper cells. Cytokine patterns were also sexually dimorphic: females displayed sustained increases in IL‐18 and TNF‐α in the MHV + FX group alone, whereas males showed distinct modulation of IL‐2/IL‐2R and transient changes in chemokines such as CCL7 and IL‐4 in both the MHV and MHV + FX groups. Notably, these differences were minimal or moderate in control or fracture alone groups. Our findings indicate that sex‐divergent immune programs under a dual viral‐trauma insult, marked by cytotoxic vs helper T‐cell biases and distinct cytokine signatures, help explain the heightened risk when COVID‐19 and fractures coincide. These insights support sex‐aware immunomodulatory strategies to improve outcomes for COVID‐19 patients with musculoskeletal trauma.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/82df6ea50d24aa4274f906f42c0817976127dd56" target='_blank'>
              Sexual Dimorphism in Systemic Inflammatory Responses to Femur Fracture in Mice Infected With SARS‐CoV‐2‐Like Virus
              </a>
            </td>
          <td>
            Matthew Patrick, Austin Foster, Arun Aneja, Ramkumar T. Annamalai
          </td>
          <td>2025-10-23</td>
          <td>Journal of Medical Virology</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the causative agent of COVID‐19, has caused widespread morbidity and mortality worldwide. SARS‐CoV‐2 infection triggers innate and adaptive immune responses, but excessive cytokine release can drive hyperinflammation, acute respiratory distress syndrome and poor clinical outcomes. Although serological and molecular assays, such as ELISA and RT‐qPCR, remain central to COVID‐19 diagnostics, they have limited capacity to reveal host–pathogen interactions at the tissue level. Therefore, profiling the human lung proteome offers a powerful strategy to identify molecular signatures associated with viral pathogenesis and disease severity. This review emphasises emerging technologies that advance lung proteome profiling during SARS‐CoV‐2 infection. Novel strategies include phage display for high‐throughput identification of antibody–antigen interactions, yeast two‐hybrid for mapping virus–host protein interactions and lateral flow immunoassays for rapid, point‐of‐care detection. Conversely, omics‐based technologies such as single‐cell RNA sequencing, microarrays and mass spectrometry are transforming our understanding of the lung proteome by revealing patterns of gene expression, protein abundance and immune heterogeneity. Therefore, comparing these conventional diagnostic assays with innovative approaches, we highlight their unique contributions to lung proteome research. These tools not only improve diagnostic precision but also hold the potential to uncover biomarkers for early risk stratification and therapeutic targeting. Prioritising integrative proteome‐focused strategies may ultimately guide personalised interventions and enhance preparedness for future viral outbreaks.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/bbbfd30116540e19ec56315bbd933a000cc82f6f" target='_blank'>
              Novel Strategies to Profile SARS‐CoV‐2 and Human Lung Proteome: Inflammatory Pathways in the Spotlight
              </a>
            </td>
          <td>
            E. Mankayi, T. E. Chiliza, N. Mvubu
          </td>
          <td>2025-01-01</td>
          <td>BioMed Research International</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0df155cef961a4919322a6e793a6b887b5332168" target='_blank'>
              Evolutionary rewiring of host metabolism and interferon signalling by SARS-CoV-2 variants
              </a>
            </td>
          <td>
            Riaz-Ali Somji, Jonathan C. Brown, Shahid Rowles-Khalid, Tukur Abdullahi, Dongsheng Luo, Natalie Barthel, Michael Mülleder, M. Ralser, Wendy S. Barclay, C. Rallis, E. S. Giotis
          </td>
          <td>2025-11-28</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>23</td>
        </tr>

        <tr id="Enterovirus D68 (EV-D68) is a significant global pathogen associated with severe respiratory infections and acute flaccid myelitis in children. Currently, there are no vaccines or antiviral drugs available for EV-D68, and a robust model to elucidate the pathogenesis of EV-D68 and evaluate treatment methods is lacking. We developed a mouse-adapted EV-D68 strain that caused progressive limb paralysis after intramuscular inoculation in 7-day-old mice. Viral load analysis showed that the skeletal muscle and spinal cord had the highest titers and most severe injuries. RNA sequencing of the infected muscle, brain, spinal cord, and lung tissues revealed differentially expressed genes (DEGs) associated with viral infection and pathogenesis. DEGs were significantly enriched in various pathways associated with antiviral immunity, interferon responses, and cytokine signaling. In the spinal cord, DEGs highlighted mitochondrial dysfunction and oxidative stress as crucial contributors to neural damage. Flow cytometry analysis of spinal cord cells showed that EV-D68 activates the immune system, leading to systemic inflammation and significant increases in CD8+ and CD4+ T cells, but limited neutrophil and monocyte infiltration. This mouse model provides a valuable tool for studying EV-D68 pathogenesis and evaluating antiviral and vaccine efficacy, thereby advancing the understanding of its neuropathological mechanisms. Importance: We developed a novel mouse model of EV-D68 that provides a valuable tool for studying its pathogenesis and evaluating antiviral and vaccine efficacy, deepening the understanding of its neuropathological basis.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ec65cdb91c340614db24a50d4f78be18da8803ac" target='_blank'>
              Spinal Cord Injury in Enterovirus D68 Infection: Mechanisms and Pathophysiology in a Mouse Model
              </a>
            </td>
          <td>
            Wei Duan, Jichen Li, Ying Liu, Rui Wang, Qian Yang, Huijie Li, Yucai Liang, Qi Shi, Jiao Wang, Jinbo Xiao, Jianfang Zhou, Qiang Sun, Yong Zhang
          </td>
          <td>2025-11-01</td>
          <td>Viruses</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="Bacterial infection is a key trigger of inflammatory pathways that damage the preterm brain, even without direct bacterial brain invasion. However, the mechanisms underlying the involvement of intracranial tissues and cells in early immune responses to acute systemic inflammation in preterm infants remain unknown. Lipopolysaccharide (LPS) was administered with a single intraperitoneal injection into postnatal day (P) 7 mice. Four hours later, the leptomeningeal macrophages initiated an intracranial reaction by producing IL-1β, which set the stage for the arachnoid, pial, and perivascular fibroblasts to act. These brain fibroblasts produced CCL2, which increased the number of brain parenchymal macrophages/microglia and led to their hypertrophy. The macrophages/microglia isolated from the brains of mice with systemic inflammation showed marked transcript expression of genes including Saa3, Irg1, Lcn2, and Cxcl9. The expression level of Saa3 reached its peak 4 and 12 h after LPS administration. Saa3 expression was upregulated in the macrophages in the leptomeninges, perivascular space, and cerebellar medulla, as well as in the fibroblasts of the leptomeninges, choroid plexus stroma, and perivascular space. The leptomeningeal macrophages expressing Saa3 continued their developmental migration from the leptomeninges to the brain parenchyma. The blood-brain barrier of pups remained intact up to 72 h after LPS administration at P7. The expression levels of Irg1, Lcn2, and Cxcl9 peaked 4 and 12 h after LPS administration. The cells that prominently expressed Irg1, Lcn2, and Cxcl9 were the leptomeningeal macrophages, perivascular fibroblasts and choroid plexus epithelial cells, and leptomeningeal fibroblasts, respectively. The early enhancement of Saa3 expression played a key role in priming inflammation initiated by macrophages and fibroblasts. Early enhancement of Irg1 expression was crucial for determining the direction of the inflammatory response. The increase of Lcn2 was vital, sequestering the iron siderophore to limit bacterial growth. It was interesting to observe how the early immune responses to systemic inflammation in the postnatal mouse brain were initiated by migrating macrophages and leptomeningeal fibroblasts, leading to immediate gene upregulation to protect immature brain tissue.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f0b35f26b99383b11b5240dc52d6f9e54408658a" target='_blank'>
              Early immune responses to systemic inflammation in the postnatal mouse brain initiated by migrating macrophages and leptomeningeal fibroblasts
              </a>
            </td>
          <td>
            Rei Settsu, Aki Obara, Takehiko Tarui, S. Hasegawa-Ishii, Atsuyoshi Shimada
          </td>
          <td>2025-10-11</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>19</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/6ff39811b58af3141f8b13471490c1f390abe0d9" target='_blank'>
              Non-canonical inflammasome drives intrinsic anti-microbial responses in human Natural Killer cells
              </a>
            </td>
          <td>
            N. G. Leborgne, Jadie Acklam, Alexander J. Hogg, Zarema Albakova, Karen Hogg, K. Robinson, Grant Calder, Arnel Villamin, Callum Robson, Freya Pealing, Matthew A. Care, Monika Gonka, James M. Fox, James Iremonger, J. Hewitson, David G. Kent, Alison M. Layton, Frances E. Pearson, Max E. Noble, W. Grey, Jillian L. Barlow, Dave Boucher
          </td>
          <td>2025-10-21</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>26</td>
        </tr>

        <tr id="


 Multiple sclerosis (MS) is a chronic disease of the central nervous system (CNS). Comparison of COVID-19 and MS brain autopsies showed similar neuropathology and preliminary work in our lab revealed the presence of immune cell aggregates in the meningeal layers surrounding the brain of Syrian Hamsters infected with SARS-CoV2. As such, it is critical to learn whether SARS-CoV2-induced brain pathology augments MS disease severity or accelerates progression. More specifically, we wish to determine whether SARS-CoV2 infection augments the neuropathogenic potential of myelin-primed Th17 cells in animal models of MS. I have established a working model in humanized ACE2 knock-in (hACE2-KI) mice that combines experimental autoimmune encephalomyelitis (EAE) with SARS-CoV-2 infection. Following resolution of infection with a non-lethal dose of the delta strain of SARS-CoV2, I induce passive EAE and assess: (1) clinical presentation of disease and (2) CNS pathology. Thus far, we have seen that mice with prior SARS-CoV2 infection exhibited reduced incidence of EAE by approximately 50% and less severe EAE clinical symptoms during the chronic phase of EAE. Immunophenotyping of the spinal cord revealed a reduction in CD4+ T cell numbers in these mice. These findings suggest that SARS-CoV2 infection prior to EAE reduces the impact of encephalogenic T cells and/or delays their progression to the CNS. We wish to further investigate the mechanism behind this observed phenotype.



 Supported by the Coronavirus Variants Rapid Response Network (CoVaRR-Net), the MS Society of Canada, and the Emerging and Pandemic Infections Consortium



 Neuroimmunology (NEUR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b0b463f6e24123fcf44514b3edccf3d2b816b173" target='_blank'>
              Impact of SARS-CoV2 infection on the neuropathogenic potential of myelin-primed Th17 cells in an animal model of MS 2436
              </a>
            </td>
          <td>
            B. Isho, Catherine Chi, Salma Sheikh-Mohamed, J. Gommerman
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>49</td>
        </tr>

        <tr id="Mutations or polymorphisms in GRN, encoding the CNS glycoprotein progranulin (PGRN), have been linked to several neurodegenerative diseases. In this study, we explored the role of PGRN in prion diseases. We observed that prion infection upregulated microglial PGRN expression. Following intracerebral inoculation with RML6 prions, Grn-/- mice exhibited accelerated disease progression compared to Grn+/- and Grn+/+ littermates. Histological analysis revealed augmented microglial activation in Grn-/- mice. Temporal analysis revealed enhanced early microglial activation and prion clearance at 120 dpi, followed by excessive complement activation but inadequate clearance by 150 dpi. Additionally, Grn-/- brains exhibited exacerbated astrogliosis and vacuolation. RNA-seq analysis indicated that complete PGRN deficiency in prion-infected mice shifted microglia from homeostatic to pro-inflammatory states. Notably, microglia-specific depletion of PGRN did not affect prion pathogenesis, suggesting that PGRN deficiency affects microglial activation and prion progression in a non-cell autonomous manner. These findings suggest that microglia respond to prion infection in a stepwise manner, and PGRN plays a critical role in modulating prion-induced microglial activation. Our results highlight the neuroprotective role of PGRN in prion disease and suggest that supplementation or boosting expression of PGRN could represent a promising therapeutic strategy.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/9ee59fe5ea0f47a6b4d9e13f7f501e11376bf5ad" target='_blank'>
              Ablation of progranulin augments microglial activation and accelerates prion progression
              </a>
            </td>
          <td>
            Bei Li, Yiyue Shi, Wenyu Hou, Haoyuan Guan, Jun Li, Tuo Yi, Wei Li, Donglin Cai, Petra Schwarz, Adriano Aguzzi, Caihong Zhu
          </td>
          <td>2025-10-13</td>
          <td>Acta Neuropathologica Communications</td>
          <td>0</td>
          <td>35</td>
        </tr>

        <tr id="Introduction Neuroinflammation triggered by viral infections is increasingly recognized as a driving force in neurodegenerative disease, promoting chronic neuronal injury and cognitive decline. A central mechanism in this process is impaired glutamate clearance due to downregulation of the astrocytic glutamate transporter GLT-1 (EAAT2/SLC1A2), which exacerbates excitotoxicity and neuronal death. Methods In this study, we assessed the neuroprotective effects of the β-lactam antibiotic ceftriaxone—a known upregulator of GLT-1—in an in vitro tri-culture model of neurons, microglia, and astrocytes challenged with the viral mimic polyinosinic:polycytidylic acid (Poly I:C). Results and discussion Poly I:C exposure elicited robust microglial and astrocytic activation and increased levels of TNF-α, IL-6, and IL-10. Concomitantly, we observed significant downregulation of GLT-1, synapse loss, impaired synaptic plasticity, and disrupted amino acid metabolism. A complementary Mendelian randomization analysis of GWAS data revealed that genetically determined alterations in plasma amino acid levels are significantly associated with the risk of five major neurodegenerative disorders, underscoring the role of metabolic dysregulation in disease pathogenesis. Treatment with ceftriaxone effectively reversed the Poly I:C–induced phenotypes: GLT-1 expression, dendritic spine density, and measures of synaptic plasticity were all restored, and abnormalities in amino acid and tricarboxylic acid cycle metabolites normalized. These findings highlight ceftriaxone’s multifaceted neuroprotective profile—modulating glutamate homeostasis, preserving synaptic integrity, and rebalancing metabolic pathways—and support its potential as a therapeutic agent to prevent neuronal degeneration in the context of virus-driven neuroinflammation.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/40b63bf1f6fcbfab7da258e50a2adaf9994182d6" target='_blank'>
              Ceftriaxone attenuates Poly I:C–induced neuroinflammation in vitro by modulating glutamate transport, synaptic integrity, and immunometabolic reprogramming
              </a>
            </td>
          <td>
            Xizi Shi, Yesheng Sun, Shirin Hosseini, Fangfang Chen, Thekla Cordes, Kristin Michaelsen-Preusse, Martin Korte
          </td>
          <td>2025-10-28</td>
          <td>Frontiers in Cellular Neuroscience</td>
          <td>0</td>
          <td>14</td>
        </tr>

        <tr id="Early immune perturbations increase the risk of neurodegenerative and neurodevelopmental disorders, yet the mechanisms underlying the maturation of microglia, the resident immune cells of the brain parenchyma, remain poorly defined. Specifically, how proliferation, morphological differentiation, and phagocytosis are coordinated among microglia progenitors as they colonize the embryonic brain remains unclear. Here, we combined mathematical modeling with spatiotemporal analyses of the murine hippocampus and cerebellum from postnatal day 2 (P2) to P60 to reconstruct the trajectory of microglial development. We identified a proliferative-to-quiescent (P/Q) switch around P3/P4 that preceded the acquisition of morphological complexity and efficient phagocytosis and was accompanied by coordinated shifts in cell-cycle dynamics and metabolic state. Strikingly, this P/Q switch was recapitulated in repopulation contexts in mice and in the human fetal brain, where later stages displayed enhanced phagocytic function coupled to reduced proliferation. Perturbing the proliferative phase through pharmacological or genetic disruption of CSF1R signaling impaired subsequent microglial complexity and phagocytosis efficiency, revealing an unexpected reliance of phagocytosis on proliferation-driven colonization. Finally, we show that microglia stepwise maturation during development is associated with chromatin remodeling and driven by the epigenetic regulator Ikaros. Together, these findings uncover the sequential milestones of microglial development, revealing a potential period of early vulnerability and establishing an unexpected linkage between proliferation and phagocytosis essential to understanding how these processes are coordinated in neurodegenerative disorders.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/bb674fe85695033b3a066007d0322414981ac69f" target='_blank'>
              Epigenetic control of microglial developmental milestones from proliferative progenitors to efficient phagocytes
              </a>
            </td>
          <td>
            Marta Pereira-Iglesias, Duncan Martinson, Carles Falcó, Joel Maldonado-Teixidó, Marco González-Domínguez, Rodrigo Senovilla-Ganzo, S. Beccari, Jorge Valero, Bella Mora-Romero, I. Ballasch, Sarah Viguier, Philipp Hane, Molly Boettiger, J. Reisz, Alba Elías-Tersa, Yasmina Manso, L. Parkkinen, A. M. Aransay, Federico N. Soria, A. D'alessandro, Eduardo Soriano, M. S. Thion, S. Garel, M. Greter, A. Giralt, Alberto Pascual, Fernando García-Moreno, D. Menassa, José A. Carrillo, Amanda Sierra
          </td>
          <td>2025-11-04</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>49</td>
        </tr>

        <tr id="As primary immune sentinels of the central nervous system (CNS), microglia respond rapidly to acute brain injury and engage in dynamic crosstalk with infiltrating peripheral immune cells. This interplay critically shapes the neuroinflammatory microenvironment—a key determinant of secondary brain injury (SBI) following intracerebral hemorrhage (ICH). Fatty acid-binding protein 4 (FABP4), an adipokine associated with metabolic disorders, is recognized as a pivotal modulator of inflammatory responses; however, its role in ICH-induced SBI remains undefined. To investigate the pathogenic functions of FABP4 in microglia after ICH, elucidate its molecular mechanisms, and develop targeted therapeutic strategies. Blood and brain tissue samples from ICH patients were analyzed to evaluate the relationships between FABP4 expression and prognosis. Behavioral tests, Nissl staining, and Golgi-Cox staining were used to quantify neuronal damage. Immunofluorescence and flow cytometry were used to assess microglial activation and immune cell infiltration. Transcriptomic, proteomic, co-immunoprecipitation, western blotting, and ChIP‒qPCR analyses were used to examine the FABP4 regulatory network. Brain-targeted nanoparticles were engineered to deliver FABP4-specific siRNA. Clinical analyses revealed microglia-specific FABP4 upregulation in ICH patients, correlating with poor neurological outcomes. Microglial Fabp4 knockout in mice attenuated neuronal loss, ameliorated cerebral edema, and enhanced functional recovery after ICH. Mechanistically, FABP4 promoted lipid droplet accumulation and inhibited the ubiquitin–proteasome-mediated degradation of S100A9 in microglia, synergistically amplifying neuroinflammation. Moreover, the activity of FABP4 in microglia facilitated neutrophil transendothelial migration into the brain parenchyma, exacerbating injury via the release of neutrophil extracellular traps (NETs). Finally, pharmacological FABP4 inhibition using brain-targeted nanoparticles conferred significant neuroprotective effects in ICH models. This study establishes that FABP4 acts as a novel orchestrator of post-ICH neuroinflammation through dual enzymatic and nonenzymatic pathways. We also demonstrate a targeted nanotherapeutic strategy to suppress FABP4 and improve neurological outcomes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/cbd6afea19f2780d62b43438f150276eb07542a8" target='_blank'>
              Fatty acid-binding protein 4 drives microglia-mediated neuroinflammation through promoting S100A9 expression and lipid droplet accumulation after intracerebral hemorrhage
              </a>
            </td>
          <td>
            Jiaqing He, Zijuan Qin, Haixiao Liu, Yaning Cai, Hao Wu, Tinghao Wang, Qing Hu, Yanni Xu, Pan Yang, Xun Wu, Yan Qu, Wei Guo
          </td>
          <td>2025-11-07</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="The simultaneous occurrence of tuberculosis (TB) and COVID-19 posed a major public health challenge, particularly in regions heavily impacted by both diseases, due to their shared effects on the lungs, immune system dysfunction, and the possibility of more severe clinical outcomes. The role of immunopathogenesis is crucial in influencing the progression of co-infection, which is marked by heightened inflammation, immune exhaustion, weakened T-cell responses, and unregulated cytokine production. To better understand the intricate interactions between host and pathogen and the immune disruptions associated with this dual epidemic, multi-omics approaches such as genomics, transcriptomics, proteomics, metabolomics, epigenomics, and microbiomics have proven to be effective methods. These comprehensive strategies provide detailed insights into the mechanisms of disease, help identify potential biomarkers, and aid in the identification of therapeutic targets. This review emphasizes the importance of immune responses and systems biology in comprehending the TB-COVID-19 syndemic and highlights the promise of multi-omics in advancing precision medicine and enhancing disease management.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0d3df397da3ddeae07ab95bd6589b7a3a1244d20" target='_blank'>
              Insights into Molecular Interplay in Tuberculosis–COVID-19 Co-Infection via Integrated Multi-Omics Strategies
              </a>
            </td>
          <td>
            Megha Chaudhari, Sunita Verma, Sushanta Deb
          </td>
          <td>2025-10-22</td>
          <td>J</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="Abstract Background Postacute sequelae of SARS-CoV-2 infection, also known as long COVID (LC), is a complex and heterogenous condition affecting millions worldwide with a poorly understood underlying pathology. Although metabolic dysregulations have been described in LC, it remains unclear whether circulating immune cells exhibit immunometabolic alterations. Methods We conducted a detailed clinical, immunologic, and mitochondrial analysis on 27 patients with LC and 27 who recovered from COVID-19 and were healthy. Symptom burden and severity were assessed and quantified via a digital platform with the modified COVID-19 Yorkshire Rehabilitation Scale. Mitochondrial function of circulating immune cell populations (lymphocytes and monocytes) was analyzed by measuring mitochondrial mass and mitochondrial membrane potential. Production of 11 cytokines after whole blood stimulation with bacterial and viral agonists was measured by multiplex immunoassay. Relationships between mitochondrial and immune parameters with LC symptoms were investigated. Results Patients with LC exhibited significant symptom burden, with worsening across all symptom domains as compared with their health state before SARS-CoV-2 infection. They also had a decreased mitochondrial membrane potential of CD56bright natural killer cells, particularly in patients experiencing dizziness, whereas reduced mitochondrial membrane potential in CD4+ lymphocytes was found in patients with worsening breathlessness. Upon LPS stimulation, patients with LC demonstrated significantly lower IFN-γ production. In response to viral ligand R848, impaired IFN-β and IL-10 responses were associated with worsening cough and executive functions. Conclusions Symptom severity in LC is associated with immune cell mitochondrial dysfunction and altered cytokine responses, highlighting potential disease biomarkers and targets for future therapeutic strategies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0904ca34a4e483fad93aba4e12dab5090971f617" target='_blank'>
              Digitally Assessed Long COVID Symptomatology Is Associated With Lymphocyte Mitochondrial Dysfunction and Altered Immune Potential
              </a>
            </td>
          <td>
            Vasile Mihai Sularea, L. Townsend, Cian Reid, Andreea V Atanasescu, A. Dyer, F. Giangrazi, R. Lawrence, Manoj Sivan, Barry Moran, Derek G Doherty, Niall P Conlon, A. Long, Cliona O’Farrelly
          </td>
          <td>2025-11-01</td>
          <td>Open Forum Infectious Diseases</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="COVID-19 is a multi-system disease that affects not only the respiratory system but also the neurological, hematological, and immune cells and tissues. The understanding of how the virus infiltrates and impacts a diverse set of human cells is still incomplete. This work examined bulk RNA-seq data from recovered COVID-19 patients (COVID-19 survivors with or without post-acute complications) to uncover the persisting perturbations in biological pathways. The investigation also analyzed the transcriptomic signatures in the lungs and brain tissues of deceased patients during the acute phase of infection to understand COVID-19 impact on these organs. In recovered COVID-19 patients, the severity of acute COVID-19 influenced the subsequent disturbance of gene expression patterns in the post-acute disease phase. Gene expression patterns in the lungs and brain tissues of deceased COVID-19 patients correlate with the diverse pulmonary and neurological symptoms observed in these patients. We have detected significant alterations in the expression of mitochondrial genes, such as COX7C, COX7A2, ATP5PO, ATP5F1C and NDUFB8, which reflect a compensatory upregulation in response to viral suppression of mitochondrial function. This COVID-19 induced response persists up to 24 weeks post-infection, suggesting a sustained effort of the host to mitigate mitochondrial dysfunction. Additionally, in critical and severe COVID-19 cases, gradual upregulation of UBE3A expression was detected, which previously has been linked to favorable COVID-19 outcomes. Long-term anosmia related SHH gene was upregulated in recovered critically-ill COVID-19 patients. IL6 emerged as a central hub gene consistently expressed in both lung and brain tissues of deceased COVID-19 patients, underscoring its role in driving the inflammatory pathophysiology of COVID-19 within these organs. Collectively, our study emphasizes IL6 as a central cytokine driving the inflammatory response in both lung and brain tissues, and demonstrates the virus’s capacity to induce long-lasting changes in nuclear-encoded mitochondrial gene expression in the blood of recovered patients. Our findings have significant implications for developing targeted interventions for post-COVID-sequelae.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a404a8f1d8876ed3a8c4d5cb1c99d51ab2f6b6a8" target='_blank'>
              Peripheral blood, lung and brain gene signatures in recovered and deceased patients with COVID-19
              </a>
            </td>
          <td>
            Eric Twum, Ancha Baranova, Aman Ullah
          </td>
          <td>2025-10-22</td>
          <td>In Silico Pharmacology</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="Introduction Despite extensive research, the pathogenesis and predispositions underlying long COVID (long-term coronavirus disease 2019) remain poorly understood. Methods To address this, we analyzed the immunological landscapes of 44 patients with long COVID and 44 matched convalescents using single-cell RNA sequencing (scRNA-seq) of peripheral blood mononuclear cells (PBMCs) and validated the findings with plasma cytokine measurements via Luminex technology. Results While the immune cell compositions showed minimal quantitative differences only among natural killer (NK) cells, the transcriptome analyses identified distinct gene expression patterns, particularly in classical monocytes: patients with long COVID exhibited downregulation of the inflammation-associated genes, including IL1B and CXCL2. Imputation of the transcription factor activity hinted at a reduced inflammasome activity (via SNAI1) and an impaired monocyte differentiation (via ATF2) in long COVID. The RNA velocity data supported the presence of immature classical monocytes in these patients. Discussion These findings show that monocytes might be dysregulated and/or exhausted in patients with long COVID.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/3892a0439deb222191d646b042b2e39ae2bf0fef" target='_blank'>
              Transcriptome analysis of classical blood cells reveals downregulation of pro-inflammatory genes in the classical monocytes of long COVID patients
              </a>
            </td>
          <td>
            Florian Fricke, Franz Mai, Christine Wossidlo, Felix Steinbeck, Wendy Bergmann-Ewert, Marcel Kordt, Karin Kraft, Britta Müller, Emil C. Reisinger, Brigitte Müller-Hilke
          </td>
          <td>2025-11-07</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) preferentially infects airway epithelial cells. This infection is mediated by the binding of SARS-CoV-2 spike (S) protein to ACE2 expressed on target cells. Patients with allergic (type-2) asthma have been reported to be less susceptible to coronavirus disease 2019 (COVID-19), but these effects are controversial and mechanistically unclear. We previously showed lower expression of ACE2 mRNA in airway epithelial cells from type-2 asthmatics compared to healthy donors. Moreover, we and others demonstrated that the type-2 cytokine interleukin 13 (IL-13) suppresses ACE2 expression and SARS-CoV-2 infection in human epithelial cells. To better understand the relationship between type-2 inflammation, ACE2 expression, and SARS-CoV-2 infection, we investigated the effects of IL-13 on critical steps of epithelial cell infection by SARS-CoV-2: S protein-mediated binding to ACE2 on epithelial cells, and ACE2-mediated SARS-CoV-2 entry into these cells. Recombinant IL-13 significantly inhibited both these processes. This inhibition appeared to be mediated by IL-13-induced suppression of ACE2 transcription because IL-13 failed to affect S protein-mediated viral entry into cells that express ACE2 under the control of an IL-13 unresponsive heterologous promoter. We propose that IL-13 protects epithelial cells from SARS-CoV-2 infection largely by inhibiting ACE2 expression and ACE2-mediated downstream events that allow the virus to access its cellular targets.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/df8083f73ae8478fb1031798b020e6d2348e4b62" target='_blank'>
              IL-13 protects epithelial cells from SARS-CoV-2 infection by inhibiting ACE2-mediated virus binding and cell entry
              </a>
            </td>
          <td>
            Vadim Pivniouk, Oksana Pivniouk, J. Uhrlaub, Seongmin Hahn, Allyson Molzahn, Hiroki Kimura, Mari Numata, H. Chu, J. Ledford, Monica Kraft, J. Nikolich, Donata Vercelli
          </td>
          <td>2025-11-24</td>
          <td>ImmunoHorizons</td>
          <td>0</td>
          <td>28</td>
        </tr>

        <tr id="


 SARS-CoV2 infection is uniquely characterized by the sudden onset of anosmia and dysgeusia in many individuals. While most recover, a subset continues to experience persistent symptoms known as long-COVID, with 30% reporting dysgeusia. In our long-COVID cohort, objective testing revealed significant distortion in the perception of bitter and sweet tastes. Although polymorphisms in TAS2R38 and gustin genes are linked to bitter taste perception, haplotype analysis in our long-COVID cohort was inconclusive. We hypothesized that a disrupted homeostasis between taste cell loss and replenishment due to chronic inflammation leads to dysgeusia. Single cell transcriptomic analysis revealed cellular heterogeneity including epithelial cells (such as KRT14, KRT15, SPRR3), cells exhibiting neuronal markers (such as SNAP25, SNAP47, KCNQ2) suggestive of taste receptor cells and immune cells in saliva. However, differences in marker expressions between the long-COVID and healthy cohort were not significant except for inflammatory chemokine and interleukin genes. Immunofluorescence and flow cytometry confirmed the presence of epithelial cells, taste receptor like cells and immune cells in saliva. Elevated proinflammatory cytokine expression in saliva indicated persistent localized inflammatory immune response. Collectively these findings suggest that persistent epithelial-neuro-immune response locally in the tongue following SARS-CoV2 infection contributes to the dysgeusia in long-COVID.



 DENTAL RESEARCH FOUNDATION #44-76-254



 Innate Immune Responses and Host Defense: Molecular Mechanisms (INM)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/605d94a3b6b43a60bc2e61018169ec477647406c" target='_blank'>
              Epithelial-neuro-immune dynamics in dysgeusia triggered by chronic viral infection 3795
              </a>
            </td>
          <td>
            Shveta Jaishankar, David Schaeper, S. Janga, Mythily Srinivasan
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>39</td>
        </tr>

        <tr id="Mpox re-emerged globally in 2022 with atypical clinical features and efficient human-to-human transmission, which underscores the need to better understand host immune responses. We conducted an integrative transcriptomic analysis of mpox virus (MPXV) infection in nonhuman primates by leveraging RNA-Seq datasets from whole-blood and skin. We applied the Generalized Linear Model with Quasi-Likelihood F-test and Magnitude-Altitude Score (GLMQL-MAS), a method that combines rigorous statistical testing with a ranking metric to identify and prioritize differentially expressed genes (DEGs), and the Cross-Magnitude-Altitude Score (Cross-MAS) gene selection strategy, which integrates results across multiple time points to identify reproducible signatures, to define compact and robust markers of infection. Longitudinal analysis of whole-blood revealed a staged immune trajectory: early induction of interferon-stimulated genes (IFI27, ISG15) was followed by proliferative and hematopoietic programs and later enrichment of adaptive immune signatures, including B cell activation and TNF signaling. A minimal six-gene panel (IFI27, ISG15, MYO7B, HEY1, VASH1, CNTD2) distinguished infected from control animals with 100% accuracy in both training and independent held-out test sets. In contrast, skin transcriptomes showed upregulation of keratinocyte-related genes (KRT10, KRT1, SOSTDC1) and downregulation of immune mediators (IL1B, CXCL8, S100A8, ISG15), which suggests epithelial remodeling with limited local immune activation. Cross-tissue comparisons revealed that under stringent criteria (BH-adjusted p-value < 0.05 and |log₂FC|> 1), only 10 genes were commonly significant between whole-blood and skin, and all (100%) exhibited opposite regulation. When thresholds were relaxed for exploratory purposes (unadjusted p-value < 0.05 and |log₂FC|> 1), 58 common significant immune-related genes were identified from the curated nCounter® Host Response Panel, of which 74.1% were oppositely regulated. Shared immune genes such as ISG15, MX1, IFIT2, and OAS2 were upregulated in blood but suppressed in skin, and Reactome enrichment of discordant genes highlighted interferon and cytokine signaling pathways. These contrasts suggest that MPXV may trigger systemic interferon activation while suppressing local antiviral responses in lesions; however, because they are derived from independent secondary datasets in different species, they should be regarded as hypothesis-generating signals that require confirmation in matched, longitudinal studies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f42e167ab73e8ee0f1b9da83613dfa3150236874" target='_blank'>
              Opposite regulation of immune genes in blood and skin highlights tissue-specific dynamics of mpox virus
              </a>
            </td>
          <td>
            Mostafa Rezapour, Sean V. Murphy, D. Ornelles, Patrick M. McNutt, Anthony Atala
          </td>
          <td>2025-11-07</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>34</td>
        </tr>

        <tr id="Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) closely interacts with host cellular mechanisms, with mitochondria playing a crucial role in this process. As essential organelles that control cellular energy production, apoptosis, reactive oxygen species (ROS) metabolism, and innate immune responses, mitochondria are vital to the development of COVID-19. However, the exact molecular interactions between mitochondria and SARS-CoV-2 remain under active investigation. Gaining a comprehensive understanding of mitochondrial involvement in SARS-CoV-2 infection is therefore essential for uncovering complex disease mechanisms, identifying prognostic biomarkers, and developing effective treatments. Ultimately, exploring these virus–host interactions may provide new insights into the fundamental and complex aspects of mitochondrial physiology and pathophysiology.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/14c37c435aca0f6081c81be5983a6d3cd20878ee" target='_blank'>
              Mechanisms of Mitochondrial Impairment by SARS-CoV-2 Proteins: A Nexus of Pathogenesis with Significant Biochemical and Clinical Implications
              </a>
            </td>
          <td>
            Marco Refrigeri, Alessandra Tola, Rosangela Mogavero, Maria Michela Pietracupa, Giulia Gionta, Roberto Scatena
          </td>
          <td>2025-10-01</td>
          <td>International Journal of Molecular Sciences</td>
          <td>1</td>
          <td>1</td>
        </tr>

        <tr id="

 The long-term dynamics of T-cell immunity following SARS-CoV-2 vaccination, essential for durable protection, remain incompletely understood. This study, therefore, aimed to investigate the kinetics and persistence of spike-specific T-cell responses in vaccinated healthcare workers.



 Within the framework of the ORCHESTRA Project, we conducted a longitudinal study on the kinetics and persistence of CD4+ and CD8+ T cell immunity in healthcare workers (n=305) from four hospitals and public health centers across two European countries who received either 2 or 3 doses of an mRNA vaccine, with or without prior SARS-CoV-2 infection. Specifically, the anti-spike adaptive immune cellular response was evaluated, focusing on its crosstalk with the B cell response as measured by serology. Circulating cellular adaptive immune cells were extensively analyzed using flow cytometry to assess pro-inflammatory cytokine production (TNF-α, IFN-γ, IL-2), functional activation (CD154), and memory differentiation (CD45RO).



 Our findings show that anti-spike T cell reactivity is not influenced by age, with the only exception of a weak positive correlation with spike-specific CD8+CD45RO+ T lymphocytes (Spearman’s rho = 0.34, p<0.001), and an equally weak negative correlation with CD8+TNF+ (Spearman’s rho = -0.23, p<0.01). Other variables, such as gender and job category, did not significantly impact the vaccine-induced, anti-spike T cell immune response.



 No distinct relationship between CD4+ and CD8+ T cell subsets was observed post-vaccination. However, specific dynamic changes in vaccine-induced T cells were identified showing clear dose- and time-dependence. Finally, the median level of CD8+CD154+ lymphocytes, indicative of activated T cells, was significantly associated with infection incidence and may represent a reliable predictive biomarker. This study provides evidence that the vaccine-induced anti-spike cellular immune response should be considered when making vaccination decisions, as it has predictive value for infection risk.
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/07ae26ae5551412fdb1a4df495b2f7c4fe3ee344" target='_blank'>
              A comprehensive longitudinal analysis of the cellular immune response specific to the spike protein in healthcare workers vaccinated against SARS-CoV-2– ORCHESTRA Project
              </a>
            </td>
          <td>
            S. Ugel, Akshita Gupta, Gianluca Spiteri, P. Marchetti, F. De Sanctis, Shari Wouters, Angelina Konnova, M. Monaco, A. Carta, M. Pezzani, F. Liviero, S. Pavanello, Marco dell’Omo, Eleonóra Fabiánová, Jana Bérešová, F. Larese Filon, Marcella Mauro, Giuseppe Verlato, Vincenzo Bronte, Samir Kumar-Singh, S. Porru
          </td>
          <td>2025-11-25</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>38</td>
        </tr>

        <tr id="Introduction Long COVID (LC) affects approximately 10% of individuals post-SARS-CoV-2 infection, with symptoms persisting beyond 12 weeks. The underlying mechanisms remain unclear, and current models often focus on pre-existing comorbidities. Methods This cohort study aimed to identify robust biomarkers and clarify LC pathogenesis through a comprehensive analysis performed in 32 LC individuals 26 months post-infection compared with 35 fully recovered individuals recruited between March and July 2022. Blood and fecal samples were collected, and multiple parameters associated with immune dysfunction, endothelial damage, bacterial translocation, and coagulation alterations, alongside signs of viral persistence and sociodemographic and clinical features, were analyzed. Results Although viral RNA was undetected on blood or stool, elevated plasma IgG against the nucleocapsid may indicate frequent reinfections, greater infection severity, or delayed immune normalization. Increased levels of prothrombin, thrombin, fibrinogen, sEPCR, and CRP pointed to persistent endothelial dysfunction and coagulation imbalance. Lower levels of the bactericidal protein REG3A suggest potential disruptions in mucosal immune response. We found no major differences in traditional comorbidities, highlighting that LC may stem from distinct pathogenic mechanisms beyond pre-existing conditions. Importantly, our study revealed impaired humoral immunity and identified an association between vaccine heterogeneity and increased LC risk, emphasizing the relevance of consistent vaccination strategies. A Random Forest model using the measured biomarkers achieved 100% accuracy in classifying LC individuals, reinforcing their diagnostic potential. Discussion These findings support a multifactorial model of LC involving immune dysregulation and persistent endothelial damage that led to coagulation abnormalities and a pro-thrombotic profile, supporting that LC is more closely related to a sustained, uncontrolled inflammatory response rather than immunodeficiency, and underscoring the value of multidimensional biomarker profiling for guiding clinical management and prevention strategies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/06f623d391f1681dd1b187cc2fd209fa57362606" target='_blank'>
              Immune dysregulation and endothelial dysfunction associate with a pro-thrombotic profile in Long COVID
              </a>
            </td>
          <td>
            Alicia Simón-Rueda, Clara Sánchez-Menéndez, G. Casado, Daniel Fuertes, María Aránzazu Murciano-Antón, E. Mateos, Susana Domínguez-Mateos, Francisco Pozo, Javier García-Pérez, M. Pérez-Olmeda, Miguel Cervero, M. Massanella, Gemma Moncunill, Montserrat Torres, M. Coiras
          </td>
          <td>2025-10-16</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>34</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d6db7c438373e1be32f3e8f8962c7eb002d2e0ff" target='_blank'>
              Single-cell profiling reveals that dynamic lung immune responses distinguish protection from susceptibility to tuberculosis
              </a>
            </td>
          <td>
            Fergal J. Duffy, M. L. Neal, Courtney R. Plumlee, Sarah Cohen, B. Gern, A. Diercks, Michael Y Gerner, K. Urdahl, J. Aitchison
          </td>
          <td>2025-10-16</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>36</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2fef0ecf5b990a10a1f0fae7554cfa28ceb163d2" target='_blank'>
              SARS-CoV-2-induced damage to rat cortical neuronal networks ex vivo is mediated by the pro-inflammatory activation of the cGAS-STING pathway.
              </a>
            </td>
          <td>
            Pamela Martinez-Orellana, Matteo Manzati, Diletta Pozzi, Yingying Xiao, Alessio Di Clemente, Marika Mearelli, Chiara Kalebić, Valentina Perrera, Denise Ferrarini, Tea Carletti, Carmen Falcone, Michele Giugliano, Alessandro Marcello
          </td>
          <td>2025-10-25</td>
          <td>Journal of neurovirology</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5d5581192995f28d24b781c1e7c2e69bf2aa53d8" target='_blank'>
              Systems Immunology of Long Covid: Insights from the STOP-PASC Clinical Trial
              </a>
            </td>
          <td>
            E. Maestri, W. J. Kwon, H. Zheng, T. Prestwood, H. Hedlin, J. W. Liang, H. McCann, B. Shaw, , B. Jones, , G. Wiley, E. Haraguchi, O. Wirz, J. Afaghani, B. Lam, D. F. D. Mahmood, N. A. Phillips, M. M. S. Sim, , J. R. Heath, S. D. Boyd, J. Guthridge, U. Singh, H. Bonilla, P. Jagannathan, P. Utz, L. Geng, P. Khatri
          </td>
          <td>2025-12-05</td>
          <td>None</td>
          <td>0</td>
          <td>61</td>
        </tr>

        <tr id="Despite effective viral suppression with antiretroviral therapy (ART), people living with HIV (PLWH) experience persistent inflammation, immune dysfunction, and premature onset of cardiovascular and aging-related comorbidities. To define the underlying mechanisms, we performed longitudinal transcriptomic profiling in peripheral blood mononuclear cells (PBMCs) from a cohort of simian immunodeficiency virus (SIV)-infected rhesus macaques spanning four key stages: pre-infection, acute infection, short-term ART, and long-term ART. Bulk RNA sequencing revealed dynamic immune remodeling across infection and treatment. Acute SIV infection induced robust antiviral and inflammatory programs, with upregulation of interferon-stimulated genes (ISGs), IL-27, JAK/STAT, and NF-κB signaling, coupled with suppression of T- and B-cell activation pathways. Short-term ART effectively reversed these transcriptional perturbations, restoring adaptive immune gene expression and reducing innate antiviral responses to near-baseline levels. In contrast, chronic SIV infection on long-term ART maintained viral suppression but was characterized by reactivation of innate immune pathways, including TLR2/TLR4/MYD88, NF-κB, and inflammasome (NLRP3/or NLRP12, caspase-1) signaling, along with sustained macrophage activation, platelet/coagulation signaling, and senescence-associated secretory phenotype. Protein analyses confirmed persistent CASPASE-1 and NF-κB activation in spleen tissue. Pathologic evaluation of a carotid artery from an SIV-infected, long-term ART– treated macaque revealed macrophage-rich plaques with p21⁺ senescent cells with intraluminal thrombus formation, recapitulating key features of HIV-associated atherogenesis. Together, these findings demonstrate that while ART normalizes acute infection–induced immune dysregulation, chronic SIV infection sustains a chronic, macrophage- and TLR-driven inflammatory state linked to vascular injury and aging process regardless of long-term suppression of viremia. Targeting inflammasome, NF-κB, and senescence pathways may mitigate non-AIDS comorbidities in PLWH.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c7a8f96a2324d1327914a92bba9009e04dbf070e" target='_blank'>
              Persistent Activation of Monocytes/Macrophages and Cell Senescence in SIV-Infected Macaques on ART
              </a>
            </td>
          <td>
            Yilin Chen, Xiaofeng Ding, Sonalika Ray, Siva Thirugnanam, Robert V. Blair, Ahmad Saied, S. Sukhanov, J. Kolls, Woong-Ki Kim, P. Delafontaine, Jay Rappaport, Xuebin Qin, Namita Rout
          </td>
          <td>2025-11-06</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>46</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c67902287b707e2a864fa94a99930bc5171cdb8e" target='_blank'>
              Susceptibility of Human Neural Stem Cells to SARS-CoV-2: Entry Mechanisms and Glycocalyx Influence
              </a>
            </td>
          <td>
            Ann Song, Cori Zuvia, P. Talbot
          </td>
          <td>2025-11-10</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>43</td>
        </tr>

        <tr id="In the context of neurodegeneration, activated microglia facilitate inflammation via secretion of TNF-α, IL-1α, and C1q. Astrocytes exposed to this signaling array polarize to a reactive inflammatory phenotype, termed A1 or A1-like. Astrocytes are essential for neuronal survival, synaptic support, and blood–brain barrier (BBB) function, but A1-like astrocytes upregulate inflammatory gene expression, downregulate neurotrophic factors, and secrete neurotoxic signals. The consequences of A1-like polarization on BBB function are unknown but may have etiological implications for some diseases. Frequently identified by upregulation of complement component 3 (C3), A1-like astrocytes have been characterized in neurodegenerative disorders like Alzheimer’s disease, with polarization correlated with disease progression and severity. However, the role of A1-like astrocytes in neurodegeneration associated with chronic viral infections, like HIV-1-associated neurocognitive disorder (HAND), remains unclear. An in vitro system using primary human astrocytes, as well as a BBB model featuring primary human brain microvascular endothelial cells (BMECs) co-cultured with astrocytes, was used to elucidate cellular and molecular consequences of chronic astrocyte activation. As measured by whole transcriptome analysis and protein expression assays, repeated treatment with TNF-α, IL-1α, and C1q induced A1-like polarization of astrocytes both in monoculture and in a BBB model, resulting in increased secretion of pro-inflammatory signals. No substantial change to BBB permeability was observed. In contrast, exposure to HIV-1 viral protein Tat did not independently induce A1-like polarization. Ongoing investigations into the effect of astrocyte polarization on BBB integrity and treatment with pathogenic proteins may provide insights into the role of neurotoxic astrocytes in neurovirologic pathologies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/33a034aeaf82d86cd18ab74f1a0b8c466df7ff53" target='_blank'>
              Inflammatory microglia signals drive A1-like polarization of astrocytes even in the presence of HIV-1 Tat
              </a>
            </td>
          <td>
            Jill M. Lawrence, W. Dampier, J. Mell, Diehl R. De Souza, Kayla Schardien, Kyle Yeakle, R. J. Barnett, Bhaswati Sen, Azad Ahmed, Michael Bouchard, Brian Wigdahl, Micheal Nonnemacher
          </td>
          <td>2025-12-04</td>
          <td>Molecular Neurobiology</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/9df2277f357c0fd18798c74d6fb74d89892b540f" target='_blank'>
              Spatiotemporal-multimodal integration reveals BCG-induced skin-blood crosstalk
              </a>
            </td>
          <td>
            Amrit Singh, Ole Bæk, F. Schaltz-Buchholzer, James Campbell, N. P. West, Basam Elgamoudi, Anita J Campbell, Elsi J. C. Ca, S. Tebbutt, C. Shannon, P. Aaby, Tobias R. Kollmann, C. S. Benn, Nelly Amenyogbe
          </td>
          <td>2025-11-19</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>20</td>
        </tr>

        <tr id="Inflammatory responses including glial activation, and upregulated inflammatory factors occurred after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected central nervous system. Blood-brain barrier (BBB) disruption has been implicated in coronavirus disease 2019 (COVID-19) pathogenesis and may predispose to the long-lasting neurological damage even after the epidemic ends. The BBB is a highly selective dynamic interface to protects the brain from neurotoxins and the elimination of byproducts of brain metabolism via efflux transporters. The COVID-19 pandemic has introduced new challenges in managing neurological conditions, and understanding SARS-CoV-2 journey through BBB and the interconnections between the members of BBB is crucial. This review aims to summarize and elucidate the damage to the main constituent cells of BBB, including brain microvascular endothelial cells, astrocytes, and microglia and its contribution to COVID-19. Further understanding of these interactions may facilitate the development of improved treatment options and preventative measures of central nervous system injury due to COVID-19.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/85e1f8e6db59f325d648f88b5923eb205b1a3a64" target='_blank'>
              Exploring SARS-CoV-2 impact on blood-brain barrier and its composition: A review
              </a>
            </td>
          <td>
            Jin Li, Shangfu Xu, Sixu Guo
          </td>
          <td>2025-11-21</td>
          <td>Medicine</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="A hallmark of COVID-19 patients is the reduction of the lymphocyte population accompanied by activation, senescence, and exhaustion markers. We investigated patients admitted to hospital wards who either recovered after a short hospitalization or progressed to critical illness. Patients (n=48) were recruited between May and September 2020; 19 healthy volunteers were enrolled as controls. Blood samples were collected on days 0, 3, and 7 of hospitalization and around 30 days after discharge (convalescence sample, CS30). Lymphocyte counts and extended immunophenotyping were performed by flow cytometry and analyzed using conventional and stochastic methods. At D0 and D7, total lymphocytes, natural killer cells, T cells, TCD4 cells, and TCD8 cells were lower in patients than in volunteers but were restored at CS30. The stochastic analysis identified 11 distinct clusters of lymphocytes, nine of them with significant differences between patients and healthy controls. Clusters of TCD8+ memory cells showing activation, senescence, and exhaustion were increased in patients during hospitalization and in the convalescence samples. In contrast, clusters 5 (TCD4+ Central Memory exhausted activated) and 7 (TCD4+ Central Memory exhausted) were decreased in patients during the disease compared to healthy controls. Overall, the conventional flow cytometry analyses corroborated the findings from the stochastic analysis, showing that effector memory (EM) and TEMRA subsets exhibited sustained markers of exhaustion and senescence, particularly in TCD8+ cells. Our findings reinforce lymphopenia, T cell activation, senescence, and exhaustion as essential immunological features of COVID-19; while cell counts fully recovered, lymphocytes remained dysfunctional in convalescent samples.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ccf36a0bfe213bfeb842f9d7a3a65163a5e63e4c" target='_blank'>
              Tracking immune dysregulation in COVID-19: lymphocyte dynamics from hospitalization to recovery
              </a>
            </td>
          <td>
            G.S. Eburneo, M.B. Sousa, M. Brunialti, S. Santos, J.G.D. Silva, P. Ferreira, N.C.J. Bellei, J.S.O. Arakaki, G. Leite, R. Salomão
          </td>
          <td>2025-11-14</td>
          <td>Brazilian Journal of Medical and Biological Research</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="


 SARS-CoV2 devastated the world in 2019, with over 774 million cases and around 7 million deaths. Our lab has previously reported the role Caspase-4/11 plays in the innate immune response against SARS-CoV2, associating it with exacerbated lung pathology and immunothrombosis, indicating its therapeutic potential. In a recent project, we investigated how Casp-11 affects the adaptive immune response. We infected C57/BL6 mice expressing or lacking Casp-11 with the mouse-adapted SARS-CoV-2 strain (MA10). We then assessed the mice for signs of severe disease, such as weight loss, and their localized and systemic immune responses, measuring virus-specific immunoglobulins, circulating or lung resident CD4+ and CD8+ T cells (Trm), and lung cytokines. Our results indicated that Casp-11-/- mice have faster recovery than wild-type mice, along with reduced proinflammatory cytokine levels, further confirming the role of Casp-11 in lung inflammation. Additionally, the number of virus-specific CD8+ Trm cells was significantly lower in Casp-11-/- mice’s lungs than in wild-type mice. However, both groups’ levels of virus-specific CD4+ Trm and lung IgGs remained comparable. Notably, Casp-11-/- mice had higher serum levels of spike-specific IgG, suggesting a potential dichotomy in the localized versus systemic immune responses. These findings indicate that targeting Casp-11 may effectively decrease disease severity while improving the acquired protective immune response.



 Viral Immunology (VIR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d1a9cc4379a0daa37f9489968ae37c42b020811d" target='_blank'>
              Caspase-4/11 induces lung inflammation and dampens the humoral immune response in SARS-CoV2 infected mice 3644
              </a>
            </td>
          <td>
            Mohamed Medhat Samir Ibrahim Ahmed Shamseldin, Mostafa Eltobgy, Heba M Amer, Owen Witham, Jihad Omran, Rabab Abdelaleem, Amal O Amer
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="Long COVID (LC) is characterized by a wide range of symptoms, the causes of which remain unclear. We investigated associations between inflammatory and coagulation factors, adaptive immune response to SARS-CoV-2, and LC. We enrolled 196 unvaccinated individuals with SARS-CoV-2 (March–June 2020). Blood samples were collected at three (T3M) and twelve (T12M) months post infection. Plasma concentrations of coagulation factors (D-Dimer, E-Selectin, ICAM-1, VCAM-1) and inflammatory markers (IL-6, IL-8, TNF-α, IL-1β) were measured by ELISA, and SARS-CoV-2-specific T-cell response was assessed by Elispot. LC occurred in 66/196 patients (34%); 77.8% had been hospitalized. Respiratory symptoms were present in 54%, fatigue in 30%, and neuropsychological symptoms in 14%. At T3M, hospitalized patients exhibited higher levels of ICAM-1, VCAM-1, and IL-6, along with increased immunoreactivity. LC patients exhibited elevated IL-8 and TNF-α and enhanced immunoreactivity at T3M, though these differences were not observed at T12M. Inflammatory and coagulation markers were altered at three months after acute infection, with some changes persisting at one year, suggesting a long-term immunological impact of SARS-CoV-2 on the inflammatory response. A SARS-CoV-2-specific T-cell response was still detectable at T12M, albeit at a lower level than at T3M, suggesting the persistence of protective memory T-cells beyond the acute phase.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/661662040cb49d22a81b08c21000921af6c27b9d" target='_blank'>
              Inflammatory Milieu and Specific T-Cell Response Observed Three Months and One Year After SARS-CoV-2 Infection in Long COVID Subjects
              </a>
            </td>
          <td>
            E. Cimini, A. Vergori, C. Cimaglia, Eleonora Tartaglia, S. Notari, F. Colavita, G. Matusali, I. Mastrorosa, V. Mazzotta, P. Chinello, P. Mencarini, M. L. Giancola, A. Abdeddaim, R. Casetti, G. Grassi, Simona Gili, Flavia Cristofanelli, F. Maggi, P. Piselli, E. Girardi, A. Antinori, M. Camici
          </td>
          <td>2025-10-27</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>35</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4b30b34de10d73c9f922bb678272c07c41f6fdb9" target='_blank'>
              Dysregulation of homeostatic cytokine receptors drives prolonged T cell activation following acute SARS-CoV-2 infection in humans.
              </a>
            </td>
          <td>
            Laura Ceglarek, Patrick Taeschler, Alp Inci, Yves Zurbuchen, Sarah Adamo, Carlo Cervia-Hasler, M. E. Raeber, O. Boyman
          </td>
          <td>2025-11-27</td>
          <td>Nature communications</td>
          <td>0</td>
          <td>63</td>
        </tr>

        <tr id="Primary open-angle glaucoma (POAG), a leading cause of irreversible blindness, involves complex neurodegeneration in which the contribution of systemic immunity remains enigmatic. Here, we dissect the circulating immune landscape in POAG patients via high-resolution single-cell RNA sequencing of ~1.4 million peripheral blood mononuclear cells (PBMCs) from 110 patients and 110 controls of Chinese ancestry. We revealed significant immune remodeling in POAG, characterized by increased CD4+ T lymphocytes and myeloid cells and impaired cytolytic potential, as evidenced by reduced cell proportions of terminally differentiated CD8+ GZMK+ T cells and NK cells. Transcriptomic analysis revealed a sophisticated dual transcriptional landscape in which both proinflammatory and neuroprotective signaling pathways coexist across multiple immune cell lineages. While TNF and IFNG pathway genes were broadly downregulated, specific inflammatory activation components and neuroprotective genes were upregulated in distinct cell populations, suggesting that POAG represents a complex immunometabolic syndrome characterized by a dysregulated balance between inflammatory and neuroprotective signaling. Cell type-specific eQTL mapping and SMR analysis revealed that POAG genetic risk loci exert their effects through immune gene regulation in specific PBMC subsets. Functional validation using Ifng-/- and Tnf+/- mice in an LPS/NMDA-induced retinal injury model, which mirrored the immune alterations observed in human POAG, demonstrated that genetic deficiency in these pathways markedly exacerbated retinal ganglion cell loss and visual pathway deficits. Our study establishes a crucial link between systemic immune dysregulation—specifically the disrupted balance between inflammatory and neuroprotective signaling—and retinal health, highlighting the importance of restoring this balance for future POAG therapeutic strategies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fae6abc08a14880e3feddb70f5fc769e7cfeff07" target='_blank'>
              Single-cell RNA-seq reveals cell type-specific molecular and genetic associations with primary open-angle glaucoma
              </a>
            </td>
          <td>
            Huaping Tian, Yuhong Chen, Tujing Zhao, Lin Ye, Hongjing Li, Zheng Li, Wenqiao Qiu, Wentao Wang, Runze Li, Fulin Liu, Haojue Xue, Ruilin Liao, Chao Qu, Jie Li, Liang Zou, Yi Shi, Zhenglin Yang, Lulin Huang
          </td>
          <td>2025-10-10</td>
          <td>Signal Transduction and Targeted Therapy</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="A certain degree of self-repair is initiated following spinal cord injury (SCI). Although intraneuronal regeneration and a supportive growth environment are limited, they serve as the foundation for functional recovery after SCI. In this study, we conducted single-cell RNA sequencing combined with spatial transcriptomics and spatial metabolomics to reveal the spatial molecular characteristics of self-repair processes after SCI at single-cell resolution. We identified three cell subsets-Mic2 (a microglia subset), Mac4 (a macrophage subset), and Fib4 (a fibroblast subset)-that express markers associated with spinal cord repair. Mic2 and Mac4 exhibit clustered spatial distribution patterns, whereas Fib4 is predominantly located around the injured spinal cord. Additionally, Mic2 is predominantly distributed in the white matter, particularly in the dorsal region of the injured spinal cord, and exhibits high expression of taurine. Mac4 and Fib4 exhibit high expression of copalic acid and uridine, respectively. In this study, we have identified three distinct cell subsets that express markers associated with wound healing and may promote regenerative processes, and we have determined their spatial transcriptional and metabolic features enriched within these regions. Our dataset represents a valuable resource that offers novel mechanistic insights into the pathobiology of spinal cord injury.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ac7f990261ab040d2dcb9732e55fa91a396956f2" target='_blank'>
              Integrating single-cell RNA sequencing and spatial multi-omics reveals the molecular signature of regeneration after spinal cord injury
              </a>
            </td>
          <td>
            Haoru Dong, Yuanqing Ding, Xingyu Chen, Xiao Xiao, Longnian Zhou, Haiyue Lin, Zezhen Zhang, Yiming Tao, Shiyi Cai, Jianlan Zhao, Xiaomu Li, Rong Xie
          </td>
          <td>2025-10-21</td>
          <td>Biomarker Research</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="Neuroinflammation is implicated in the pathogenesis of several central nervous system disorders. Excessive and prolonged neuroinflammation impacts disease progression and potential interventions. A widely used model of peripherally-induced neuroinflammation involves the intraperitoneal administration of the endotoxin lipopolysaccharide (LPS) to mice. In this exploratory study, magnetic resonance imaging (MRI) was used to non-invasively investigate in the brain acute neuroinflammation induced by peripheral LPS stimulation and in combination with the microglia depleting effects of the colony stimulating factor 1 receptor kinase inhibitor BLZ945. Multiparametric MRI, including T2-weighted signal, magnetization transfer ratio MTR, and apparent diffusion coefficient ADC, was applied to analyze the model. LPS was administered intraperitoneally once daily from day 1 to day 4 at a dose of 0.5 mg/kg. Post-mortem analyses comprised cytokine/chemokine measurements in the blood and brain, immunohistochemistry of microglia and astrocytes, and brain autoradiography using the TSPO radiotracer [3H]PK11195. BLZ945 (200 mg/kg p.o. daily) was given from day − 7 to day 4. On day 4 of LPS administration, T2-weighted signal and MTR increased, while ADC decreased in several brain regions. Neuroinflammation was confirmed by immunohistochemistry, which revealed an increase of microglia and astrocytes in the cortex. Additionally, autoradiography showed increased uptake of [3H]PK11195 in the cortex and thalamus/midbrain of animals receiving LPS. Treatment with BLZ945 resulted in a reduction of the LPS-elicited response, as revealed in vivo by MRI and confirmed by post-mortem histology and autoradiography analysis. The present findings highlight the potential of non-contrast-enhanced MRI to assess acute neuroinflammation-related changes in several mouse brain areas upon peripheral LPS stimulation. The assessment of multiple parameters provided sufficient sensitivity to detect pharmacological modulation of the neuroinflammatory response elicited by the endotoxin.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/47d3a7d60bc5a52d26ae2ccd9afde4845c8a2a01" target='_blank'>
              Multiparametric MRI assessment of acute neuroinflammation in a murine model of peripheral LPS stimulation
              </a>
            </td>
          <td>
            D. Shimshek, S. Zurbruegg, Anna Neuhaus, Anna Schubart, Fabrizio Gasparini, N. Beckmann
          </td>
          <td>2025-10-17</td>
          <td>BMC Medical Imaging</td>
          <td>0</td>
          <td>35</td>
        </tr>

        <tr id="


 SARS-CoV-2 infected individuals frequently develop mild disease; however, the underlying mechanisms of improved outcomes are unknown. Using a training cohort, integrated clinical and molecular parameters revealed signatures that discriminated mild from moderate and severe outcomes. Early on, some mild individuals had higher antibody titer, lower viral loads, had allergic diseases and increased expression of Th2 cytokines. In contrast, moderate/severe individuals had higher viral loads, lower antibody titers, and increased IL-8, IP10 and IL-10 levels. A distinct blood transcriptional profile of these mild individuals suggested a mechanistic role for Th2 responses in modulating disease severity. Human tracheobronchial epithelial cells (HTBE) incubated with IL-4 and/or IL-13 to recapitulate a Th2 milieu in vitro, had increased levels of IFNγ, decreased SARS-CoV-2 replication, and inhibited IL-6 induction. IL-4 and IL-13 induced a differential gene expression profile that was not significantly altered upon SARS-CoV-2 infection. Multiome analysis of treated HTBEs showed an enrichment in the transcription factor binding sites of STAT6 and KLF4. Th2 treatment induced cell specific antiviral pathways, including SLC, autophagy and RAS genes, whereas pro-viral and inflammatory gene pathways, such as IL1B/IL6, cell cycle and transcription, were repressed. This suggests that during mild COVID-19, Th2 responses modulate early innate immune responses leading to the control of viral load.



 Supported by the FLUOMICS and SYBIL Consortium NIH-NIAID grant U19AI135972), Center for Research on Influenza Pathogenesis (CRIP), an NIAID Center of Excellence for Influenza Research and Surveillance (CEIRS) contract HHSN272201400008C, FONDECYT 1212023 grant from ANID of Chile, Postdoctoral grants FONDECYT 3190706 and 3190648, ANID Becas/Doctorado Nacional 21212258.



 Viral Immunology (VIR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d8cf3072db740d91b488dff672f775c71c4bf63f" target='_blank'>
              Th2 immune responses promote anti-viral and anti-inflammatory activity during mild COVID-19 9405
              </a>
            </td>
          <td>
            Rafael A. Medina, Tamara García-Salum, Slim Fourati, Gonzalo Valenzuela, C. Pardo-Roa, E. Serrano, Susan Pereira, Michael Schotsaert, Jorge Levica, M. Avendaño, Ana Carolina Santana, Perla Del Rio, S. Jangra, Clara Schulze-Schiappacasse, Gonzalo Alarcón-Andrade, M. Suthar, F. Krammer, Adolfo Garcia-Sastre, A. Riquelme, R. Sekaly
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>110</td>
        </tr>

        <tr id="Atherosclerosis is a chronic inflammatory disease characterized by lipid accumulation and immune dysregulation, including expansion of pro-inflammatory monocytes and effector T cells, alongside reduced regulatory T cells (Tregs). Bacillus subtilis natto, a spore-forming probiotic, has shown anti-atherosclerotic effects, though its systemic immunomodulatory mechanisms remain unclear. In this study, we employed an AAV-mPCSK9-induced murine atherosclerotic model to investigate the effects of daily B. subtilis natto NTU-18 administration over 16 weeks. High-dimensional flow cytometry using two 13-marker panels enabled longitudinal profiling of 18 peripheral immune cell subsets across lymphoid and myeloid compartments. While no significant changes in serum cholesterol and mild decrease of body weight were observed, B. subtilis natto NTU-18-treated mice presented a significant reduction in aortic lesion area compared to PBS-treated controls. Immune profiling revealed a transient expansion of peripheral myeloid cells and CD44⁺ trained CD8⁺ T cells, followed by increased frequencies of naïve CD8⁺ T cells and reduced central/effector memory subsets at longer time point treatment. In the CD4⁺ T cell compartment, a transient increase in trained cells was accompanied by a sustained enrichment of CD25⁺CD4⁺ Tregs throughout the daily B. subtilis natto NTU-18 treatment. In contrast, no significant differences were observed in Ly6C⁻ or Ly6C⁺ monocytes, neutrophils, or eosinophils. These findings suggest that B. subtilis natto NTU-18 attenuates atherosclerosis progression not through lipid lowering or broad myeloid modulation, but via targeted reprogramming of peripheral T cell responses. This work provides mechanistic insight into the immunotherapeutic potential of B. subtilis natto NTU-18 in atherosclerosis prevention and treatment. • B. subtilis natto NTU-18 significantly reduces aortic plaque burden in atherosclerotic mice without affecting serum cholesterol levels. • B. subtilis natto NTU-18 induces transient immune remodeling, marked by early expansion of trained CD8⁺ and CD4⁺ T cells, followed by increased naïve and regulatory T cells. • The atheroprotective effect is primarily mediated through adaptive immunity as myeloid subsets remain unchanged throughout B. subtilis natto NTU-18 treatment.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/45dd339de260cb5a70cef21d3c450ab6682f7820" target='_blank'>
              Bacillus subtilis natto NTU-18 attenuates atherosclerosis progression by modulating peripheral immune cell alterations
              </a>
            </td>
          <td>
            Jian-Da Lin, Yu-Zhen Ye, Sin-Ren Wang, Wen-Yi Kao, Kung-Ta Lee
          </td>
          <td>2025-10-17</td>
          <td>Applied Microbiology and Biotechnology</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="Long- and post-COVID-19 syndromes have emerged as a significant global health challenge, with millions of individuals experiencing persistent or the development of new symptoms after a long period of an initial SARS-CoV-2 infection. These symptoms are multisystemic and may indicate changes in the respiratory, neurological, cardiovascular and gastrointestinal systems, in addition to prolonged fatigue. Vaccination has played a crucial role in reducing severe disease and mortality, but the impact of the different vaccine combinations on the development and resolution of Long COVID remains a topic of debate. This review synthesizes current evidence on how different vaccine platforms, dosing strategies and booster doses influence the immunological response, protection, incidence, severity, and persistence of Long COVID symptoms. We discuss key immunological mechanisms by which vaccination may modulate and protect post-COVID syndrome outcomes, including its effects on viral clearance, immune response reprogramming, inflammation, and autoimmunity, seeking to combat misinformation and concepts spread by fake news. The review also highlights controversies and research gaps, such as variability in vaccine response among different populations and the role in the selection of more transmissible and virulent SARS-CoV-2 variants, as well as the potential differences between vaccine-induced and infection-induced immunity, and the role of pre-existing immune conditions in this scenario.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c1877f162e92139adf77d3156392d030444bf043" target='_blank'>
              Vaccination and COVID-19: impact on long-COVID
              </a>
            </td>
          <td>
            Gustavo N. Guimarães, N. S. Brunetti, D. G. de Lima, J. Proença-Módena, Alessandro S Farias
          </td>
          <td>2025-11-19</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>32</td>
        </tr>

        <tr id="Acute respiratory distress syndrome (ARDS) is a critical condition characterized by diffuse alveolar damage and intense inflammatory responses. During the COVID‐19 pandemic, its incidence and mortality have remained persistently high. Conventional approaches have struggled to uncover the complex cellular heterogeneity and dynamic inflammatory networks underlying ARDS. The advent of single‐cell sequencing technologies has revolutionized our ability to dissect the molecular mechanisms of ARDS. This review systematically summarizes recent advances in the application of single‐cell sequencing in studying pulmonary inflammation in ARDS, with a focus on its strengths in elucidating immune cell heterogeneity, reconstructing intercellular communication networks, and identifying potential therapeutic targets. Furthermore, we discuss current technical limitations and translational challenges, aiming to provide a theoretical foundation and future direction for translating mechanistic insights into precision medicine for ARDS.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b7061390b06d4776270be5e5161ae41668426e25" target='_blank'>
              Single‐Cell Sequencing Redefines Immune Heterogeneity and Communication Networks in ARDS: Toward Precision Therapeutics
              </a>
            </td>
          <td>
            Han-Bing Chen, Anmin Xu, H. Qiu, Jie Chao, Songyun Zhao
          </td>
          <td>2025-01-01</td>
          <td>International Journal of Genomics</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2d6e91515a8577a13c2aa3d6af7329fea8d2e1e5" target='_blank'>
              Brain infiltrating T cells mediate microglial dysregulation and neuronal loss following SAH
              </a>
            </td>
          <td>
            F. Moro, E. Mazzone, R. Pascente, M. Bataclan, S. Monticelli, F. Pischiutta, MC Trolese, C. Vasco, J. Geginat, M. Di Feliciantonio, F. Ortolano, T. Zoerle, E. Zanier
          </td>
          <td>2025-10-11</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>45</td>
        </tr>

        <tr id="Inflammation and excess cytokine release are hallmarks of severe COVID-19. While programmed cell death is known to drive inflammation, its role in SARS-CoV-2 pathogenesis remains unclear. Using gene-targeted murine COVID-19 models, we here find that caspase-8 is critical for cytokine release and inflammation. Loss of caspase-8 reduces disease severity and viral load in mice, and this occurs independently of its apoptotic function. Instead, reduction in SARS-CoV-2 pathology is linked to decreased IL-1β levels and inflammation. Loss of pyroptosis and necroptosis mediators in gene-targeted animals provides no additional benefits in mitigating disease outcomes beyond that conferred by loss of caspase-8. Spatial transcriptomic and proteomic analyses of caspase-8-deficient mice confirm that improved outcomes are due to reduced pro-inflammatory responses, rather than changes in cell death signalling. Elevated expression of caspase-8 and cFLIP in infected lungs, alongside caspase-8-mediated cleavage of N4BP1, a suppressor of NF-kB signalling, indicates a role of this signalling axis in pathological inflammation. Collectively, these findings highlight non-apoptotic functions of caspase-8 as a driver of severe COVID-19 through modulation of inflammation, not through the induction of apoptosis. During SARS-CoV-2 infection caspase-8 fuels harmful inflammation independent of apoptosis. Genetic loss of caspase-8 reduces cytokine levels, lowers viral load and mitigates disease severity, revealing non-apoptotic caspase-8 as a key driver of severe COVID-19.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5fdd57c7d51f242c164bb60fdb057ec943038a10" target='_blank'>
              Non-apoptotic caspase-8 is critical for orchestrating exaggerated inflammation during severe SARS-CoV-2 infection
              </a>
            </td>
          <td>
            Stefanie M. Bader, Lena Scherer, Reet Bhandari, Allan J. Motyer, James P. Cooney, Liana Mackiewicz, Merle Dayton, Dylan Sheerin, David V. L. Romero, Jan Schaefer, J. Pang, Siqi Chen, Kael Schoffer, Le Wang, Xinyi Jin, D. Batey, Raymond K. H. Yip, Ishrat Zaman, P. Rajasekhar, Matthew J. Gartner, Stephen Wilcox, Lachlan L Whitehead, S. R. Georgy, Ana Maluenda, Kathryn C. Davidson, C. Allison, R. Bowden, Kerstin Brinkmann, M.-L. Asselin-Labat, B. Phipson, Maria C. Tanzer, Marco J. Herold, A. Samson, J. Vince, Andreas Strasser, Marc Pellegrini, Marcel Doerflinger
          </td>
          <td>2025-11-13</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>50</td>
        </tr>

        <tr id="


 Long COVID (LC) is a debilitating condition characterized by neurological, respiratory and/or gastrointestinal symptoms persisting after the infection with SARS-CoV-2. It has been hypothesized that LC is caused by suboptimal immune responses failing to clear SARS-CoV-2. Memory B cells and antibody-secreting plasma cells with high affinity for viruses, which confer protection from infection and contribute to viral clearance, canonically originate from germinal center (GC) reactions in lymphoid organs. By using a Fine Needle Aspirate (FNA) approach, which we previously deployed to probe GC responses to vaccination (Lederer et al. Cell 2022), we collected biopsies from cervical lymph nodes of LC and healthy COVID-19 convalescents. High-parameter flow cytometry analysis of FNA samples showed that convalescents mounted efficient GC B cell responses to SARS-CoV-2 that correlated with the generation of neutralizing antibodies. Conversely, GC responses to SARS-CoV-2 were severely hindered in LC patients and linked to a decreased production of binding and neutralizing antibodies against SARS-CoV-2 that waned faster than in convalescents. CITE-seq analysis of FNA samples also revealed transcriptional alterations in GC B and memory B cells from LC patients that were coupled to inferior clonal expansion. Overall, the direct analysis of lymph nodes uncovered major abnormalities in B cell responses to SARS-CoV-2 that might be connected to the incomplete lack of viral clearance in LC.



 This work is supported by PolyBio Research Foundation and by NIH 2U19AI082630-16 grant



 Immune Mechanisms of Human Disease (HUM)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/24f5872cdd72612847ef9e146aeeb304ba0f7497" target='_blank'>
              Alterations of B cell responses to SARS-CoV-2 in Long COVID 2566
              </a>
            </td>
          <td>
            M. Locci, Hannah Sharpe
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>21</td>
        </tr>

        <tr id="


 CD8+ T-cells are crucial for resolving SARS-CoV-2 infection. However, the persistence of SARS-CoV-2 epitope-specific CD8+ T-cell responses post-infection and their impact on COVID-19 pathogenesis remain unclear due to limited epitope-specific resolution. Using DNA-barcoded peptide-major histocompatibility complex (pMHC) multimers, we profiled CD8+ T-cell dynamics in severe and mild COVID-19 through a longitudinal analysis of 553 SARS-CoV-2 epitopes up to six months post-infection. In the acute phase, a large number of antigens (n = 199) contributed to CD8+ T-cell responses, while long-term memory formed towards a smaller antigen pool. Severe COVID-19 patients exhibited higher T-cell frequencies, primarily in HLA-A01:01-restricted responses, with an effector memory phenotype; however, despite the comparatively low frequency, T-cells in mild patients showed more cytotoxic terminally differentiated cells. Single-cell analysis revealed functionally impaired T-cells with low cytotoxicity and IFN-I signaling in severe cases, while mild patients had higher expression of cytotoxicity-associated genes (PRF1, GZMH, GZMB, GNLY). Importantly, the ORF1-derived HLA-A*01:01 restricted immunodominant epitope TTDPSFLGRY was found associated with increased T-cell frequency and the observed functional deregulation exclusively in severe COVID-19 patients. This study contributes to our understanding of the kinetics and durability of CD8+ T-cell responses and their role in COVID-19 severity.



 Grants: - REACT- Horizon Europe - Grant agreement No 101057129 - DFF Sapere Aude



 Viral Immunology (VIR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/08c7fc5af67bbe2868fd03106a073c4527165d57" target='_blank'>
              Comprehensive longitudinal profiling of SARS-CoV-2 antigens reveals COVID-19 severity-associated CD8+ T-cell activation and functional impairment 3496
              </a>
            </td>
          <td>
            Susana Patricia Amaya Hernandez, K. K. Munk, Konstantin Danilov, M. Kadivar, D. Hersby, Tripti Tamhane, Simone Majken Stegenborg-Grathwohl, Anne Ortved Gang, S. Hadrup, Sunil Kumar Saini
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>46</td>
        </tr>

        <tr id="Despite heavy exposure to Mycobacterium tuberculosis (Mtb), some individuals are resistant to TST and IGRA conversion (RSTRs). The functional and immunological mechanisms governing resistance are poorly understood. We hypothesized that RSTR and LTBI alveolar macrophages (AMs) respond differently to Mtb infection with transcriptional programs that are distinct from peripheral blood monocytes. We examined media and Mtb-infected AMs from bronchoalveolar lavage fluid collected from a RSTR cohort in Uganda with over 10 years of clinical follow-up. With transcriptional profiles of BAL cells analyzed immediately after collection, gene set enrichment analysis (GSEA) revealed 13 differentially expressed gene sets between RSTR (n = 19) and LTBI (n = 26) groups, including one (Hallmark E2F targets) which was positively enriched in the RSTR group (FDR < 0.3). In a subset of this cohort (n = 7 RSTR and 8 LTBI), AMs were examined with and without Mtb infection. When comparing the RSTR and LTBI groups, we identified 52 DEGs including 22 in the media condition, 15 with Mtb stimulation, and 11 with the interaction term (FDR < 0.2, Log 2-fold change > 1/<-1). Notably, RSTR AMs appear to upregulate inflammation more strongly than LTBI counterparts, including Hallmark inflammatory response (FDR < 0.2), IFNγ response (FDR < 0.1), and IFNα response (FDR < 0.1) while existing in a more non-inflammatory state at baseline (Hallmark TNF signaling via NF-kB (down, FDR < 0.1), inflammatory response (down, FDR < 0.1). In a comparison of peripheral blood monocyte gene expression profiles from the same cohort, there were both shared and AM-specific RSTR profiles detected. Together, these results suggest that RSTR and LTBI AMs have different basal and Mtb-induced transcriptional profiles, including some that differ from peripheral blood monocytes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/74f6f6a91106ca8fedadea27abfb904beaf5f882" target='_blank'>
              Alveolar macrophage transcriptional signatures associated with resistance to TST/IGRA conversion following Mycobacterium tuberculosis exposure
              </a>
            </td>
          <td>
            Austin M. Haynes, Cristian Ovadiuc, G. Peterson, W. Worodria, Sophie Nalukwago, Timothy Muwanguzi, M. Nsereko, Catherine M. Stein, Kimberly A. Dill-McFarland, Harriet Mayanja-Kizza, W. H. Boom, R. M. Segnitz, T. Hawn
          </td>
          <td>2025-10-31</td>
          <td>BMC Genomics</td>
          <td>0</td>
          <td>37</td>
        </tr>

        <tr id="Post-viral neuroinflammatory syndromes, particularly those occurring after SARS-CoV-2 infection, have received increasing attention due to their complex and persistent neurological manifestations. The aim of this narrative review is to integrate current evidence on the molecular and cellular mechanisms underlying chronic neuroinflammation following viral infections, with a focus on dysregulated innate immune responses, macrophage–microglia interactions, oxidative–mitochondrial stress, and impaired inflammation resolution pathways. Our synthesis shows that prolonged activation of macrophages and glial cells promotes the continuous release of pro-inflammatory mediators, while defective phagocytosis and inadequate clearance of cellular debris maintain an inflammatory microenvironment. Mitochondrial dysfunction further amplifies immune activation by stimulating metabolic stress and reactive oxygen species production. In parallel, deficiencies in mediators specialized in inflammation resolution impede the transition from inflammation to resolution, allowing neuroimmune imbalance and nociceptive sensitization to persist long after virus clearance. Key conclusions indicate that these interconnected mechanisms collectively contribute to the long-term neurological symptoms observed in post-viral states, including cognitive impairment, neuropathic pain, and fatigue. Emerging therapeutic strategies targeting cytokine signaling, microglial reactivity, mitochondrial function, and resolution pathways are promising, but remain insufficiently validated in clinical practice. Overall, evidence suggests that post-viral neuroinflammation results from the convergence of sustained immune activation and failure of endogenous resolution mechanisms, highlighting the need for further mechanistic studies and targeted interventions.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1486b2a0665ed52ccf9a17b86e0809646ad8755a" target='_blank'>
              Dysregulated Resolution of Inflammation After Respiratory Viral Infections: Molecular Pathways Linking Neuroinflammation to Post-Viral Neuropathic Pain—A Narrative Review
              </a>
            </td>
          <td>
            A. Popa, Elena Popa, Tatiana Dramba, Elena-Adorata Coman, Mihaela Poroch, M. Ungureanu, A. Bacușcă, Ana-Maria Slanina, Gema Băcăoanu, V. Poroch
          </td>
          <td>2025-11-25</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="


 While many patients only experience flu like symptoms after contracting SARS-CoV-2, a small subset of patients will go on to develop acute respiratory distress syndrome (ARDS). ARDS is characterized by an overzealous inflammatory response brought on by downstream signaling of pattern recognition receptors. One such receptor, NLRX1, is shown to negatively regulate downstream inflammatory signaling during viral infections. However, its actions can be dichotomous depending on cellular context. ssRNA can be sensed by the C-terminal of NLRX1 implicating it in the host response of ssRNA viruses, such as SARS-CoV-2. The exact role of NLRX1 during SARS-CoV-2 infection remains unclear. We show NLRX1 to be protective in SARS-CoV-2 pathology. snRNA data taken from COVID-19 positive lung autopsy samples showed a down regulation of NLRX1 in airway epithelial cells while pathways modulated by NLRX1 were shown to be deferentially enriched. Nlrx1-/- mice infected with the mouse adapted SARS-CoV-2 virus had a greater viral titer and airway inflammation, including increased cellular denuding at 2 days post infection compared to wild-type animals. Furthermore, human airway epithelial cells over-expressing NLRX1, not only had decreased viral replication but may be protecting against a viral shift of host metabolism to limit viral replication. Our results suggest NLRX1 antagonizes SARS-CoV-2 through multiple pathways. With more research, NLRX1 could be a promising drug target for Covid-19.



 Viral Immunology (VIR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ae354c65901bd74c8236f5f8ee4e01955dd63dbe" target='_blank'>
              Fighting Covid-19 with NLRX1 9340
              </a>
            </td>
          <td>
            Mackenzie K Woolls, Hannah M. Ivester, Julia A Gregory, I. Allen
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0a891d2740ad2db98b44c1bca0f35faa07a82811" target='_blank'>
              Spatial and Single-Cell Transcriptomics Decipher the Crosstalk Environment of DEFB1+ Cancer Cells and IFI30+ Macrophages in Intrahepatic Cholangiocarcinoma
              </a>
            </td>
          <td>
            Guoliang Wang, Hang Meng, Meng Li, Xiangdong Fang, Weilong Zou, H. Qu
          </td>
          <td>2025-11-25</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="Viral encephalitis, characterized by inflammation of the brain parenchyma, poses a significant threat to public health due to its high rates of morbidity and mortality. Microglia, the central nervous system’s resident immune cells, are crucial in the pathophysiology and development of this condition. These microglia exhibit a dual function, being involved in both neuroprotection and neurotoxicity during viral encephalitis. To address this complex interplay, targeted therapeutic strategies that modulate microglia activation state have emerged as a promising approach. These strategies aim to either inhibit excessive microglia activation or promote their neuroprotective functions. By targeting microglia, these therapies hold the potential to improve outcomes for patients with viral encephalitis. This review synthesizes current evidence revealing that microglial responses during viral encephalitis exhibit context-dependent heterogeneity that extends beyond traditional M1/M2 paradigms. Critically, our review reveals a significant translational gap, with no current clinical trials investigating microglial-targeted therapies for viral encephalitis despite promising preclinical evidence. This review provides a comprehensive framework for understanding microglial complexity in viral encephalitis and establishes research priorities for advancing these insights toward clinical application.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7e0caaffaa21a65c0a881f9db458d953a11cab66" target='_blank'>
              Dual immune modulation of microglia in viral encephalitis: current understanding and future perspectives
              </a>
            </td>
          <td>
            Li Zong, Pei Chen, Jing Shi, Huijie Chen, Wen-wen Lin, Guanyong Ou, Xuxiang Chen
          </td>
          <td>2025-10-27</td>
          <td>Frontiers in Molecular Biosciences</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="


 Recent studies suggest respiratory infections like SARS-CoV-2 can influence brain glial cell behavior. Early-life stress, such as neonatal stress, may predispose the nervous system to an exacerbated response during immune challenges. Thus, we investigated how early-life stress modifies glial cell activation and function during Sendai virus-induced lung inflammation, and assess its impact on neuroimmune responses and susceptibility to respiratory diseases in adulthood.



 This study used a neonatal maternal separation (NMS) rat model in which Sprague Dawley rats were separated from their mother for 3 hours daily from postnatal days 3 to 12. At 8-10 weeks, rats were infected intranasally with Sendai virus, and brain glial cells were analyzed by flow cytometry post-infection.



 Activation markers of the microglia and astrocytes are modulated by Sendaï infection differently in response to stress and sex. Viral infection increased CD200 on astrocytes 4 days post-infection. At the same time, activated microglia MHCII levels were lower, with differences across sexes and between NMS and control groups.



 Respiratory viral infections may affect glial cell activation, showing a pattern aligning with human SARS-CoV-2 observations. Early-life stress may further influence the glial response to such infections, emphasizing the role of developmental factors and immune challenges in shaping neuroimmune responses.



 Supported by CIHR, FRQS, Quebec Respiratory Health Network and Fondation IUCPQ.



 Neuroimmunology (NEUR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/bffc63259177c779d5068e71a7d6a6f22be2dddc" target='_blank'>
              Sex-specific impacts of lung viral infection on brain microglia and astrocytes 2565
              </a>
            </td>
          <td>
            J. Lauzon-Joset, Karine Bouchard, Joanny Roy, Danuzia Ambrozio-Marques, Richard Kinkead, Dany Patoine
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="


 MIS-C is a pediatric hyperinflammatory disease characterized by inflammatory shock involving multiple organ systems. MIS-C is linked with prior SARS-CoV-2 infection, approximately 4-6 weeks before symptom onset. Acute patients display distinct circulating immune cell profiles, marked by an increase in inflammatory cytokines and chemokines. Here, we used single-cell RNA- and TCR-sequencing paired with multiplexed cytokine profiling and mass cytometry to characterize the immune signatures of PBMCs and plasma in 8 acute MIS-C patients, 15 recovered MIS-C follow-ups over a range of time points (“early”: 1-3 months, “late”: 6-18 months), and 10 healthy pediatric controls. Levels of various proinflammatory cytokines and chemokines, including IL-6, IL-15, and IL-1β, were elevated in the plasma of early follow-ups; similarly, perforin, pSTAT-3, and pSTAT-4 protein expression was higher in PBMCs within this 3-month follow-up window. Multiome analysis of 151,420 PBMCs revealed an enrichment of inflammatory pathways in genes more highly expressed in early compared to late follow-ups, specifically in monocytes. Significant expansions of various paired TCR α/β-chains were also observed in acute patients, which persisted in early follow-ups. Together, our findings establish a prolonged inflammatory phenotype up to 3 months after MIS-C resolves, suggesting that the effects of SARS-CoV-2 infection-caused MIS-C may linger well after the virus is cleared despite fast clinical resolution.



 Supported by NIH/NICHD R01HD108467-01; Helen Hay Whitney Fndn. Fellowship.



 Computational and Systems Immunology (COMP)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/700fb0f1fd9b6efe4945ffb81edc27b02688ee5b" target='_blank'>
              Disseminated autoimmunity is associated with MIS-C pathogenesis 2925
              </a>
            </td>
          <td>
            Haley E. Randolph, Ashley Richardson, S. Buta, Julie Samuels, Sarah S Geisler, Mark W Russell, R. Trachtman, Dusan Bogunovic
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="A Proliferation-Inducing Ligand (APRIL) is a tumour necrosis factor superfamily member with multiple effector roles in the peripheral and central nervous system (CNS). In the CNS, APRIL helps maintain immune homeostasis and supports neuronal survival, yet whether it can therapeutically modulate acute neuro-inflammatory and neurodegenerative processes is unclear. To investigate this in a severe neuro-inflammatory context, we tested whether local APRIL delivery can influence microglial/astrocytic responses and demyelination in the cuprizone (CPZ) mouse model of neuro-inflammation and demyelination. We applied adeno-associated virus (AAV)–mediated gene transfer to drive APRIL expression by cortical neurons positioned directly above the splenium of the corpus callosum. Following CPZ intoxication, we evaluated microglial and astrocytic activation and myelin content by in vivo T2 and diffusion magnetic resonance imaging (MRI), and validated them by post-mortem quantitative immunohistochemistry (IHC) and bulk transcriptomic and proteomic profiling. T2 and diffusion MRI, corroborated by quantitative IHC, demonstrated that secretion of APRIL by cortical neurons attenuated CPZ-induced microglial recruitment and demyelination in the splenium, but not in the cortex. Integrated transcriptome-proteome analysis of splenium and cortex, further supported by IHC, highlighted astroglial lipid-metabolic circuitry - marked by the astrocytic fatty-acid-binding protein 7 (Fabp7) - as a candidate axis underlying APRIL’s effects to reduce inflammatory cell recruitment and myelin preservation. AAV-mediated expression of APRIL by cortical neuron counteracted microglial recruitment and demyelination in the splenium of CPZ-treated mice. Our multi-omics integration analysis nominated several pathways, including Fabp7-linked astrocytic lipid metabolism, to elucidate APRIL’s mechanism of action. Together, these findings provide a framework for the mechanistic dissection of APRIL’s therapeutic potential and further translational evaluation in CNS pathologies characterised by acute neuro-inflammatory responses.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/b73ba8336580ec9e7f5e7539d0fbcc48e4944d3b" target='_blank'>
              AAV-mediated delivery of a proliferation inducing ligand (APRIL) to cortical neurons limits inflammation and demyelination in the corpus callosum of the cuprizone mouse model
              </a>
            </td>
          <td>
            Leonardo Ricciardi, Federica Di Marco, Marion Decrop, Julia Di Stefano, Tejaswini Kakunuri, Joëlle van Rijswijk, N. Vidas-Guscic, Yousra El Ouaamari, Alexandro A. Bufi, Ignace Van Spilbeeck, Johan Van Audekerke, Carole Faghel, Esther Bartholomeus, Eva Lion, Nathalie Cools, Steven Van Laere, I. Cicalini, Vincenzo de Laurenzi, Una FitzGerald, D. Pieragostino, B. Huard, P. Del Boccio, Peter Ponsaerts, M. Verhoye
          </td>
          <td>2025-10-27</td>
          <td>Journal of Neuroinflammation</td>
          <td>0</td>
          <td>31</td>
        </tr>

        <tr id="


 The immune system is essential to control and eliminate pathogens such as SARS-CoV-2, the agent of COVID-19. Studying the differential responses of individuals exposed to the same viral strain within discordant couples (one partner infected, the other not) can enhance our understanding of infection responses. This study focuses on the neutrophil response in such couples, aiming to identify and evaluate resistance and susceptibility markers through the expression of ACE2, TLR4, and TLR9 receptors, cytokine production, and NETs release following different stimuli. Our findings reveal significant differences in responses. When COVID-19-negative cells were stimulated with ODN CpG, the percentage of ACE2+ neutrophils were increased, being higher than positive individuals. COVID-19-positive individuals have higher expression of TLR4+ in neutrophils without stimulation and after stimulation with LPS, ODN CpG, and inactivated SARS-CoV-2 in different concentrations. For TLR9 expression, this behavior is maintained in COVID-19-positive groups, except for those stimulated with ODN CpG. Regarding NETs release, COVID-19-positive individuals showed higher levels of NETs produced by neutrophils, even without acute infection, mainly at serum levels. After stimulation, COVID-19 negative have the highest levels comparatively and were also able to produce more IL-8. These differences in neutrophil responses may indicate potential resistance and susceptibility factors to SARS-CoV-2 infection.



 Funding: Supported by The São Paulo Research Foundation, FAPESP (process number 2021/13354-1)



 Viral Immunology (VIR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/dc25fff247ac3b1005ac3dd50861c2c33b641107" target='_blank'>
              Resistance and susceptibility markers of SARS-CoV-2 infection in neutrophils response from discordant couples 4014
              </a>
            </td>
          <td>
            L. A. Dias-Melicio, Thayná Ruiz Ferreira, Ana Laura Ortega Dezen, Fernando Couso Correa, Larissa Ragozo Cardoso de Oliveira, C. Simeoni, José Luiz, Proença Módena
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>19</td>
        </tr>

        <tr id="


 Passive administration of SARS-CoV-2 neutralizing monoclonal antibodies, such as the CAS+IMD (REGEN-COV®, Ronapreve, REGN-COV2) antibody cocktail, benefits viral load, mortality rate, and clinical course in COVID-19 patients. However, their impact on resolving pathogenic inflammatory response and host immunity is less understood. This study examined CAS+IMD’s interaction with host immunity using longitudinal plasma proteomics and high-dimensional flow cytometry data. Unbiased clustering identified unique immunophenotypes linked to acute inflammation and disease resolution. Compared to the placebo group, CAS+IMD accelerated the shift from an acute inflammatory to a less inflammatory or “resolving” immunophenotype, marked by reduced tissue injury, lower proinflammatory markers, and restored lymphocyte/monocyte balance, regardless of baseline serostatus. Additionally, CAS+IMD did not impair the magnitude or quality of host T cell immunity against the SARS-CoV-2 spike protein. These findings suggest that SARS-CoV-2 neutralizing antibodies can rapidly resolve inflammatory responses, reducing the need for systemic steroids, without compromising cellular antiviral immunity.



 Supported Regeneron Pharmaceuticals and Department of Health and human service under OT number: HHSO100201700020C.



 Translational and Interventional Immunology (TI)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/bdc47269dd307201822bd21fc999c62b8e1b1965" target='_blank'>
              Unraveling the Dynamic Interplay of SARS-CoV-2 Neutralizing Monoclonal Antibodies and Host Immunity in Hospitalized Patients with COVID-19 2264
              </a>
            </td>
          <td>
            Bei Wang, Jacquelynn Golubov, P. Poon, Qiaozhi Wei, Clarissa Lett, Fadi Shehadeh, Matthew Kaczynski, Lewis Oscar Felix, Biswajit Mishra, Evangelia K. Mylona, Matthew Wipperman, E. Chio, Sara C Hamon, A. Hooper, S. Somersan-Karakaya, Bret J. Musser, Christopher D Petro, Jennifer D Hamilton, Matthew A. Sleeman, G. Kalliolias, Eleftherios Mylonakis, D. Skokos
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>27</td>
        </tr>

        <tr id="


 Our goal was to understand the host immune response following the SARS-CoV-2 infection and finding an effective immune-therapeutic intervention. Mice infected with a mouse-adapted strain of SARS-CoV-2 (MA-10) showed increased CXCR3 signaling compared to sham-challenged mice, as observed by the increased expression of CXCR3 and its ligands CXCL9, CXCL10, and CXCL11 in lungs. Flow cytometry revealed that CXCR3+ T cells, Innate lymphoid cells, and macrophages were associated with the recovery following MA-10 infection. Interestingly, blocking CXCR3 signaling with monoclonal antibodies worsened disease outcomes measured by survival (P = 0.02), clinical scores (P = 0.006 on day 5 pi), and weight loss (P = 0.002 on day 5 pi). A plaque assay of lung lysates showed that aCXCR3 treated mice had impaired viral clearance (P = 0.02). Administering aCXCR3 showed a similar phenotype in Rag2-/- mice, suggesting that the CXCR3-mediated protection was conferred by innate immune cells. To investigate the role of alveolar macrophages, we stained for CD169, CD11c, and the SARS-CoV2 nucleocapsid. Immunostains confirmed that aCXCR3-treated mice had higher viral loads in the lungs. Although CD169+CD11c+ alveolar macrophages were comparable between the groups, the number of alveolar macrophages that phagocytosed viruses were significantly lower in aCXCR3 treated mice (P < 0.0001). We conclude that CXCR3 signaling in alveolar macrophages is indispensable to clear viral load during SARS-CoV2 infection.



 Innate Immune Responses and Host Defense: Cellular Mechanisms (INC)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c93327417a4edf7f16144b0bb41ca1916c870d3f" target='_blank'>
              CXCR3+ Alveolar macrophages help to clear viral load during SARS-CoV-2 infection 9049
              </a>
            </td>
          <td>
            Md Jashim Uddin
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="Zika virus (ZIKV) is a neurotropic flavivirus capable of infecting the adult brain, however its impact on hypothalamic function and metabolic regulation remains unclear. Here, we show that ZIKV invades the hypothalamus of immunocompetent adult mice, where it replicates and persists, leading to sustained insulin resistance. Following infection, ZIKV RNA and negative strand were detected in the hypothalamus of mice and immunostaining confirmed viral proteins in neurons, especially POMC-positive cells. At 6 dpi, ZIKV induced hypothalamic neuroinflammation, as shown by the upregulation of TNF-α, IL-6, IFN-β, and ISG-15, as well as microglial activation. These inflammatory responses were associated with impaired insulin signaling, characterized by reduced phosphorylation of IRS-1 and S6K, downregulation of insulin receptor mRNA, and decreased anorexigenic response following intracerebral insulin administration. Our data also showed that, despite viral clearance and resolution of hypothalamic inflammation at 30 dpi, reduction in insulin receptor protein levels and hypothalamic insulin resistance persisted. These findings demonstrate that ZIKV replicates in the hypothalamus of immunocompetent adult mice, leading to long-lasting disruption of central insulin signaling. Our study identifies hypothalamic insulin resistance as a novel consequence of ZIKV central nervous system invasion and suggests that viral infections may contribute to long-term metabolic dysfunction, highlighting the need to investigate persistent hypothalamic and metabolic alterations in ZIKV infection-recovered individuals.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/deff0518eb16d110cb9b78adc5fc218285716fcf" target='_blank'>
              Central Zika virus infection causes hypothalamic inflammation and persistent insulin resistance in adult mice
              </a>
            </td>
          <td>
            E. V. de Lima, Clara O. Nogueira, R. R. Christoff, Emylle Costa-Bartuli, Tathiany Igreja-Silva, M. D. da Silva, Daniel Gavino-Leopoldino, Maria Luiza Móra Santos, F. S. Lemos, Jaderson C. da Costa, G. Venturin, I. Assunção-Miranda, João M. N. Duarte, Claudia P. Figueiredo, G. F. Passos, Julia R. Clarke
          </td>
          <td>2025-10-13</td>
          <td>Cell Death & Disease</td>
          <td>0</td>
          <td>18</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0d70a7f410d7273941b555f5d38eb406c7358fb4" target='_blank'>
              Distinct cytotoxic cell subsets underlie protective and non-protective immunity to African swine fever virus
              </a>
            </td>
          <td>
            D. Marín-Moraleda, A. Tort-Miró, E. Ezcurra, S. Montaner-Tarbes, J. Muñoz-Basagoiti, E. Coatu, M. J. Navas, M. Muñoz, P. Monleón, J. González-Oliver, L. Pailler-García, S. Pina-Pedrero, F. Accensi, , J. Argilaguet
          </td>
          <td>2025-12-03</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>23</td>
        </tr>

        <tr id="Long COVID has emerged as a major global health concern, yet the long-term trajectory of immune recovery and its contribution to persistent symptoms remain to be elucidated. Here, we conducted a three-year longitudinal follow-up of the 47 COVID-19 patients and applied single-cell RNA sequencing (scRNA-seq) and multiplex cytokine profiling to comprehensively characterize the peripheral immune landscape during convalescence. We observed persistent immune dysregulation up to three years post-infection, characterized by chronic inflammation and impaired restoration of naïve CD4⁺ T cells, naïve CD8⁺ T cells, and SLC4A10⁺ MAIT cells—features reminiscent of immunosenescence. Notably, Th17 cells, rather than monocytes, emerged as key drivers of chronic inflammation beyond one year. We identified two distinct Th17 subsets: RORC⁺ Th17 cells and LTB⁺ Th17 cells. While RORC⁺ Th17 cells were negatively correlated with inflammatory cytokine levels, LTB⁺ Th17 cells showed proinflammatory features and were positively associated with long COVID symptoms. Sustained elevation of S100A8 and IL-16 in follow-up patients may contribute to the persistent presence of LTB⁺ Th17 cells. Together, our study provides an in-depth longitudinal map of immune remodeling in COVID-19 convalescents, revealing key cellular and molecular drivers of sustained inflammation up to three years post-infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f682ef5df5972e318b0093c3cf2459508e92d089" target='_blank'>
              T cell-driven sustained inflammation and immune dysregulation mimicking immunosenescence for up to three years post-COVID-19
              </a>
            </td>
          <td>
            Tian Zheng, Ru Gao, Yiwei Liu, Ye-ming Wang, Chao Wu, Li Guo, Lan Chen, Xinming Wang, Yan Xiao, Jingchuan Zhong, Rongling Zhang, Ying Wang, Xianwen Ren, Bin Cao, Lili Ren, Jianwei Wang
          </td>
          <td>2025-11-20</td>
          <td>Immunity & Inflammation</td>
          <td>0</td>
          <td>34</td>
        </tr>

        <tr id="


 Obesity is a significant risk factor for worse clinical outcomes in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. Although obesity is known to alter immune function, the mechanisms by which it affects local and systemic SARS-CoV-2 immunity and worsens disease severity remain unclear. Here, we compared virus–host dynamics in genetically obese Lepob (ob/ob) mice and lean control mice after intranasal infection with SARS-CoV-2 Beta (B.1.351). Obese mice exhibited delayed viral clearance from the lungs, worse histopathologic pulmonary injury, and worse clinical outcomes compared with infected lean mice. Pulmonary CD8+ T cells in obese mice displayed an exaggerated SARS-CoV-2-specific cytokine response and a marked shift in energy metabolism towards preferential fatty acid utilization. SARS-CoV-2 clearance from the lungs of obese mice was normalized by adoptive transfer of CD8+ T cells from SARS-CoV-2-immune lean mice. Collectively, these data suggest that obesity is associated with cell-autonomous metabolic and immunologic abnormalities in pulmonary SARS-CoV-2-specific CD8+ T cells that contribute to delayed viral clearance and worse clinical outcomes in infected obese mice.



 This study was funded by National Institutes of Health grants U19 AI142790-02S1 (to SS and EOS), the GHR Foundation (to SS and EOS), the Arvin Gottleib Foundation (to SS), and the Overton family (to SS and EOS). This research was also supported by a La Jolla Institute for Immunology (LJI) /Kyowa Kirin Inc. (KKNA) Interactive Fund.



 Viral Immunology (VIR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fa87bcd3d35d948a0e1cb2e9e259c54c267d8b95" target='_blank'>
              Obesity Alters the Metabolic and Immunologic Response of Pulmonary T Cells to SARS-CoV-2 Infection 2143
              </a>
            </td>
          <td>
            Shailendra Kumar Verma, Julia Timis, Erin Maule, A. E. Ngono, Fernanda Ana-Sosa-Batiz, Robyn Miller, Kathryn Hastie, E. Saphire, Kenneth Kim, Thomas Riffelmacher, S. Shresta
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>54</td>
        </tr>

        <tr id="Since its emergence, the coronavirus (SARS-CoV-2) outbreak has been a pandemic responsible for about 7 million deaths worldwide. Numerous studies have been conducted to determine the virus’s multiorgan system involvement, particularly its relation to cancer biology. Spontaneous regression of cancer has been observed in some patients with the coronavirus, which may be attributed to the virus’s ability to trigger specific immune responses that can be oncolytic and help reduce and eliminate oncogenic cells. This study aims to explore the paradoxical effects of COVID-19 in inducing cancer regression. The paradoxical effect of SARS-CoV-2 infection has been attributed to the possibility of a heightened immune activation possibly triggered by the virus, and some of these include increased levels of cytokines such as interferon and tumor necrosis factor-alpha (TNF-α), as well as the activation of T cells and natural killer (NK) cells. COVID-19-induced cancer regression presents new perspectives on the relationship between viral infections and the immune system’s antitumor capabilities. This would help foster future research investigating specific immune pathways activated during SARS-CoV-2 and discover how these can be therapeutically harnessed to aid cancer regression. Not applicable.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/2b70234ee10e35d21e82680c57b0003d8503d4e0" target='_blank'>
              COVID-19 infection and cancer regression: a review of current evidence, potential mechanisms, and clinical perspectives on a Paradoxical phenomenon
              </a>
            </td>
          <td>
            I. Ogieuhi, V. Ajekiigbe, C. Agbo, Chidera Stanley Anthony, Adegbesan Abiodun Christopher, Jennifer Chinaecherem Onyehalu, M. C. Agu, Sylvia Mmesomachi Mbaji, Adewunmi Akingbola, Bisharat Ahmed, Owa Ogieuhi, O. Akinmeji
          </td>
          <td>2025-10-23</td>
          <td>Infectious Agents and Cancer</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="Background. Asthma is a chronic progressive heterogeneous respiratory disease accompanied by the development of a systemic inflammatory response. Due to the widespread prevalence of the novel coronavirus infection, there is concern about the impact of COVID-19 on patients with asthma. Current evidence suggests that SARS-CoV-2 activates the inflammasome response, triggering a hyperinflammatory reaction in patients with asthma, but the long-term consequences are still insufficiently studied. 
Purpose. To study the features of the systemic inflammatory process over six months after SARS-COV-2 infection in individuals with asthma. 
Materials and methods. In patients with mild, partially controlled asthma after mild COVID-19 infection (n = 52) and individuals with asthma (n = 34) who did not contract COVID-19, an assessment of inflammatory markers in peripheral blood was performed. Patients were examined immediately after recovery and confirmation of a negative SARS-COV-2 test result; one month, three months, and six months after the infection. The control group included conditionally healthy volunteers (n=15) who did not contract COVID-19. The cellular composition of peripheral blood, ESR, CRP, D-dimer levels were determined by classical methods; interleukin concentrations: (IL)-1β, IL-6, IL-18, NOD-like receptor protein 3 (NLRP3) inflammasome, gasdermin D (GSDMD) were measured by ELISA methods. 
Results. It was revealed that for all studied parameters, there is a slow decrease in the level of indicators by six months. The levels of GSDMD, platelets, IL-1β, D-dimer, ESR, IL-6, NLRP3 after six months do not reach the values of the control group, which indicates a persistent hyperinflammatory response of the immune system. 
Conclusion. Activation of NLRP3 and gasdermin D by the SARS-CoV-2 virus directly or indirectly can lead to dysregulation of inflammasome-mediated mechanisms, triggering and maintaining a hyperinflammatory reaction for six months, prolonging the recovery process in patients with asthma. The study of these processes will expand the understanding of the pathological mechanism. This will allow the development of new therapeutic strategies for asthma patients who have suffered from the novel coronavirus infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4989330952617c30321fd95e1d3a822ad386e019" target='_blank'>
              Dynamics of inflammatory markers over six months in patients with asthma who underwent COVID‑19
              </a>
            </td>
          <td>
            T. G. Lobova, T. Vitkina
          </td>
          <td>2025-10-31</td>
          <td>Siberian Journal of Life Sciences and Agriculture</td>
          <td>0</td>
          <td>10</td>
        </tr>

        <tr id="Salivary gland dysfunction and inflammation are common following SARS-CoV-2 infection. This study aimed to investigate the effects of SARS-CoV-2 spike and envelope proteins on glandular function in healthy C57BL/6 mice through direct intra-glandular injection into the submandibular glands. Local administration of spike protein significantly reduced salivary secretion, while the envelope protein had no measurable impact. Histological analysis revealed the presence of leukocyte foci in two-thirds of spike protein-treated mice, while none were detected in the vehicle- or envelope protein-treated groups. Furthermore, spike protein treatment led to a significant increase in total immune cells and B cells, and an expansion of the CD44high CD62Llow effector/effector memory subsets within CD4 T cells and B cells in the submandibular glands. Notably, serum antinuclear antibodies developed in one-third of spike-treated mice, consistent with the reported salivary gland pathology in COVID-19 patients that resemble autoimmune Sjögren’s disease. Moreover, spike protein treatment increased phospho-STAT3 levels and induced transcriptomic changes indicating impaired acinar compartment, heightened adaptive immune responses, and altered tissue remodeling activity. These findings show that SARS-CoV-2 spike protein alone is sufficient to initiate significant salivary gland pathology in the absence of intact virus or ACE2 interaction, providing evidence for a novel mechanism by which SARS-CoV-2 induces salivary gland dysfunction and pathology with autoimmune features.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0ed181b81ada91ccc763c713a424a697626f932b" target='_blank'>
              SARS-CoV-2 spike protein induces salivary gland dysfunction and immune infiltration in C57BL/6 mice
              </a>
            </td>
          <td>
            Fernanda Aragão Felix, Yuqiao Jiang, Jing Zhou, Dongfang Li, Victoria Zhou, Sílvia Ferreira de Sousa, Kevin Matthew Byrd, Qing Yu
          </td>
          <td>2025-11-21</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="Five years ago, we launched the COVID Human Genetic Effort. Our goal was to explain the clinical variability among SARS-CoV-2-exposed individuals by searching for monogenic inborn errors of immunity (IEI) and their phenocopies. We deciphered the pathogenesis of critical COVID-19 pneumonia and multisystemic inflammatory syndrome in children (MIS-C) in ~15% and 2% of cases, respectively, thereby revealing general mechanisms of severe disease. We also defined neuro-COVID-19 genetically and immunologically in one child, while we delineated the immunological mechanisms of COVID-toes in healthy children and young adults, paving the way for their genetic study. Understanding the human genetic and immunological basis of resistance to SARS-CoV-2 infection, long COVID, and myocarditis post mRNA vaccination, has been challenging and investigations remain ongoing. This work highlights the power of patient-based basic research and large-scale international collaborative efforts to discover human genetic and immunological drivers of infectious disease phenotypes, with implications for the timely development of new medical strategies before the next pandemic arrives.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/33c1dd728132f42ffee69c7f2731779fab0acc3c" target='_blank'>
              The seven enigmas of SARS-CoV-2: from the past to the future
              </a>
            </td>
          <td>
            E. Andreakos, L. Arkin, P. Bastard, A. Bolze, A. Borghesi, Petter Brodin, J. Casanova, Giorgio Casari, A. Cobat, Beth A. Drolet, J. Fellay, Elena W. Y. Hsieh, I. Meyts, T. H. Mogensen, V. Sancho-Shimizu, A. Spaan, H. Su, Donald C. Vinh, Ahmad Yatim, Qian Zhang, Shen-Ying Zhang
          </td>
          <td>2025-10-24</td>
          <td>Journal of human immunity</td>
          <td>0</td>
          <td>67</td>
        </tr>

        <tr id="Tuberculosis (TB) remains a major global health challenge. Peripheral blood immune cell composition provides valuable insights into TB progression and management. In this study, we analyzed cellular dynamics across the TB disease spectrum using 43 global transcriptomic datasets encompassing 5,902 blood samples. Distinct immune changes were identified during the early stages of TB progression. Transition from latent infection to incipient TB was associated with reduced proportions of natural killer (NK) cells. In subclinical TB, monocyte proportions increased further, accompanied by additional reductions in NK cells and B cells. These early immune shifts preceded the pronounced alterations observed in active TB, characterized by elevated monocytes and neutrophils alongside markedly decreased lymphocyte populations. During successful anti-TB treatment, immune profiles gradually normalized. Cellular dynamics were also influenced by TB burden, age, and HIV coinfection, with stronger immune responses observed in adults and in regions with lower TB burdens. Overall, this study highlights early-stage peripheral blood biomarkers, particularly NK cell changes, as potential indicators of TB progression and targets for preventive interventions.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f8574e17dda1b09d6c703a7d3ef93ad3a9f3cdff" target='_blank'>
              Peripheral blood cellular dynamics during the progression of human tuberculosis
              </a>
            </td>
          <td>
            Shanshan Zhu, Qiuchen Dai, Kai Wang, Hanlin Yan, Yuexuan Ma, Yayan Niu, Cheng Chen, Meiying Wu, Xueying Xie, Wanjun Gu
          </td>
          <td>2025-10-27</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="


 Cancer patients, particularly with hematologic malignancies, remain a vulnerable cohort for COVID-19 disease caused by SARS-CoV-2. In primary infection studies, hematologic cancer patients exhibited a distinct immune cell signature vs. solid tumor cancer patients. However, prolonged viral shedding was observed in both hematologic & solid cancer patients, while some cleared infection adequately. Studies have also shown impaired serologic vaccine responses in hematologic cancer patients. It remains unclear whether differential biological pathway perturbations in hematologic & solid cancer responses to either primary infection (infection cohort) or to primary COVID-19 vaccination (vaccine cohort) may explain these discrepancies.
 To address this, we utilised LC-MS PBMC proteomics, flow cytometry & blood counts, assessing 6 patient groups: an infection cohort (short & long viral shedders) & a vaccine cohort (solid / hematologic cancer patients with / without serologic COVID-19 vaccine response). Infection samples were taken at first positive SARS-CoV-2 RT-PCR; short shedders (n=5) cleared virus within 14 days, while prolonged shedders (n=13) did not. Proteomics data were available for 4 short and 9 prolonged shedders & were compared to 17 COVID negative cancer controls. For the vaccine cohort, we analysed proteomic changes from baseline to 3 weeks post–first dose in 16 haematologic & 15 solid cancer patients. Responders were defined by anti-Spike IgG EC50 >70.
 Within the infection cohort, prolonged shedders exhibited higher eosinophil counts & increased CD103+VD1 gd T % & TIM3+PD1+ / PD1+Naïve CD4+ T % compared to short shedders (p<0.05). Proteomic analysis of COVID+ patients (irrespective of shedder status) vs. COVID- patients revealed alterations including CRP & KRT1(adj.p<0.05). SERPINA1 was upregulated in short shedders(log2FC=0.86,adj.p<0.05) but not prolonged(log2FC=0.04,adj.p=0.97). α1AT has been shown to block SARS-CoV-2 viral entry & replication in cell lines & primary human airway cells. Gene set enrichment analysis revealed that inflammatory response, fatty acid metabolism, TNFa, coagulation & complement pathways were upregulated in short shedders, not prolonged.
 Within the vaccine cohort responders, coagulation, humoral, complement & B cell pathways were upregulated. However, this collective profile was driven differently in solid vs hematologic patients. Hematologic responders upregulated coagulation, platelet activation & hemostasis, solid responders did not. Both groups activated classical complement (C1Q, C1R, C4A/B), but their downstream profiles differed. Hematologic responders upregulated CFP & CLU, consistent with an innate-skewed alternate complement response while solid patients did not. B cell related pathways were only upregulated in solid responders, likely reflecting that 62.5% of hematologic patients were on treatment for B cell malignancies.
 We next performed comparative pathway analysis across 6 groups to assess whether differential immune responses to vaccination mirrored those seen after infection. Solid vaccine responders exhibited classical complement & B cell pathway protein engagement including CD19, MYD88, suggesting intact coordination between innate & adaptive immunity. Hematologic vaccine responders upregulated classical & alternative complement pathways with enrichment of ‘B cell–mediated immunity’ pathway; however, lacked expression of CD19, MYD88, instead increased IL21R indicating incomplete B cell development. Hematologic vaccine non-responders also did not upregulate CD19, MYD88 instead expressing ERCC1, HSPD1, LIG4, RIF1, MSH6 suggesting cellular stress. Short shedders activated complement & lacked B cell pathway upregulation, whereas prolonged shedders showed active downregulation of B cell activation & BCR signalling, with no complement engagement.
 In conclusion, these data indicate that hematologic cancer patients in particular are associated with impaired coordination between innate & adaptive immunity following SARS-CoV-2 exposure. This immune dysregulation, observed after infection & vaccination, may underlie increased clinical vulnerability. Indeed, prolonged shedders & hematologic vaccine non-responders show blunted immune activation. Notably, even hematologic vaccine responders exhibit a dysregulated profile, with complement activation but lacking B cell recovery, suggesting that apparent serological response may not equate to full immune competence in this group.
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5f2748b0d7139cd460c7cd09bb2405514513ccc4" target='_blank'>
              Impaired coordination between innate and adaptive immunity in hematologic and solid cancer patients following sars-cov-2 infection or vaccination
              </a>
            </td>
          <td>
            Paul R Buckley, H. Kakkassery, Theo Roumeliotis, R. Graham, Sheeba Irshad, P. Patten
          </td>
          <td>2025-11-03</td>
          <td>Blood</td>
          <td>0</td>
          <td>14</td>
        </tr>

        <tr id="Multisystem Inflammatory Syndrome in Children (MIS-C) is a serious condition emerging during the COVID-19 pandemic, strongly associated with prior SARS-CoV-2 infection. Characterized by systemic inflammation affecting multiple organs, MIS-C presents a complex clinical picture including fever, gastrointestinal distress, cardiac dysfunction, and neurological manifestations. Although its exact pathogenesis remains incompletely understood, immune dysregulation is recognized as a central mechanism. This review examines current understanding of MIS-C pathogenesis, focusing on immune dysfunction and viral triggers, particularly SARS-CoV-2. We analyze both innate and adaptive immune responses, cytokine storm dynamics, molecular mimicry, and virus-induced inflammatory cascades. Additionally, we discuss potential immunomodulatory therapeutic strategies and identify future research directions to improve MIS-C management and treatment outcomes.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fb906afaca8efa1a4927662eab78d7c57c8c42b9" target='_blank'>
              MIS-C pathogenesis: immune dysregulation & viral triggers
              </a>
            </td>
          <td>
            Tiantian Xu, Jiamin Zhang, Xiangyuan Hou, Xinyu Xie, Junye Qi, Chang-bing Wang, Yuqing Yan, Lu Kuang, Bing Zhu
          </td>
          <td>2025-11-26</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>28</td>
        </tr>

        <tr id="ABSTRACT Biological sex significantly influences susceptibility to tuberculosis (TB), with males typically experiencing a greater disease burden than females. However, the mechanisms underlying sex-specific immune regulation during TB pathogenesis remain incompletely understood. In this study, we examined sex-based differences in pulmonary immune cell composition, inflammatory signaling pathways, and macrophage transcriptomic responses in C57BL/6 mice infected with the Mycobacterium tuberculosis (Mtb) HN878 strain during the sub-acute stage of infection. Our results show that female mice had significantly lower pulmonary Mtb burdens and enhanced protein kinase B (AKT)–interferon gamma (IFN-γ) signaling, which is associated with autophagy, lysosomal activation, and effective intracellular bacterial clearance. In contrast, male mice exhibited higher bacterial loads and elevated IL-6 signaling, a pathway linked to exacerbated inflammation and impaired pathogen control. Histological analysis revealed greater lymphocytic aggregation in female lungs, despite comparable levels of pulmonary macrophages between sexes. Importantly, transcriptomic profiling of lung macrophages uncovered distinct sex-specific gene expression patterns, wherein female macrophages upregulated genes involved in tissue remodeling, phagocytosis, autophagy/lipophagy, and cell survival, whereas male macrophages showed enrichment of genes related to pro-inflammatory and adaptive immune responses. Notably, male macrophages expressed higher levels of Ighg1 (Immunoglobulin Heavy Constant Gamma 1), suggesting a potential sex-dependent modulation of humoral immunity during TB. Together, these findings demonstrate that biological sex shapes immune cell programming and host-pathogen interactions during TB, underscoring the importance of incorporating sex as a biological variable in TB research and therapeutic development. IMPORTANCE Men and women often respond differently to diseases like tuberculosis (TB), with men typically facing more severe illness, though the underlying reasons are unclear. To this end, our study investigated how male and female mice combat TB infection at a cellular and molecular level. We discovered that female mice controlled TB more effectively, as their immune systems activated specific pathways to break down and clear bacteria efficiently. Conversely, male mice showed higher bacterial loads and triggered more inflammatory, yet less effective, immune responses. Crucially, despite similar numbers of key immune cells (macrophages) in the lungs, their functional responses differed significantly by sex. These findings underscore that biological sex profoundly impacts the immune system’s fight against TB, paving the way for more personalized treatments and improved outcomes for all. Men and women often respond differently to diseases like tuberculosis (TB), with men typically facing more severe illness, though the underlying reasons are unclear. To this end, our study investigated how male and female mice combat TB infection at a cellular and molecular level. We discovered that female mice controlled TB more effectively, as their immune systems activated specific pathways to break down and clear bacteria efficiently. Conversely, male mice showed higher bacterial loads and triggered more inflammatory, yet less effective, immune responses. Crucially, despite similar numbers of key immune cells (macrophages) in the lungs, their functional responses differed significantly by sex. These findings underscore that biological sex profoundly impacts the immune system’s fight against TB, paving the way for more personalized treatments and improved outcomes for all.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a4287a0838a97c49b64dc2f6538c24df65cefe80" target='_blank'>
              Sex-specific transcriptional regulation in lung macrophages during sub-acute Mycobacterium tuberculosis infection
              </a>
            </td>
          <td>
            D. Dhanyalayam, Hariprasad Thangavel, Kezia Lizardo, Jigar V. Desai, J. Nagajyothi
          </td>
          <td>2025-11-12</td>
          <td>Microbiology Spectrum</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="The Natterin protein family represents an evolutionarily conserved group of immune effectors in teleosts, yet its broader regulatory role in host defense remains poorly understood. Here, we demonstrate that Natterin functions as a master upstream regulator, orchestrating a critical immune network that integrates type I interferon (IFN-I) signaling with non-canonical inflammasome activation during Salmonella Typhimurium (ST) challenge. Using wild-type embryos treated with IFN-I neutralizing antibody followed by the use of natterin (loc795232) knockout (KO) embryos generated by CRISPR/Cas9 and integrated approaches—including RT-qPCR, Western blotting, immunohistochemistry, and behavioral assays—we found that its absence completely abrogates the ST-induced IFN-I response, including the ablation of the interferon regulatory factors irf3 and irf7 and the IFN-φ1 receptor crfb1. Consequently, Natterin deficiency prevented the expression of the LPS sensor GBP4 and the proteolytic maturation of the inflammatory caspases Caspy and Caspy2. This disruption abolished downstream gsdme-a/b expression, which may result in the non-formation of pores. The critical role of IFN-I signaling was independently confirmed by its neutralization in wild-type embryos, which abolished the protein-level localization of IL-1β and IFN-β and mirrored the KO phenotype. Functionally, this disruption led to a sixfold increase in mortality and exacerbated ST-induced pathogenesis. Our results establish Natterin not merely as an effector molecule but as a pivotal regulator that integrates IFN-I and inflammasome signaling, orchestrating a coordinated immune response essential for host survival. This work reveals a previously unrecognized level of regulation in teleost innate immunity with significant evolutionary parallels to mammalian defense mechanisms.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/50b7032e9ba4954a47afe09a04d6af4c891a32f1" target='_blank'>
              Natterin bridges IFN-φ1 and non-canonical inflammasome pathways via CRFB1/Gbp4 to license Caspy2-mediated antibacterial immunity
              </a>
            </td>
          <td>
            Darlan Gusso, Felipe Justiniano Pinto, Aline Ingrid Andrade-Barros, Jefferson Thiago Gonçalves Bernardo, Carlos DeOcesano-Pereira, M. Lopes-Ferreira, Carla Lima
          </td>
          <td>2025-10-27</td>
          <td>Frontiers in Cellular and Infection Microbiology</td>
          <td>0</td>
          <td>31</td>
        </tr>

        <tr id="Background
Little information is available on the immune signaling pathway that drives severe COVID-19 in asthma. Our study evaluates the association between immune dysfunction and progression to severe COVID-19 in asthma using single-cell RNA sequencing.


Methods
Four patients with asthma and eight patients without asthma from three centers in South Korea were used for this analysis. For each patient, samples were collected over three-time points: at the time of COVID-19 infection, one week later, and two weeks later.


Results
They were classified into four groups according to the presence or absence of asthma and COVID-19 severity; non-asthma/mild COVID-19 (n=5), non-asthma/severe COVID-19 (n=3), asthma/mild COVID-19 (n=3), and asthma/severe COVID-19 (n=1) groups. A high-quality scRNA-seq dataset composed of 155,565 cells was generated that characterized peripheral immune cells. When the proportion of cell type was analyzed by time points, a decrease in T-cells was shown at the second time point in asthma/severe COVID-19 group compared to other groups. When the proportion of T-cell subtype was analyzed by time points, an increase in the proportion of CD8+ T cell was shown at the second time point in asthma/severe COVID-19 group than in other groups: in DEG analysis, notably, we observed relatively higher levels of cytotoxicity-related genes in asthma/severe COVID-19 compared to other groups.


Conclusion
Our study provides new insights into the mechanisms underlying the progression of COVID-19 infection in patients with asthma. A reduction in the proportion of T cells while expanding cytotoxic CD8+ T cell proportion was associated with severe COVID-19 presentation in asthma.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/024d563473f02b1257c1b2dc0e7510521f7669e6" target='_blank'>
              T cell immune dysfunction and progression to severe COVID-19 in asthma revealed by single-cell RNA sequencing.
              </a>
            </td>
          <td>
            B. Kim, Youlim Kim, Sang Hoon Lee, Siyoung Lee, Minjun Choi, Byeongchan Lee, Jae Seok Jeong, Sang-Heon Kim, Hyun Lee, Kwang Ha Yoo
          </td>
          <td>2025-11-18</td>
          <td>Tuberculosis and respiratory diseases</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="Sepsis remains a leading global cause of death, with immune heterogeneity’s molecular mechanisms poorly understood. This study analyzed 1,862 human peripheral blood samples, constructing a molecular interaction disturbance network that first revealed the network biology underlying sepsis immune heterogeneity. We identified 3 sepsis subtypes with marked different prognostic characteristics, with the C1 subtype showing the worst prognosis characterized by severe CD4+ T cell exhaustion—validated across 10 independent cohorts. Integrating single-cell transcriptomics from over 450,000 cells, proteomics, and functional validation, we identified monocyte-derived matrix metalloproteinase-9 (MMP9) as a key regulator driving CD4+ T cell dysfunction. Mechanistically, MMP9 modulates T cell exhaustion through dual mechanisms: promoting leukocyte-associated immunoglobulin-like receptor-1 (Lair-1) aggregation on T cell membranes, directly inhibiting zeta chain of T cell receptor associated protein kinase 70 (ZAP70) phosphorylation in T cell receptor signaling, while impairing Ca2+-release-activated Ca2+ channel function and intracellular calcium clearance, causing calcium dysregulation that blocks nuclear factor of activated T cells (NFAT) activation and nuclear translocation. The selective MMP9 inhibitor MMP9-in-1 effectively reversed T cell dysfunction, restored calcium homeostasis and NFAT nuclear translocation, markedly enhanced CD4+ T cell interleukin-2 and interferon-γ production, and reduced programmed cell death protein 1 expression. This work establishes a comprehensive translational framework from molecular network disturbances to clinical phenotypes, advancing sepsis immunopathophysiology understanding and providing effective targets for the treatment of sepsis patients.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/669347da1bb81250d0a1cfa9e2302d53bc332296" target='_blank'>
              Targeting Matrix Metalloproteinase-9 to Alleviate T Cell Exhaustion and Improve Sepsis Prognosis
              </a>
            </td>
          <td>
            Xuan Wang, Jingyuan Ning, Liang Zhou, Hongrui Li, Jinlei Cui, Jiachao Wang, Xiangyang Liang, Jinquan Li, Miao Li, Xue Gao, Wen-jian Li, Xing Chen, Fei Yu, Lin Wei, Cuiqing Ma
          </td>
          <td>2025-11-02</td>
          <td>Research</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="COVID‐19 research now provides a coherent picture of the virus's immunological impacts, highlighting immune‐evasion mechanisms, the particular vulnerabilities of patients with inborn errors of immunity (IEI), and evolving therapeutics for severe disease. SARS‐CoV‐2 exploits ACE2 for cell entry and can utilise CD147 to infect immune cells, undermining antiviral defences; recent work details cytokine storm biology, NLRP3 inflammasome activation, and suppression of type I interferon responses. IEI patients are disproportionately affected, often with severe, prolonged courses and persistent PCR positivity. Therapeutic approaches such as convalescent plasma, anti‐cytokine agents interferon alpha‐2b, and plasma exchange show variable effectiveness, while vaccine performance is challenged by ongoing viral evolution. Together, these insights underscore the need for tailored treatment strategies for IEI populations, vigilant monitoring for immune‐escape variants, and continuous adaptation of therapeutic and preventive measures. The aim of this review is to synthesise these findings, evaluate their implications for clinical management, and highlight future directions for research and patient care.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1f582b3a29cce6c91c09a0b1c7c85ccffbfc52a0" target='_blank'>
              Lessons From COVID‐19 on Inborn Errors of Immunity: A Five‐Year Narrative Review
              </a>
            </td>
          <td>
            Gamze Sonmez, Gizem Gunduz, S. Esenboğa, D. Çağdaş
          </td>
          <td>2025-10-28</td>
          <td>Scandinavian Journal of Immunology</td>
          <td>0</td>
          <td>21</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/6f8533b56cfd6745039054451557c794b2fe28b8" target='_blank'>
              Neutrophil Transcriptomics in SLE: Exploring Intrinsic, Ex Vivo Adaptation, and CAR T-Cell Therapy-Induced Changes
              </a>
            </td>
          <td>
            Ehsan Dehdashtian, Guangnan Hu, Leah Whiteman, Md Tanimul Islam, Stefania Gallucci, Manuel Garber, Dominic Borie, G. Schett, Roberto Caricchio
          </td>
          <td>2025-11-05</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>21</td>
        </tr>

        <tr id="The effects of antiretroviral therapy (ART) and treatment interruption on myeloid cell egress from the central nervous system (CNS) during human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) infection remain poorly defined. We hypothesized that CNS macrophages normally traffic out of the CNS, accumulate during viral infection and inflammation, and are released as inflammation resolves. To test this, we administered intracisternal (i.c.) injections of two different colored fluorescent superparamagnetic iron oxide nanoparticles (SPION) to SIV-infected macaques either early in infection (12–14 dpi) or 30 days before necropsy. SPION are preferentially taken up by perivascular, meningeal, and choroid plexus macrophages, enabling us to track macrophage turnover, infection, and migration. In non-infected macaques, SPION+ macrophages trafficked from the CNS to peripheral sites including the deep cervical lymph node (dCLN), lumbar lymph nodes, spleen, and dorsal root ganglia (DRG). With SIV infection, these cells accumulated in the CNS and showed reduced peripheral trafficking. ART decreased the number of SPION+ perivascular macrophages, and to a lesser extent, meningeal or choroid plexus macrophages. After ART interruption, SPION+ perivascular and choroid plexus macrophage numbers remained stable, whereas SPION+ meningeal macrophages increased. ART eliminated SIV-RNA+ perivascular macrophages, leaving few- scattered SIV-RNA+ cells in the meninges and choroid plexus. Following ART interruption, perivascular macrophages remained virus-negative, but scattered viral RNA+ meningeal macrophages persisted. In non-infected macaques, SPION+ macrophages trafficked to the dCLN, spleen, and DRG, but this trafficking diminished with SIV infection and AIDS with SIVE. Importantly, SIV-RNA+ SPION+ macrophages that exited the CNS were cleared by ART and did not reappear after treatment interruption. Using two differently colored SPION to assess establishment of CNS viral reservoirs, we observed higher numbers of early-labeled macrophages within and outside the CNS in animals with AIDS and SIVE, ART treatment, and ART interruption. These findings support a model in which SIV-infected perivascular macrophages seed an early CNS viral reservoir, while the meninges and choroid plexus undergo continual viral seeding during infection. ART reduces trafficking of infected macrophages out of the CNS and clears the perivascular macrophage reservoir, but SIV-RNA+ meningeal macrophages can persist, in low numbers, and can rebound after ART interruption.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/978817c1cd51902524161c071846dc82c1a681a8" target='_blank'>
              Resolving inflammation: The impact of antiretroviral therapy on macrophage traffic in and out of the CNS
              </a>
            </td>
          <td>
            Zoey K. Wallis, C. Midkiff, Miaoyun Zhao, P. Autissier, Soon Ok Kim, Addison Q. Amadeck, Yiwei Wang, M. Jakubowski, Tricia H Burdo, Andrew D. Miller, Qingsheng Li, Xavier Alvarez, Robert V. Blair, Kenneth C Williams
          </td>
          <td>2025-12-01</td>
          <td>PLOS Pathogens</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="Macrophages are crucial for neuroinflammatory responses following traumatic brain injury (TBI), encompassing various subtypes, such as border-associated macrophages (BAMs) that contribute to both brain damage and repair. However, the pathophysiological relevance of subtype-specific molecular markers is poorly understood. This study investigated the role of the BAM marker mannose receptor C-type 1 (MRC1, also known as CD206) during the early phase of TBI using controlled cortical impact (CCI). MRC1 gene expression was up-regulated, peaking between 3 to 7 days post-injury (dpi), and MRC1 protein expression predominantly localized to BAMs. To assess pathophysiological relevance, MRC1-deficient (MRC1-KO) and wild-type littermates (MRC1-WT) were examined following CCI for early neurological deficits, brain structural damage, intracerebral hematoma, and neuroinflammatory marker expression. At 5 dpi, MRC1-KO mice showed increased brain lesion volume and hippocampal neuron loss, with minor differences in neurological deficits compared to MRC1-WT mice. Intracerebral hematoma size increased in male but remained unchanged in female MRC1-KO mice. Immunostaining revealed no genotype-specific effects on GFAP+ astrocytes, while the number of perilesional CD68+ macrophages/microglia were reduced in MRC1-KO mice. Analysis of neuroinflammatory gene markers revealed an overall reduction in MRC1-KO mice. Sex-specific regulation was observed for the M2-like macrophage/microglia marker Arg1, with decreased expression in male and increased expression in female MRC1-KO compared to MRC1-WT mice. In conclusion, lack of MRC1 exacerbated brain tissue damage following experimental TBI. Reduced CD68+ macrophages/microglia and neuroinflammatory marker expression suggests impaired neuroinflammatory response in MRC1-KO, indicating MRC1 expression on BAMs contributes to beneficial early neuroinflammatory response following TBI.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/1ac5ec2bb9a4f897f1ee154ba78ff99b4c7b8daa" target='_blank'>
              The border-associated macrophage marker MRC1 contributes to an early neuroprotective inflammatory response to traumatic brain injury in mice
              </a>
            </td>
          <td>
            Jenny Strehle, Pawit Somnuke, Shuailong Li, Sudena Wang, Tobias Hirnet, Yong Wang, Michael K. E. Schäfer
          </td>
          <td>2025-10-30</td>
          <td>Acta Neuropathologica Communications</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="SARS-CoV-2 disrupts cellular homeostasis, including the autophagy-lysosome pathway (ALP), a critical component of innate immunity and viral clearance. By subverting autophagy, SARS-CoV-2 proteins such as ORF3a, ORF7a, and NSP6 inhibit autophagosome-lysosome (APG-L) fusion, generating “incomplete autophagy” that permits viral persistence and drives hyperinflammation. Transcription factor EB (TFEB), a master regulator of lysosomal biogenesis and autophagy, has emerged as a central player in the host response to coronavirus infection. TFEB orchestrates the expression of genes required for lysosomal function and autophagic flux while also shaping immune processes, including cytokine production, interferon-stimulated gene expression, and inflammasome clearance. This mini review synthesizes current knowledge on the TFEB-ALP axis in COVID-19 pathogenesis, highlighting its influence on acute immunopathology and its potential contribution to post-acute sequelae (Long COVID). Restoring TFEB activity and autophagic flux may counteract SARS-CoV-2 evasion strategies and restrain aberrant inflammatory responses. Harnessing the TFEB-autophagy pathway as a host-directed therapeutic strategy could help rebalance immune homeostasis, limit tissue damage during acute infection, and mitigate persistent inflammatory sequelae in Long COVID.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/16fa03377df001310b096f5bc84f1cdb14cf36a8" target='_blank'>
              Dysregulated TFEB–autophagy-lysosome pathway links acute COVID-19 immunopathology to Long COVID sequelae
              </a>
            </td>
          <td>
            Magdalena Gabig-Cimińska
          </td>
          <td>2025-11-28</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>0</td>
        </tr>

        <tr id="The Coronavirus Disease 2019 (COVID-19) pandemic, caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), has revealed the virus's ability to induce multi-organ damage, including significant liver injury. The molecular mechanisms of liver dysfunction in COVID-19 patients are explored, focusing on direct viral infection, immune-mediated damage, and the gut-liver axis. SARS-CoV-2 enters liver cells through the Angiotensin-Converting Enzyme 2 (ACE2) and Transmembrane Serine Protease 2 (TMPRSS2) receptors, but alternative pathways, such as CD209/Dendritic Cell-Specific Intercellular adhesion molecule-3-Grabbing Non-integrin (DC-SIGN) and AXL receptors, can also contribute to viral entry. Additionally, immune responses, particularly the cytokine storm, exacerbate liver inflammation, leading to hepatocyte damage. Pre-existing liver conditions, such as metabolic-associated fatty liver disease (MAFLD), alcohol-related liver disease (ALD), and liver fibrosis, heighten the risk of severe outcomes in COVID-19 patients. Post-COVID-19 liver complications, including fibrosis progression and persistent liver damage, have been reported, with emerging evidence suggesting chronic inflammation, viral persistence, and autoimmune reactions as potential contributors. Furthermore, Drug-Induced Liver Injury (DILI) from COVID-19 treatments remains a concern, highlighting the need for careful management. Consequently, understanding the interplay between SARS-CoV-2 and the liver is critical for improving patient outcomes and developing targeted therapies to mitigate liver-related complications in both acute and Long COVID-19 phases. This article is categorized under: Infectious Diseases > Molecular and Cellular Physiology.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d8e7ab48363fa154c104250ae482911ee316a6df" target='_blank'>
              SARS-CoV-2: A Liver Brief.
              </a>
            </td>
          <td>
            Youness Limami, Hicham Wahnou, Martin Ndayambaje, Soufyane Hba, Oumaima Chgari, Mounia Ammara, Riad El Kebbaj, Abdallah Naya, M. Oudghiri, Raphael Georges Duval
          </td>
          <td>2025-11-01</td>
          <td>WIREs mechanisms of disease</td>
          <td>0</td>
          <td>19</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e1cbb648633a5a3e51107b7f82904595c2267c25" target='_blank'>
              SARS-CoV-2 variants: biology, pathogenicity, immunity and control
              </a>
            </td>
          <td>
            Ryuta Uraki, Bette Korber, Michael S. Diamond, Yoshihiro Kawaoka
          </td>
          <td>2025-11-10</td>
          <td>Nature Reviews Microbiology</td>
          <td>1</td>
          <td>28</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4affc89bf67fc05b617d2d032b1ac2bfae33c8c8" target='_blank'>
              The effects of denifanstat on hepatitis E virus replication and triggered inflammatory response
              </a>
            </td>
          <td>
            Jiahua Zhou, M. Peppelenbosch, Qiuwei Pan, I. Ayada
          </td>
          <td>2025-10-17</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="B cells are essential for the defense against various infectious agents including severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) causing coronavirus disease 2019 (COVID-19). COVID-19 is caused by interaction of the spike protein (SP) with the receptor-binding domain (RBD) and its receptor, angiotensin converting enzyme 2 (ACE2). Bisphenol A (BPA), a plasticizer and endocrine-disrupting chemical, can enter the human body through several exposure routes. Previously, we reported human B cell death by BPA treatment via autophagy induction. Here, we investigated whether the exposure to BPA affects B cell susceptibility to SP of COVID-19 and how to interfere the interaction of SP and ACE2. We observed an increase in ACE2 gene expression in human B cells by BPA treatment and more SP binding in BPA-treated B cells. Our data also showed more B cell death accompanying increased autophagic puncta count and lysosomal intracellular activity by co-treatment with BPA and SP compared to those in BPA treatment alone. Ursodeoxycholic acid (UDCA) reduced SP binding in B cells in BPA-exposed B cells. UDCA treatment also inhibited B cell death and lysosomal enzyme activity which were enhanced by co-treatment of BPA and SP. Taken together, results demonstrate that BPA-exposed B cells are more susceptible to COVID-19. It also suggests that UDCA could be protective to SP-responding B cells exposed to BPA.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/9418048ea44978a0e4005ffc042dc853d1a51170" target='_blank'>
              Ursodeoxycholic Acid Attenuates B Cell Susceptibility to SARS-CoV-2 Spike Protein by Interfering Its Binding to ACE2
              </a>
            </td>
          <td>
            So-Jeong Park, Eun-Yi Moon
          </td>
          <td>2025-10-17</td>
          <td>Biomolecules & Therapeutics</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/96d3861c110e5ae3f35e700cedd4412c7f059c98" target='_blank'>
              T-cell Multiomic Analysis Identifies Subsets and Mechanisms of Interaction with Epithelial Cells in Idiopathic Pulmonary Fibrosis
              </a>
            </td>
          <td>
            A. Serezani, Julia M. R. Bazzano, B. Pascoalino, Ludmilla da Silva, Abigail J. Dietrich, Chase J. Taylor, T. Sherrill, C. Calvi, Paula I. Gonzalez-Ericsson, E. Wilfong, Matthew D Bacchetta, C. Shaver, Lorraine B. Ware, M.L. Salisbury, Luc Van Kaer, N. Banovich, JA Kropski, Timothy S. Blackwell
          </td>
          <td>2025-11-19</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>31</td>
        </tr>

        <tr id="Inflammasomes, particularly NLRC4, play crucial roles in immune responses to intracellular bacterial infections. However, gain-of-function mutations in NLRC4 are linked to severe autoinflammatory diseases, including autoinflammation with infantile enterocolitis (AIFEC). AIFEC patients who survive infancy typically have no further intestinal symptoms but retain susceptibility to macrophage activation syndrome (MAS). However, existing mouse models do not adequately replicate the inflammation observed in AIFEC patients. To better understand this, we developed a mouse model capable of conditional expression of the activating V341A mutation in NLRC4 (NLRC4-V341A KI). Global conversion to NLRC4-V341A at the germline resulted in symptoms closely mirroring those of human AIFEC, including severe infantile enterocolitis characterized by heightened intestinal inflammation, disrupted gut epithelium, compromised intestinal barrier integrity, severe diarrhea, and mortality within 10 days post-natally. Additionally, they displayed systemic autoinflammation marked by elevated levels of IL-1β, IL-18, and IL-6, alongside cytopenia and hemophagocytosis. In contrast, conditional conversion to NLRC4-V341A in adulthood caused systemic autoinflammation with only mild enterocolitis, mirroring AIFEC patients. Using this model, we demonstrated that IL-18 and TNF blockade effectively ameliorated AIFEC disease symptoms. Unexpectedly, glucose supplementation has emerged as a promising therapeutic strategy. These findings advance our understanding of AIFEC and illuminate the ways in which inflammasome activation contributes to very early onset inflammatory bowel disease (VEO-IBD) in the developing gut.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/beb31db8e6067d8d16e0db0caa0f1081c201e966" target='_blank'>
              An animal model of NLRC4-associated autoinflammation and infantile enterocolitis reveals novel therapeutic strategies
              </a>
            </td>
          <td>
            Yuhang Wang, Joyce Z. Gao, Prajwal Gurung, Sarah P Short, Yiqin Xiong, S. Canna, Zizhen Kang
          </td>
          <td>2025-10-20</td>
          <td>Cellular and Molecular Immunology</td>
          <td>1</td>
          <td>37</td>
        </tr>

        <tr id="Long COVID (LC) is a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection-associated chronic condition and is present for at least 3 months as a continuous, relapsing and remitting, or progressive disease state that affects one or more organ systems, including cardiovascular. Extensive literature supports an association between SARS-CoV-2 infection and cardiovascular complications and increased cardiovascular risk after infection. The cardiovascular sequelae after SARS-CoV-2 infection have not yet been comprehensively characterized. A growing body of evidence suggests that endothelial dysfunction is a central mechanism in COVID-19 and has also been identified as a key pathogenic mechanism in LC. Although considerable progress has been made in characterizing the epidemiology, clinical course, and biology of LC, many questions remain unanswered. The incomplete understanding of the pathomechanisms of LC has hampered the development of targeted therapies to date. Further research and data are needed to develop effective therapeutic and preventive tools. Based on current literature this review aims to provide an up-to-date overview of the pathomechanisms affecting the cardiovascular system and the potential role of selected micronutrients, vitamins and minerals, and flavonoids as preventive and therapeutic strategies in LC.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fecb1ed06a4859e6569f30b68493347d474b7177" target='_blank'>
              Cardiovascular damage and comorbidities related to long COVID: pathomechanisms, prevention, and therapy
              </a>
            </td>
          <td>
            M. Kvandová, P. Balis, B. Kaločayová, Jana Vlkovicova, Silvia Dobrodenkova, A. Puzserova
          </td>
          <td>2025-12-03</td>
          <td>Frontiers in Cardiovascular Medicine</td>
          <td>0</td>
          <td>18</td>
        </tr>

        <tr id="


 Peroxisomes are vital yet often overlooked metabolic organelles. Here we demonstrate that exuberant interferon signaling remodeled the macrophage peroxisome compartment after severe COVID-19. Lack of macrophage peroxisomes resulted in impaired inflammation resolution and defective lung repair, causing heightened acute morbidity and mortality during SARS-CoV-2 infection. Peroxisomes exhibited cell-type specific modulation of lipid metabolism, enhancing mitochondrial health critical for lung macrophage repair program and alveolar cell self-renewal. Peroxisomes also prevented excessive inflammasome activation and IL-1β release, thereby limiting the accumulation of KRT8high dysplastic epithelial progenitors and facilitating their proper differentiation into functional alveolar cells post viral injury. Dysfunction in macrophage peroxisomes contributed to chronic lung pathology and fibrosis post SARS-CoV-2 infection. Furthermore, pharmacologically enhancing peroxisome biogenesis mitigated acute symptoms and limited chronic sequelae post SARS-CoV-2 infection (PASC). Our data reveal a peroxisome-centric pro-recovery therapeutic strategy for managing both acute and chronic conditions after respiratory viral infections.



 The study was in part supported by the US National Institutes of Health grants AI147394, AG069264, AI112844, HL170961, AI176171 and AI154598 to J.S, R01HL132287, R01HL167202 and R01HL132177 to Y.M.S, F31HL170746 and T32AI007496 to H.N, R01HL155759 and R01HL159953 to P.C, P01-HL108793 to D.J, and HL159675, HL152293 and AI163753 to J.Q.



 Viral Immunology (VIR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/31916c623de231a4bb589cd8541da198e144c336" target='_blank'>
              Macrophage peroxisomes guide alveolar regeneration and limit post-acute sequelae of SARS-CoV-2 infection (PASC) 2101
              </a>
            </td>
          <td>
            Xiaoqin Wei, Jie Sun
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="


 Understanding mucosal immunity is vital for designing vaccines against respiratory viruses like SARS-CoV-2. Immunity resulting from vaccination followed by infection may offer superior mucosal protection, yet the underlying mechanisms remain unclear. This study reveals the mucosal humoral, cellular, and molecular signatures underpinning this enhanced protection. Mice received two Spike mRNA doses and were challenged with mouse-adapted SARS-CoV-2. In these mice, bronchoalveolar lavage (BAL) single-cell RNA sequencing showed increased adaptive immune cells, enriched T and B cell activation pathways, enhanced T cell differentiation, and upregulated B cell IgA production. Flow cytometry confirmed increased SARS-CoV-2-specific IFN-γ and TNF-α producing CD4? and CD8? T cells. The group exhibited elevated mucosal RBD-specific B cell levels and significantly higher IgA responses, leading to the highest respiratory neutralizing antibody levels. In contrast, mucosal IgG levels were similar across all groups. Using K18-hACE2 mice infected with Omicron, we found that despite minimal lung pathology, these mice showed increased respiratory T and B cell responses and elevated mucosal and plasma IgA levels compared to vaccination or infection alone. This study offers insights into the cellular signaling networks providing superior mucosal protection following combined vaccination and infection, informing vaccination strategies against respiratory pathogens.



 The study was in part supported by the US National Institutes of Health grants AI147394, AG069264, AI112844, HL170961, AI154598, and AI176171



 Vaccines and Immunotherapy (VAC)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d895c20835d098df0e3aea69e7d6a244a84e33de" target='_blank'>
              Cellular signatures of hybrid immunity underpinning superior mucosal protection 2420
              </a>
            </td>
          <td>
            A. Chaudhuri, Jinyi Tang, P. Qu, Pei Li, Yajie Liu, Justin J Taylor, Haitao Hu, Shan-lu Liu, Jie Sun
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ff36a4b1a6924bc75f6af8503f56e2c97056bea0" target='_blank'>
              Dormant viral pathways underlie space-induced neural senescence – a neuroprotective strategy for spaceflight and neurological diseases
              </a>
            </td>
          <td>
            A. M. Martins, Hideyuki Nakashima, Angela Macia, Taichi Umeyama, Satoshi Miyashita, Livia Luz de Souza Nascimento, Luisa Bulcao Vieira Coelho, Pinar Mesci, Erik Viirre, Nicole Suarez, Aurian Saleh, Alex Savchenko, Beatriz Freitas, Aline L. Leite, Diego M. Assis, Masataka Ishizu, Tomoo Owa, Mikio Hoshino, John R. Yates, Kinichi Nakashima, A. Muotri
          </td>
          <td>2025-11-04</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>68</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/db70b2570d7101d2b0e5cf47bdfd6e799a249b9a" target='_blank'>
              From infection to intervention: post-acute sequelae of SARS-CoV-2 infection and cardiovascular risk
              </a>
            </td>
          <td>
            Rufaida Wasim
          </td>
          <td>2025-10-13</td>
          <td>Inflammopharmacology</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="A major health challenge resulting from the COVID-19 pandemic is the manifestation of post-acute sequelae of SARS-CoV-2 (PASC). PASC (or long COVID) is a collective term used for clinical symptoms, various pathologies, and life-quality-changing functional impairment that persist for months to years after the initial SARS-CoV-2 infection. The mechanisms underlying PASC are not understood, although advances have been made in identifying factors that may contribute to long-term pathology. Recent data have emerged, showing an association between SARS-CoV-2 viral persistence and non-SARS-CoV-2 infections (pre-existing, viral reactivation, or new infections) in facilitating or mediating PASC. However, the heterogeneous nature and timing of co-infections have made it challenging to understand, interpret, and contextualize their contribution to PASC. Here, we summarize the impact of potential viral, bacterial, and fungal infections on SARS-CoV-2 pathogenesis, with a focus on their possible roles in the development of PASC. We also provide a framework to understand the mechanisms of PASC and inform basic, translational, and clinical research initiatives, including RECOVER, a large and ongoing research initiative to understand, treat, and prevent long COVID.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/000f98d578723e631538234351febf6a80fd995b" target='_blank'>
              The role of co-infection in the pathogenesis of acute SARS-CoV-2 infection and development of post-acute sequelae: A perspective
              </a>
            </td>
          <td>
            T. Henrich, Christopher P Montgomery, Joerg Graf, Nahed Ismali, S. Mohandas, Mehul Suthar, Hassan Brim, John M Coffin, Aayush Pagaria, Jeisac Guzmán Rivera, Urmila Vudali, P.S. Keim, Guangming Zhong, Rebecca McGrath, Belinda Edwards, Adolfo García-Sastre, M. Gennaro
          </td>
          <td>2025-11-17</td>
          <td>eLife</td>
          <td>0</td>
          <td>47</td>
        </tr>

        <tr id="There is a subgroup of people infected with the SARS-CoV-2 virus who manifest lingering sequelae (LongC), with neurological symptoms (nLongC). We recruited 86 COVID-19 volunteers, 35 of whom were fully recovered (Cov) and 51 who had neurological symptoms (nLongC) 4–53 months after infection and compared them to 51 healthy pre-pandemic controls (HC). Thirty-five percent of nLongC individuals carried the apolipoprotein E4 (APOE4) gene, compared to 11% of Cov. Four plasma proteins, interleukin 1 beta (IL-1β), interleukin 8 (IL-8), glial fibrillary acidic protein (GFAP), and hemopexin, continued to be elevated in both Cov and nLongC compared to HC. Soluble CD14 was elevated in nLongC but not Cov. As a group, IL-1β decreased over time in Cov but not nLongC. Two of the elevated proteins, IL-8 and GFAP, correlated with age, with both Cov and nLongC showing higher levels than HC. Using a combination of four plasma proteins, along with age, body mass index, and APOE4 presence, we were able to achieve an area under the curve (AUC) of 0.81. These results suggest that SARS-CoV-2 infection causes a low-grade inflammatory process that, even months or years after infection, does not return to pre-COVID-19 levels, which may contribute to neurologic sequelae and accelerated aging.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d6dc097b9097119d707ae7261b40c50b96e52a07" target='_blank'>
              Chronic Inflammation and Altered Immune Responses in LongCOVID Associate with Neurological Manifestations and Accelerated Aging
              </a>
            </td>
          <td>
            Norina Tang, Judith M. Ford, Kaitlyn Dal Bon, Lynn Pulliam
          </td>
          <td>2025-11-26</td>
          <td>Cells</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Inflammasomes and interferons are two critical defense mechanisms of innate immunity, and their imbalance is a key strategy employed by viruses to evade host immune surveillance. During porcine reproductive and respiratory syndrome virus (PRRSV) infection, an arteritis virus, a characteristic “high inflammation, low interferon” immune imbalance is observed. This study identifies PRRSV non-structural protein NSP5 as a central mediator of this immune imbalance. We demonstrate that NSP5 recruits NLRP3 to the endoplasmic reticulum (ER)-mitochondrial interface, triggering ER stress and Ca2+ leakage, which subsequently activates the NLR family pyrin domain containing 3 (NLRP3) inflammasome. Notably, a specific NSP5 mutation (G30A) abolishes its ability to activate NLRP3. PRRSV carrying this mutation exhibits suppressed NLRP3 activation and IL-1β release. Concurrently, NSP5 retains STING in the ER, preventing its trafficking and inhibiting type I interferon induction. This dual mechanism ultimately drives the high inflammation and low interferon phenotype observed during PRRSV infection. Importantly, our findings reveal that a single viral protein can orchestrate immune imbalance, suggesting a potentially widespread strategy for viral evasion of host immune surveillance.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4e730d92266f5f6b0990407c8ac29dced1f7ed68" target='_blank'>
              PRRSV NSP5 orchestrates dual immune disruption by targeting NLRP3 and STING
              </a>
            </td>
          <td>
            Xiangyu Huang, Xuyan Xiang, Xiaohan Jiang, Weiyu Qu, Yufei Zhang, Zhenchao Zhao, Minjie Li, Haiwei Wang, Xin Li
          </td>
          <td>2025-10-16</td>
          <td>Veterinary Research</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="Influenza A virus (IAV) is a prevalent pathogen that causes severe respiratory infections worldwide. Currently, the incidence of coinfections between IAV and Gram-negative bacteria has been steadily increasing, and the synergistic interaction between IAV infection and bacterial exposure represents a pivotal risk factor for disease exacerbation. Lipopolysaccharide (LPS), a major Gram-negative bacterial virulence factor, is hypothesized to regulate IAV-induced immune response intensity and disease severity by reshaping the pulmonary immune microenvironment. Here, we established an in vivo coadministration model via intratracheal instillation of low-dose LPS and H1N1 to dissect their synergistic pathogenesis. LPS exposure potentiated H1N1-induced severe lung injury, manifested as persistent neutrophil and monocyte infiltration, elevated levels of cytokines (e.g., CXCL1, CCL2, and IL-6), and alveolar damage without affecting viral replication. Mechanistically, LPS triggered immune hyperactivation through early neutrophil recruitment, neutrophil extracellular trap (NET) formation, and a self-sustaining positive feedback loop. Intervention experiments revealed that the degradation of NETs by DNase I or neutrophil inhibition significantly alleviated lung damage and systemic inflammatory responses. This study establishes NET-driven innate immune amplification as a key mechanism underlying LPS-enhanced H1N1 pathogenicity, offers an immunomodulatory approach for severe bacterial-viral coinfections, and underscores the parity of immunomodulatory therapy with anti-infective treatment.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8a8204eba4e3f2c05f83c187d56985bc21d9c8f7" target='_blank'>
              Exposure to bacterial lipopolysaccharide aggravates H1N1-mediated lung immunopathology via neutrophil extracellular trap formation
              </a>
            </td>
          <td>
            Guiling Yan, Zhongwen Hu, Yuanyuan Peng, Yuqin Tu, Jingling Xie, Yuchao Zhong, Changchun Niu, Yang Luo
          </td>
          <td>2025-11-18</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="Torquetenovirus (TTV) is a prevalent virus whose clinical significance remains unclear, potentially linked to immunosenescence. This study examines TTV species in relation to immune impairment, inflammation, and cellular stress response in aging. A subset of recruited age‐stratified individuals (RASIG) from the MARK‐AGE study was divided into three groups: Cohort 1 A (healthy young adults), Cohort 1B (older adults with mild immune decline), and Cohort 1 C (older adults with marked immune impairment). Analyses included TTV load, species diversity, lymphocyte subpopulations, inflammatory markers, Poly‐(ADP‐ribose) polymerase (PARP‐1) expression/activity. Alpha‐ and beta‐diversity analyses showed the highest TTV species diversity in Cohort 1 C, with significant cohort‐dependent differences and partially cohort‐specific clustering patterns. Increased TTV species number correlated with higher TTV load, elevated CMV IgG levels, and greater immune impairment risk. Specific TTV species were associated with CD4/CD8, and reduced T‐cell receptor excision circles, suggesting impaired T‐cell homeostasis. TTV viremia positively correlated with C‐reactive protein (CRP) and α2‐macroglobulin. PARP‐1 expression and activity increased in individuals with higher TTV diversity, particularly in the presence of TTV9 and TTV20. TTV load and species diversity are associated with immunosenescence, inflammation, and PARP‐1 activation suggesting their potential as biomarkers of age‐related immune decline. Longitudinal studies are needed to clarify underlying mechanisms.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f80aaae8b6afb118dd4b1838c672bee68f10102b" target='_blank'>
              TTV Species Diversity as a Novel Biomarker of Immune Dysregulation in Aging
              </a>
            </td>
          <td>
            Federica Novazzi, P. G. Spezia, F. Ferrante, A. Genoni, Paolo Antonio Grossi, Nicasio Mancini, Marco Malavolta, Marta Ballietti, Francesco Piacenza, Serena Marcozzi, Carlo Fortunato, G. V. Badillo Pazmay, L. Cianfruglia, Alexander Bürkle, M. Moreno-Villanueva, M. Dollé, E. Jansen, Tilman Grune, E. Gonos, C. Franceschi, M. Capri, Michele Zampieri, P. Caiafa, F. Ciccarone, Anna Reale, Birgit Weinberger, E. Sikora, Florence Debacq-Chainiaux, W. Stuetz, Mikko Hurme, P. Slagboom, J. Bernhardt, Fabiola Olivieri, Fabio Filippini, F. Maggi, R. Giacconi
          </td>
          <td>2025-10-23</td>
          <td>Journal of Medical Virology</td>
          <td>0</td>
          <td>64</td>
        </tr>

        <tr id="


 Vaccination is essential for preventing viral infections and promoting public health; however, its efficacy may vary due to factors such as the nature of the pathogen, vaccine type, and individual immune response. It is known that intranasal immunizations can enhance the immune response by stimulating tissue-resident memory T cells (TRMs), which promote early viral clearance at the infection site. Our study aims to optimize the generation and maintenance of TRMs in the lungs using purinergic signaling components as adjuvants. For this, we crossed B knockout mice with hACE2 mice, generating a B cell-deficient lineage capable of internalizing active SARS-CoV-2 (BKO-hACE2). C57BL/6 and BKO-hACE2 mice were immunized with inactivated SARS-CoV-2 receiving one intravenous dose followed by three intranasal booster doses. After 30 days, lungs were analyzed by flow cytometry and histopathology. Additionally, we evaluated the effects of ATP (0.5 mM to 10 mM) during immunizations, finding that lower doses (0.5 mM) increased the frequency of TRMs (CD4+ and CD8+), while higher doses reduced this population. This suggests that ATP may interact with the P2X7 receptor, promoting either proliferation or cell death. Although infection data did not provide conclusive evidence of T cell-mediated protection in the absence of antibodies, the potential of ATP as a possible adjuvant opens new avenues for enhancing immune responses in experimental models.



 FAPESP - 2023/15373-9



 Viral Immunology (VIR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/988c1a539848238549c2d61fd24576f4f991f375" target='_blank'>
              Enhancing lung immunity against COVID-19: the role of ATP in TRM cell generation 9389
              </a>
            </td>
          <td>
            Marcos Vinícios Pinheiro Cione, Igor Santiago-Carvalho, Luciana dos Santos Barros Manhaes, Rodrigo Jose Rocha Xavier Freitas, Rogério Silva do Nascimento, Viviane Fongaro Botosso, Ana Marcia Sá Guimarães, Henrique Borges da Silva, Jose Maria Alvarez Mosig, M. R. D'Império Lima
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>24</td>
        </tr>

        <tr id="Introduction The emergence of Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) necessitated the rapid development of effective vaccines, with mRNA vaccines demonstrating high efficacy and accelerated production timelines. However, reports of myocarditis following mRNA vaccination have raised safety concerns, and the underlying molecular mechanisms remain poorly understood. Methods Human AC16 cardiomyocytes were transfected with in vitro transcribed (IVT) COVID-19 mRNA modified with N1-methylpseudouridine (m1Ψ). A panel of inflammatory cytokines, including IL-6, was quantified using a Luminex liquid suspension chip. IL-6 expression was further validated at the mRNA level by RT-qPCR and at the protein level by ELISA. Cardiomyocyte apoptosis was assessed by flow cytometry. Myocardial injury biomarkers, specifically Creatine Kinase-MB (CK-MB) and cardiac troponin I (c-TnI) were measured by ELISA. The ceRNA interaction was investigated through RNA immunoprecipitation (RIP), and dual-luciferase reporter assays. Results IVT mRNA elicited a robust inflammatory response in cardiomyocytes, markedly upregulating the proinflammatory cytokine IL-6 (~2-fold). Under inflammatory conditions, IVT mRNA further exacerbated IL-6 secretion (~2-fold) and increased cardiomyocyte apoptosis (~1.3-fold). Additionally, IVT mRNA significantly elevated the levels of CK-MB (~1.5-fold) and c-TnI (~2-fold). Mechanistically, IVT mRNA functions as a competing endogenous RNA (ceRNA) for hsa-let-7f-5p, alleviating its suppression of IL-6 mRNA, and enhancing inflammatory responses in AC16 cardiomyocytes. Discussion This study elucidated a molecular mechanism linking COVID-19 mRNA vaccines to myocarditis and highlighted the ceRNA-mediated crosstalk between IVT mRNA and IL-6. These findings underscore the importance of avoiding critical microRNA binding sites in the design of next-generation mRNA vaccine sequences to improve safety.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/ffef4e6dbfdfd824c6069fab976ca57e2dd31c73" target='_blank'>
              Exploring ceRNA mechanisms in COVID-19 mRNA vaccine-induced myocarditis: implications for future vaccine design
              </a>
            </td>
          <td>
            Jing Wang, Xin-Yi Sun, Qian Gao, Min Fu, Mian Xiao, Ning Du, Xi-Yuan Ge
          </td>
          <td>2025-10-22</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="T-cell exhaustion is a terminal state of immune dysfunction characterized by impaired proliferation and effector functions, diminished cytokine secretion, and sustained expression of inhibitory receptors. In coronavirus disease 2019 (COVID-19), increasing evidence links exhausted T-cell phenotypes with poor clinical outcomes, including severe disease, delayed viral clearance, and persistent symptoms associated with Long COVID. Exhaustion results from prolonged antigenic stimulation and inflammatory signals and is marked by transcriptional reprogramming, metabolic and epigenetic dysregulation, and co-expression of inhibitory receptors such as programmed cell death protein-1 (PD-1), T-cell immunoglobulin and mucin-domain containing-3 (TIM-3), and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4). Notably, exhausted phenotypes in COVID-19 frequently coexist with hyperactivation, raising the unresolved question of whether inhibitory receptor expression reflects transient activation or irreversible dysfunction. Emerging therapeutic strategies to reverse these dysfunctional states include immune checkpoint inhibitors, cytokine modulation, metabolic interventions, and epigenetic therapies, although their clinical translation remains at an early stage. Critical research gaps include the scarcity of longitudinal data, incomplete profiling of T-cell subsets across disease stages during COVID-19 and Long COVID-19, and contradictory evidence of vaccine-induced exhaustion with limited understanding of its consequences. This non-systematic literature review synthesizes current advances in COVID-19 immunopathology and therapeutic strategies, underscoring that understanding T-cell exhaustion is crucial to improving outcomes and shaping next-generation immunotherapies and vaccines.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fcda848fedb31d45bcaf7a6be07292887c93eed0" target='_blank'>
              T-cell exhaustion in COVID-19: what do we know?
              </a>
            </td>
          <td>
            Roderick Chen-Camaño, Rodrigo DeAntonio, S. López-Vergès
          </td>
          <td>2025-10-29</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="


 The COVID-19 pandemic remains a significant global challenge, with comorbidities like obesity and diabetes exacerbating the severe outcomes. However, the mechanisms driving heightened susceptibility in these populations are poorly understood. SARS-CoV-2 infection disrupts lipid metabolism pathways regulated by Phospholipase A2 and 12-Lipoxygenase (12-LOX), an enzyme producing pro-inflammatory lipids such as 12-S-hydroxy eicosatetraenoic acid (12-HETE). This study examined the role of 12-LOX in severe COVID-19-associated hyperinflammation and evaluated the therapeutic potential of 12-LOX inhibition. We found elevated 12-LOX expression in lung and pancreatic tissues of diabetic COVID-19 decedents compared to the diabetic individuals with non-COVID-respiratory deaths. In SARS-CoV-2-infected K18-hACE2 mice, 12-LOX expression increased in lung and pancreatic tissues, even without diabetes, mirroring human findings. Treatment with the 12-LOX inhibitor VLX-1005 improved survival in mice receiving high-challenge doses of SARS-CoV-2. VLX-1005 treatment downregulated 30 pro-inflammatory cytokine and chemokine genes while upregulating four anti-inflammatory genes. Treated mice exhibited reduced inflammation and lower viral loads in the lungs. Notably, 12-HETE was undetectable in VLX-1005-treated mice but significantly elevated in controls. These findings demonstrate that 12-LOX inhibition mitigates hyperinflammation and improves survival against severe COVID-19 infection.



 Veralox Therapeutics funded this research.



 Viral Immunology (VIR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f3243933421cc39c9103bb70aec0f64509f1226f" target='_blank'>
              12-Lipoxygenase Drives Hyperinflammatory Responses and Enhances COVID-19 Severity 9032
              </a>
            </td>
          <td>
            Chandra Shekhar Bakshi, M. D'Silva, Jerry L. Nadler, Dave Meloney
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="Abstract Background Viral reservoirs are rapidly established in peripheral and lymphoid tissues in HIV-exposed and infected infants, but the timing and consequence of viral seeding in the brain tissues remain unclear. Methods Based on previously collected samples, this study retrospectively examined early viral reservoir seeding in the brain, neuropathological alterations, and cerebrospinal fluid (CSF) metabolic changes in neonatal rhesus macaques infected with SIV at birth, with or without early initiation of antiretroviral therapy (ART). Results Viral RNA was detectable in CSF by 2 days post infection (dpi), paralleling plasma viral load, whereas brain tissue-associated viral DNA and RNA were not consistently detected until after 3 dpi. No significant neuropathological lesions or CSF proinflammatory responses were observed during the first week of infection. In contrast, profound CSF metabolic dysregulation emerged, which was largely reversed by early ART, particularly when initiated at 3 dpi. Conclusions These findings define the kinetics of brain viral reservoir seeding in neonates and highlight the critical importance of initiating ART within the earliest stages of infection to preserve brain development and function in children exposed to maternal HIV.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/62f8a755220a9c6a8e639b2e94c203a978db3683" target='_blank'>
              Viral reservoir seeding and neurological metabolic dysregulation in early-life immunodeficiency virus infection
              </a>
            </td>
          <td>
            Li Ma, Robert Blair, Yao-Zhong Liu, Xiaolei Wang, E. Vincent, Christopher Yu, Lara A. Doyle-Meyers, Cissy Zhang, Ahmad Saied, Anne Le, Ronald S. Veazey, Qigui Yu, Huanbin Xu
          </td>
          <td>2025-10-12</td>
          <td>Research Square</td>
          <td>0</td>
          <td>26</td>
        </tr>

        <tr id="Emerging evidence suggests brain-resident myeloid cells, including perivascular macrophages and microglia, provide a reservoir for HIV infection in the central nervous system (CNS), and their inflammatory activation is a proposed pathogenic mechanism in HIV-associated neurocognitive disorders (HAND). We investigated whether cannabinoid receptor 2 (CB2), an immunomodulatory receptor expressed in myeloid cells, regulates viral replication and inflammation in HIV-infected macrophages and microglia. Using the synthetic CB2-specific agonist JWH-133, we found that CB2 activation reduced HIV replication in primary human monocyte-derived macrophages (MDMs) and human induced pluripotent stem cell-derived microglia (iMg) at differing doses, corresponding to the basal expression of CNR2, which encodes CB2, and related endocannabinoid transcripts in each cell type. JWH-133 broadly reduced release of cytokines from HIV-infected MDMs but not iMg. RNA-seq revealed that CB2 agonism primarily altered interferon and integrated stress response pathways in MDMs while altering homeostatic pathways, including synapse maintenance and phagocytosis, in iMg. Further analyses in iMg revealed that NLRP3 inflammasome activation, but not priming, was reduced by CB2 activation, which did not inhibit HIV-induced nuclear factor kB activation. This study identifies key differences in CB2 response between myeloid lineage cell types and implicates CB2-specific agonists as promising candidates for the regulation of HIV-associated neuroinflammation. Created in BioRender. Espinoza, C. (2025) https://BioRender.com/mxfla3i">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/71c568f55c0cf3f5f771b5d05ce139396b2d6389" target='_blank'>
              Differential Effects of Cannabinoid Receptor 2 Agonists on HIV Replication and Inflammatory Activation in Monocyte-Derived Macrophages and Induced Pluripotent Stem Cell-Derived Microglia
              </a>
            </td>
          <td>
            Alexander Starr, Sara Rathore, Marzieh Daniali, P. J. Gaskill, Ç. Akay-Espinoza, Kelly L Jordan-Sciutto
          </td>
          <td>2025-10-11</td>
          <td>Journal of Neuroimmune Pharmacology</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="


 Recent advances in single-cell transcriptomics have revealed significant heterogeneity in microglia, brain-resident macrophages that monitor the brain microenvironment. Disease-associated microglia (DAM), a unique transcriptional state, have been implicated in neurodegeneration and aging. Despite their critical role, the signaling pathways regulating DAM development and their function remain unclear. By overexpressing α-synuclein in neurons, our lab established a mouse model of Parkinson’s Disease (PD) that recapitulates microglial activation, immune cell infiltration, and dopaminergic neuron loss. In our model, we observed an expansion of the DAM transcriptional state and successfully characterized DAM accumulation at the protein level throughout PD progression. This accumulation coincides with reduced immune cell infiltration, linking DAM to chronic neuroinflammation. Using scATAC-seq, we identified transcription factors enriched in distinct microglial states: RelA motifs in acutely activated microglia and Irf4 motifs in DAM. Conditional knockout (cKO) of RelA in microglia reduced immune cell infiltration, whereas IRF4 cKO reduced protein expression of Clec7a, a DAM marker. By blocking transitions between different microglial states, our research aims to elucidate the function and role of α-synuclein-mediated DAM in PD progression and potentially establish DAM as a therapeutic target in neurodegenerative disorders.



 Aligning Science Across Parkinson’s: ASAP



 Neuroimmunology (NEUR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4da3d370218c60ccf242a6e1d980c70ae41a4936" target='_blank'>
              The role of α-synuclein-mediated disease-associated microglia in Parkinson’s disease 3319
              </a>
            </td>
          <td>
            Ya-Ting Yang, David A. Figge, Jhodi M. Webster, Aidan T. Miller, Asta Zane, A. Harms
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>24</td>
        </tr>

        <tr id="Objective Thyroid hormones (TH) are well-known regulators of the immune system. However, the precise immunomodulatory mechanisms of TH action in immune cells remain elusive. In a previous study, an essential role of the TH receptor α (TRα) in regulatory T cell (Treg) immunity was demonstrated, affecting Treg activation at steady state. The present study therefore aimed to unravel the biological relevance of altered TRα action in protective immune responses during disease. Methods To assess the role of TRα action in immune responses, especially T cell responses, during disease, different TRα signaling mouse models (TRαKO, complete lack of TRα signaling; TRαGS, lack of canonical signaling) were challenged with influenza virus A/PR8/34, and in-depth immune phenotyping was performed. Results Upon influenza virus infection, TRαGS mice, which lack canonical TRα signaling, showed prolonged survival and reduced disease severity, correlating with enhanced anti-inflammatory Treg and decreased pro-inflammatory CD4 and CD8 T cell responses. The loss of TRα action in TRαKO mice was related to elevated viral titers upon influenza virus infection, which correlated with increased inflammatory monocyte responses early during infection. Conclusion The present study demonstrates a complex role of TRα signaling in protective immune responses during disease, with distinct effects on innate and adaptive immune cells. By exploring the understudied link between the endocrine and immune systems, this study provides novel evidence for the role of TH as modulators of immunity.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a7d2ba259d2172edff4c6833e354709fd3242434" target='_blank'>
              Thyroid hormone receptor α signaling shapes innate and adaptive immune responses during viral infection
              </a>
            </td>
          <td>
            Christina Wenzek, T. Knuschke, G. S. Hönes, A. Boelen, R. Klopfleisch, Denise Zwanziger, Heike Heuer, A. Westendorf, L. C. Moeller, Dagmar Führer
          </td>
          <td>2025-10-27</td>
          <td>European Thyroid Journal</td>
          <td>0</td>
          <td>47</td>
        </tr>

        <tr id="


 Pathogenic human coronaviruses (hCoVs) cause severe respiratory illness and continue to challenge global public health. These hCoVs suppress anti-viral immunity and elicit excessive inflammation (dysregulated immunity) resulting in acute lung injury and fatal pneumonia. However, the key PAMPs and host factors that facilitate dysregulated immunity are not well understood. Therefore, using murine bone-marrow derived macrophages, we evaluated the mechanistic basis of SARS-CoV-2-induced dysregulated immunity. In novel findings, we show that SARS-CoV-2 structural protein- and viral-RNA-induced toll-like receptor (TLR)-extracellular regulated kinase (ERK)1/2 activity promotes dysregulated immunity in macrophages. Notably, blocking ERK1/2 activity not only reduced inflammatory cytokine response in viral RNA mimic and SARS-CoV-2 structural proteins-stimulated macrophages but also enhanced antiviral IFN-I response, whereas blocking other key inflammatory pathways such as p-38 MAPK, NF-kB, and JNK only suppressed inflammation, highlighting the unique role of ERK1/2 in facilitating hCoV-induced dysregulated immunity. We further show that inhibiting ERK1/2 activity reduced viral titers in SARS-CoV-2 infected human airway epithelial cells and improved survival in MA-CoV-2 infected mice. Collectively, we identify TLR-ERK1/2 signaling as novel pathway that drives SARS-CoV-2-induced dysregulated immunity and blocking this pathway will likely facilitate protective immunity to hCoV infections.



 NIH R21AI186028-01; NIH R01HL165423-01A1; NIH: P30GM149368-02



 Innate Immune Responses and Host Defense: Cellular Mechanisms (INC)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/6727d234f219dfc749f31f2e6c430b70223abdc8" target='_blank'>
              Novel role of TLR-ERK1/2 activation in SARS-CoV-2-induced dysregulated immunity 3869
              </a>
            </td>
          <td>
            Rakshya Shrestha, Roshan Ghimire, Cody Whitley, P. Johnson, Rudra Channappanavar
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/e523d76c745ddfd1249f8e026c52a86b1e318f68" target='_blank'>
              Cordycepin Mitigates Sepsis-Associated Encephalopathy by Promoting Microglial M2 Polarization via the IL-17a/IL-17RA/NF-κB Axis
              </a>
            </td>
          <td>
            Ying Yuan, Ganyue Fu, Yunqiang Zhu, Jianning Xu, Fuxin Li, Zhiyong Sheng
          </td>
          <td>2025-11-19</td>
          <td>Molecular Neurobiology</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="The rapid evolution of SARS-CoV-2 variants, have posed significant public health challenges due to their heightened transmissibility and varying clinical outcomes. While the impact of these variants in humans has been extensively studied, their effect on domestic animals has not been explored thoroughly. Given the close contact between humans and pets, combined with documented cases of virus transmission from humans to domestic animals and the potential for these animals to act as viral reservoirs, highlights the importance of understanding the molecular dynamics of SARS-CoV-2 infection in them. Consequently, there is an increasing demand for infection models that closely mimic viral behavior in animal tissues. In vivo infection of cats or any other non-laboratory animal species is extremely resource intensive, time consuming, require ABSL3 facilities, and animal ethical clearances which are not practically possible for the majority of researchers. In this scenario the ex vivo cultures model can be an excellent alternative. Therefore, in this study, we have utilized an ex vivo lung explant culture model derived from domestic cats to examine the host’s response to Delta and Omicron variants of SARS-CoV-2 in cat lung explant culture. Comprehensive transcriptomic profiling at multiple time points post-infection revealed significant disruptions in genes associated with cell adhesion, structural components, extracellular matrix (ECM) organization and regulation, secreted and growth factors, and immune responses. Our study revealed that the Delta variant triggered early activation of genes associated with tissue damage as early as 12 hours post-infection (hpi). By 24 hpi, both the Delta and Omicron variants showed significant activation of these genes, with the Delta variant linked to the activation of a larger number of tissue damage-related genes. Notably, we identified several hub genes, including MMP9, CCL5, MCP-1/CCL2, VWF, HGF, ANGPT1, CD34, CD68, SPP1, IGF1, CSF1, and VCL, involved in critical signaling pathways such as focal adhesion, PI3K-Akt signaling, and TNF signaling. These hub genes hold potential as valuable biomarkers. This study provides key insights into the pathogenesis of SARS-CoV-2 in cats and highlights the utility of ex vivo lung explant cultures as a platform for studying viral infections.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/16a62fa43a3e05e7fdf94655592782dee97b8e0c" target='_blank'>
              Comparative temporal transcriptome analyses of SARS-CoV-2 delta and omicron variants ex-vivo infection in cat lung explant culture
              </a>
            </td>
          <td>
            Anuradha Panwar, A. Raut, Sandeep Bhatia, A. Pateriya, Amod Kumar, Richa Sood, Suneela Saran, Prakriti Sehgal, Arya J. Mohan, Akash Zararia, A. Mishra
          </td>
          <td>2025-10-22</td>
          <td>Frontiers in Cellular and Infection Microbiology</td>
          <td>0</td>
          <td>16</td>
        </tr>

        <tr id="The OPTN gene, which encodes the adaptor protein optineurin, is genetically linked to amyotrophic lateral sclerosis and frontotemporal dementia, diseases characterized by chronic microglial activation. Optineurin regulates inflammatory signaling, autophagy, and trafficking, but its role in microglia remains incompletely understood. Here, we used bulk RNA sequencing to profile CRISPR-Cas9-mediated optineurin knockout (KO) and wild-type BV2 microglia under basal conditions and upon LPS stimulation. At baseline, optineurin KO altered ~7% of the transcriptome, with a predominant downregulation of type I interferon and antiviral pathways, suggesting its role in maintaining basal immune readiness. LPS stimulation reprogrammed ~35% of genes in wild-type microglia, inducing immune effectors and suppressing cell cycle regulators, whereas in optineurin-deficient cells, the response was blunted with only ~16% of genes changing relative to the KO baseline. Furthermore, LPS-treated optineurin KO microglia notably diverged from LPS-treated wild-type cells, with ~26% differentially expressed genes (DEGs). This included impaired induction of inflammatory programs and persistence of cell cycle-associated transcripts. Most DEGs in LPS-treated KO cells were unique to this condition, highlighting optineurin-dependent pathways specific to inflammatory challenge. Overall, our study provides a systems-level framework for investigating optineurin in microglia and neurodegeneration, establishing it as a key regulator of the microglial transcriptome, with its loss reshaping innate immune and cell cycle programs.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8b5dfaf631e3130d923e28e621ce58d0fa2217b9" target='_blank'>
              Optineurin Shapes Basal and LPS-Induced Transcriptomes in BV2 Microglia
              </a>
            </td>
          <td>
            S. Cappelli, Josip Peradinovic, Nikolina Mohovic, Purba Mandal, C. Stuani, Alessandra Longo, Jason R. Cannon, Priyanka Baloni, Benedetta Leoni, Tamara Krsmanović, Katica Stojanov, G. Apic, Robert B. Russell, M. Romano, E. Buratti, Ivana Munitic
          </td>
          <td>2025-10-28</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>69</td>
        </tr>

        <tr id="


 TAFA4, also known as Fam19a4, is a neuropeptide secreted by C-low-threshold mechanoreceptors (C-LTMRs) and has been reported to attenuate inflammation-induced mechanical hypersensitivity. However, its immunological role in the central nervous system (CNS) remains unclear. We found that TAFA4 is predominantly expressed in the CNS, including C-LTMRs, the habenula-fasciculus retroflexus, hypothalamus, and olfactory bulb. In experimental autoimmune encephalomyelitis (EAE), TAFA4-knockout (TAFA4-/-) mice exhibited reduced disease severity, characterized by decreased immune cell infiltration and demyelination in the spinal cord, suggesting a pro-inflammatory role for TAFA4 in EAE progression. Further analysis revealed that TAFA4 promotes the recruitment of monocytes, macrophages, and neutrophils—but not CD4+ T cells—via the formyl peptide receptor 1 (Fpr1), as shown by in vitro migration assays. Intraperitoneal injection of TAFA4 also recruited neutrophils within 5 hours. Additionally, TAFA4 treatment increased Akt, Erk, and Fak phosphorylation in macrophages, highlighting its role in chemotaxis and inflammatory signaling. In conclusion, our study identifies a novel mechanism by which TAFA4 exacerbates neuroinflammation by promoting immune cell migration in CNS diseases, such as multiple sclerosis.



 X



 Neuroimmunology (NEUR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8282405dad6a98645d17f02ee6384ab19c3b262b" target='_blank'>
              TAFA4 regulates CNS immune cell recruitment and inflammation 3455
              </a>
            </td>
          <td>
            Xin-Mei Yeh, Hwa-Sung Tso
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="The COVID-19 pandemic, caused by SARS-CoV-2, has had a profound global impact. Diabetes mellitus is a major comorbidity associated with higher infection risk, severe disease, and mortality in COVID-19 patients. This review examines the bidirectional relationship between COVID-19 and diabetes, focussing on immunometabolic mechanisms, post-COVID metabolic effects, and therapeutic implications. A comprehensive literature search was conducted in PubMed, Scopus, and Web of Science for articles published until May 2025 using the terms "COVID-19," "SARS-CoV-2," "diabetes," and "immunometabolism." Peer-reviewed studies addressing clinical, molecular, or therapeutic interactions between the two diseases were included. Evidence shows that SARS-CoV-2 infection aggravates metabolic dysfunction through immune dysregulation, cytokine-mediated inflammation, and β-cell injury. Hyperglycemia promotes viral replication and inflammatory damage, creating a vicious cycle that worsens outcomes. Reports also indicate an increased risk of new-onset and post-COVID diabetes. Certain antidiabetic agents, such as metformin and GLP-1 receptor agonists, may improve prognosis via anti-inflammatory and metabolic effects. Diabetes significantly amplifies the severity of COVID-19 through intertwined metabolic and immune mechanisms. Understanding these interactions provides new insights into disease management and supports the development of targeted immunometabolic therapies for improving outcomes in diabetic patients affected by COVID-19.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/80e954bc39ab4c596e3acc382fff9dbe2db6d37d" target='_blank'>
              COVID-19 in Diabetic Patients: Mechanisms, Risks, and Therapeutic Considerations.
              </a>
            </td>
          <td>
            Rania Hamdy, Amal Z Barakat, Eman J Abuzaid, Tasneem Elsayed, M. Husseiny
          </td>
          <td>2025-12-04</td>
          <td>Reviews in medical virology</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="Severe Coronavirus disease 2019 (COVID-19) is associated with abnormal innate and adaptive immune responses, as well as systemic alterations, including a shift in lipid network. A case–control study was conducted to describe the systemic lipidomic profile in COVID-19 according to disease severity. Selected polyunsaturated fatty acids (PUFAs), oxylipins, and endocannabinoids were analysed using a targeted liquid chromatography coupled to mass spectrometry in tandem method. Multivariate receiver operating characteristic curve-based model evaluation was performed to define a lipidomic signature for the disease. A total of 135 hospitalized COVID-19 patients, of whom 85 had severe form, and 134 healthy individuals were included. Patients exhibited increased levels of free PUFAs, proinflammatory and pro-resolving oxylipins, and endocannabinoids compared to controls. A combination of five lipid mediators, i.e., prostaglandin D2, prostaglandin E2, thromboxane B2, lipoxin B4, and 2-archidonylglycerol, discriminates patients from control individuals with excellent accuracy [AUC, 0.977 (0.950–0.995)]. The severe form is characterized by an imbalance between proinflammatory and pro-resolving oxylipins and increased endocannabinoids. COVID-19 is associated with a lipid storm that conditions disease severity. Targeting lipid mediators-related metabolic and signalling pathways could be an interesting therapeutic option in severe forms.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a5fb8bf52683c50e4277c9e8f4f3b1e200f52531" target='_blank'>
              COVID-19 is Associated with a Lipid Storm that Worsens in Cases of Severe Pneumonia
              </a>
            </td>
          <td>
            A. Bouabdallah, M. K. Ben-Fradj, Mohamed Bessem Hammami, Rim Abdelmalek, H. Sanhaji, T. Klopfenstein, Moncef Feki
          </td>
          <td>2025-11-01</td>
          <td>Microorganisms</td>
          <td>0</td>
          <td>17</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a0bf33bdd16f38189fb9b14d44624d7f3e4abc03" target='_blank'>
              Organotypic Airway Models Derived from Primary Human Nasal Epithelial Cells
              </a>
            </td>
          <td>
            Jing Liu, H. Ong, Kun Qu, De-Yun Wang
          </td>
          <td>2025-10-23</td>
          <td>Current Allergy and Asthma Reports</td>
          <td>0</td>
          <td>18</td>
        </tr>

        <tr id="ABSTRACT The devastating clinical, psychological, and economic impact of the COVID‐19 pandemic, caused by global spread of the second Severe Acute Respiratory Syndrome Coronavirus (SARS‐CoV‐2), has engendered a massive response from the scientific community to rapidly understand the biology of SARS‐CoV‐2 and to develop interventions to prevent infection or progression to life‐threatening disease. Angiotensin converting enzyme‐2 (ACE2) and its interaction with the SARS‐CoV‐2 Spike glycoprotein, which mediates fusion of the virion envelope with the target cell membrane, have emerged as a major pharmacological target, as disruption of the Spike‐ACE2 interaction prevents cells from becoming infected and hence from producing viral progeny. Moreover, the dysregulation of ACE2 that occurs in the context of SARS‐CoV‐2 infection may have broader implications for COVID‐19 pathogenesis. Here we summarize the role of ACE2 as a physiologic regulator of human health, as a facilitator of SARS‐CoV‐2 infection, as a factor in COVID‐19 disease, and as a target for pharmacological interventions.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c2e59f0d9c946db9a9c160b8605a6c2ca92d39a0" target='_blank'>
              The Role of ACE2 in SARS‐CoV‐2 Infection, Pathogenesis, and Antiviral Interventions
              </a>
            </td>
          <td>
            M. McVoy, A. Kummarapurugu
          </td>
          <td>2025-12-01</td>
          <td>Journal of Medical Virology</td>
          <td>0</td>
          <td>34</td>
        </tr>

        <tr id="Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), has led to a global health crisis by triggering extensive systemic and immune dysregulation. Granulocytes, including neutrophils, eosinophils, and basophils, are critical components of the innate immune system that play dual roles in protection and pathogenesis during infection. In this review, we examine the multifaceted roles of granulocytes in COVID-19 and their impact on disease severity through excessive inflammation, cytokine storm, and tissue damage. Neutrophil extracellular traps (NETs) and the overactivation of neutrophil subtypes contribute to the development of thrombosis and acute respiratory distress syndrome. In contrast, eosinophils and basophils modulate T helper 2-type and allergic responses that may influence recovery or disease progression. We further summarize the therapeutic strategies targeting granulocyte activation and signaling pathways, including IL-1, IL-6, IL-17, IL-5 receptor, granulocyte-macrophage colony-stimulating factor inhibitors, and antihistamines, emphasizing their clinical outcomes, approval status, and the global regions in which they are studied. Understanding the regulatory mechanisms of granulocyte activation and inhibition provides new insights into COVID-19 immunopathology and opens pathways for targeted immunomodulatory therapy. These findings underscore the importance of balancing protective immune functions with controlled anti-inflammatory interventions to mitigate the severe complications of SARS-CoV-2 infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c1949f61557e86e96575d6b1c878127a5eaa2ccc" target='_blank'>
              COVID-19: Understanding the Granulocyte Response and Exploring Their Therapeutic Interventions.
              </a>
            </td>
          <td>
            Zahra Farjami, Mina Moradi, Neshat Ebrahimi, Mohammad Mehdi Akbarin
          </td>
          <td>2025-10-31</td>
          <td>Viral immunology</td>
          <td>0</td>
          <td>11</td>
        </tr>

        <tr id="ABSTRACT Human cytomegalovirus (HCMV) is the leading infectious cause of congenital disease, but the mechanisms governing vertical transmission remain poorly defined. Murine cytomegalovirus (MCMV) infection in mice is a widely used model to study pathogenesis in vivo. However, the mouse model cannot be used to study congenital infection as viral transmission from mother to fetus in utero does not occur. In this study, we investigated tissue-specific features of the murine materno-fetal barrier that may restrict viral infection. Following high-dose intravenous challenge of wild-type and severely immunocompromised pregnant mice, MCMV replicated efficiently in the maternal liver but infected only a few cells in the placenta, suggesting an intrinsic resistance. Ex vivo analyses of primary placental cells, trophoblast stem cells, and a trophoblast cell line revealed a low susceptibility to MCMV infection compared to other permissive cell types. The resistance of trophoblast cells to MCMV infection correlated with the absence of neuropilin-1 (NRP1), a cellular receptor required for efficient infection of several cell types. Enforced expression of NRP1 in trophoblast cells increased their susceptibility to MCMV infection and replication, suggesting that the resistance of trophoblast cells to MCMV infection is caused by the lack of a critical receptor. These findings further suggest that, in addition to immune-mediated restrictions, cell-intrinsic resistance limits MCMV infection and transmission at the murine materno-fetal interface. IMPORTANCE Congenital cytomegalovirus (CMV) infection is a major cause of developmental disabilities in newborns, yet the biological factors that influence transmission from mother to fetus remain unclear. In this study, we demonstrate that trophoblast cells of the murine placenta are naturally resistant to CMV infection as they lack expression of a host protein, neuropilin-1 (NRP1), that the virus requires for entry. By introducing this protein into resistant cells, we demonstrated that susceptibility to infection can be reinstated, indicating that the absence of NRP1 plays a key protective role at the materno-fetal barrier. These results provide insight into why mice rarely transmit CMV to their offspring and how species-specific differences in placental biology shape susceptibility. Understanding these mechanisms will aid in refining animal models and may help identify new targets to prevent congenital infection in humans. Congenital cytomegalovirus (CMV) infection is a major cause of developmental disabilities in newborns, yet the biological factors that influence transmission from mother to fetus remain unclear. In this study, we demonstrate that trophoblast cells of the murine placenta are naturally resistant to CMV infection as they lack expression of a host protein, neuropilin-1 (NRP1), that the virus requires for entry. By introducing this protein into resistant cells, we demonstrated that susceptibility to infection can be reinstated, indicating that the absence of NRP1 plays a key protective role at the materno-fetal barrier. These results provide insight into why mice rarely transmit CMV to their offspring and how species-specific differences in placental biology shape susceptibility. Understanding these mechanisms will aid in refining animal models and may help identify new targets to prevent congenital infection in humans.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/9cbd6c22e934e054b77f04de63086fae7b8a20b3" target='_blank'>
              Neuropilin-1 expression modulates infection susceptibility to murine cytomegalovirus at the materno-fetal interface
              </a>
            </td>
          <td>
            Luís Fonseca Brito, E. Ostermann, Julian Kottlau, Silvia Tödter, Renke Brixel, Roland Schüle, Maria Emilia Solano, Wolfram Brune, F. Stahl
          </td>
          <td>2025-11-25</td>
          <td>Journal of Virology</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7c6680175abb418a05b168b252653ec024e4fd0b" target='_blank'>
              Activation of Toll and IMD pathways in the Drosophila brain following local and systemic bacterial infection
              </a>
            </td>
          <td>
            Sameekshya Mainali, Isaac Toles, Paige Magid, Jordan Grammer, Lauren Harper, Elizabeth Kitchens, Kaitlin Davis, Stanislava Chtarbanova
          </td>
          <td>2025-10-20</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="


 Neuroinflammation is typically attributed to the sustained activation of resident immune cells in the brain, such as microglia. However, in acute inflammation, cells are activated rapidly and reconstruct the blood-brain barrier (BBB) in order to prevent further damage. Given that acute inflammation causes significant damage to the brain in a short period of time, the impact on the immune system may persist for an extended duration. In this study, we observed a significant infiltration of monocytes and macrophages into the brain following the induction of acute inflammation by LPS. This infiltration was accompanied by a reduction in IL-10 and an increase in IL-1β levels one day after injection, which then returned to baseline within a week. The number of microglia decreased transiently; however the cytokine expression pattern was comparable to that of macrophages. Notably, despite restoring motor and memory functions in mice, the microglial phenotype remained unresponsive even after one month. Also, those microglia exhibited numerous similarities with the chronic Alzheimer’s model at the gene level. Furthermore, acute inflammation induced by LCMV also results in temporal BBB impairment and persistent microglial phenotype alteration. In conclusion, our findings verified that acute inflammation affects the immune microenvironments of the brain in a long-lasting way, suggesting that severe inflammation may increase the risk of developing neurodegenerative disease in the future.



 Neuroimmunology (NEUR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fbbbe2df01483e14f37d0ce2b02a958d1cfe3f64" target='_blank'>
              The impact of acute inflammation on the brain immune environment 2896
              </a>
            </td>
          <td>
            Sehoon Moon, Cheol Gyun Kim, Min-Kyoo Shin, Hyungseok Seo
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="The immunopathogenesis of KFDV is not well understood. The study's primary objective was to investigate the magnitude and dynamics of cytokine and cellular immune responses during the acute and convalescent phases of KFDV infection in humans. Additionally, the study aimed to identify potential biomarkers that could indicate severe KFD and help predict disease prognosis. In this study, KFDV‐positive patients were prospectively enrolled, and peripheral blood samples were collected and analyzed for cellular and cytokine levels, along with the clinical and virological characteristics. Our findings revealed distinctive cytokine profiles differentiating severe from mild KFD during the acute phase of illness. Serum levels of IFN‐γ, IP‐10, MCP‐1, HGF, and IL‐2R were markedly elevated in severe KFD. Also, the frequency of activated B cells (CD20lowCD71high) and expression of exhaustion markers (PD‐1, CTLA‐4) on CD8+ T cells was significantly increased in severe cases. The study also describes the persistence of elevated cytokines during the convalescent phase, indicating that prolonged inflammation may be due to dysregulated immune response characterized by sustained T cell activation, cytotoxic activity (Granzyme B, Perforin), and elevated exhaustion markers (PD‐1, CTLA‐4), particularly in patients with severe KFD. This novel work has important implications for KFDV vaccine research and may aid clinical decision‐making in treating severe KFDV infections in humans.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/d4e3ac58f066ecd1e55540367ff4cfb8eedc9b2c" target='_blank'>
              Temporal Dynamics of the Immune Response in Severe Cases of Human Kyasanur Forest Disease Virus (KFDV) Infection
              </a>
            </td>
          <td>
            Naren Babu N, Nitin Gupta, A. Pattanaik, C. Mukhopadhyay, Santhosha Devadiga
          </td>
          <td>2025-11-01</td>
          <td>Journal of Medical Virology</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c18b6c3d94e0b245a2073ceeb35d02bd592fc6fc" target='_blank'>
              The compounding roles of gut-immune-brain axis and COVID19 in manifestation of idiopathic Parkinson’s disease
              </a>
            </td>
          <td>
            Ankita Das, V. Vivek, P. Aich
          </td>
          <td>2025-11-08</td>
          <td>Discover Immunity</td>
          <td>0</td>
          <td>21</td>
        </tr>

        <tr id="Traumatic brain injury (TBI) initiates a prolonged and complex immune response that critically shapes both secondary injury and long-term recovery. Among adaptive immune cells, CD4⁺ T cells have emerged as central regulators of neuroinflammatory processes, acting as a double-edged sword that can be either neuroprotective or neurotoxic. This review focuses on the roles of major CD4⁺ T cell subsets-Th1, Th2, Th17, and Tregs-in modulating the immune landscape following TBI, with an emphasis on their temporal dynamics, phenotypic plasticity, and therapeutic potential. We examine how blood-brain barrier disruption and innate immune activation facilitate T cell infiltration into the central nervous system, and outline the cytokine networks and signaling pathways that orchestrate CD4⁺ T cell differentiation and functional polarization. Advances in single-cell RNA sequencing (scRNA-seq) have provided new insights into the transcriptional heterogeneity of CD4⁺ T cells post-TBI, offering novel angles for therapeutic targeting. In addition, we assess current strategies for targeting CD4⁺ T cells therapeutically and examine translational challenges, particularly the translational gap between animal models and human disease. To provide a focused synthesis, this review does not delve into all immune cell types or other aspects of neuroinflammation that may also play significant roles in TBI.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5bb08683dbcd2c252e04f0b54a89e13ce83a8999" target='_blank'>
              The immunological paradox of CD4⁺ T cells in traumatic brain injury (Review Article).
              </a>
            </td>
          <td>
            Qian Zhao, Bo-Ao Chen, Wen-Qing Ai, Nadezhda Brazhe, Dan Liu, Ling-Qiang Zhu, Ming Wen
          </td>
          <td>2025-10-15</td>
          <td>International journal of surgery</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/618bcfb789463c1d6cd34f9be203229ced80b89b" target='_blank'>
              Multi-omic profiling reveals age-related immune dynamics in healthy adults.
              </a>
            </td>
          <td>
            Qiuyu Gong, Mehul Sharma, Marla C. Glass, Emma L. Kuan, Aishwarya Chander, Mansi Singh, Lucas T. Graybuck, Z. Thomson, Christian M. LaFrance, S. Rachid Zaim, Tao Peng, L. Okada, Palak C. Genge, Kathy Henderson, Elisabeth M. Dornisch, Erik Layton, Peter J. Wittig, A. Heubeck, Nelson M. Mukuka, Julian Reading, Garrett Strawn, Teminijesu Titus-Adewunmi, Kathleen Abadie, Charles R. Roll, Veronica Hernandez, Vaishnavi Parthasarathy, Tyanna J. Stuckey, B. Musgrove, Elliott G. Swanson, Cara Lord, M. Weiss, C. Phalen, Regina R Mettey, Kevin J. Lee, John B. Johanneson, Erin K. Kawelo, Jessica Garber, Upaasana Krishnan, Megan E. Smithmyer, E. Wherry, L. Vella, S. E. Henrickson, Mackenzie S. Kopp, Adam K. Savage, Lynne A. Becker, Paul Meijer, E. Coffey, Jörg J. Goronzy, Mikael Sigvardsson, Cate Speake, Thomas F. Bumol, Ananda W. Goldrath, Troy R. Torgerson, Xiao-jun Li, Peter J. Skene, J. Buckner, Claire E. Gustafson
          </td>
          <td>2025-10-29</td>
          <td>Nature</td>
          <td>2</td>
          <td>65</td>
        </tr>

        <tr id="


 Understanding pulmonary pathogenesis during influenza infection is critical for developing effective therapies. We are investigating BALB/c mice infected with the PR8 strain of Influenza A virus at days 1, 3, and 6 post-infection. These time points were selected because viral content peaks at day 3 and returns to day 1 levels by day 6, during which mice experience nearly a 30% loss in body weight. Single-cell RNA sequencing of lungs from these mice is ongoing. In the meantime, reanalysis of a publicly available dataset has revealed dynamic changes in lung cellularity, characterized by significant infiltration of myeloid and lymphoid cells. Early recruitment of inflammatory monocytes (Ccr2, Ly6c2) was observed, followed by increased lymphocytes, including activated T and B cells, by day 3. In late infection, there was a shift towards increased tissue-resident macrophages (Cd11c, Siglec-F) and profibrotic macrophages (Spp1), indicating a transition from acute inflammation to fibrotic processes. Interferon pathways were activated, with elevated expression of genes such as Isg15, Irf7, and Oas1a. Pro-inflammatory cytokines (Cxcl10, Ccl5) also increased, indicating strong immune activation. These findings offer preliminary insights into lung immune responses during influenza infection. We aim to corroborate these results with our data and enhance understanding of pulmonary pathogenesis to inform targeted interventions against influenza-induced lung disease.



 Funding provided by Laboratory Directed Research and Development funds (24-ERD-025) to N.R.H. This work was performed under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory under Contract DE-AC52-07NA27344. LLNL-ABS-2001043.



 Computational and Systems Immunology (COMP)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/24f6285628c930dcb159470bd05ab366cbc46db2" target='_blank'>
              Single-cell RNA sequencing reveals dynamic immune cell infiltration in mouse lungs during influenza A infection 4062
              </a>
            </td>
          <td>
            Oscar A. Davalos, D. Murugesh, N. Leon, D. Weilhammer, A. Sebastian, N. Hum
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>21</td>
        </tr>

        <tr id="Chlamydia invades multiple mucosal tissues in humans and animals. The body’s first line of defense against chlamydial infection is provided by innate immunity, whereas adaptive immunity plays a crucial role in managing the infection’s progression and preparing the immune system to combat reinfection. Host resistance to chlamydial infection necessitates a coordinated effort between innate and adaptive immune cells. Numerous cell types are capable of producing interferon gamma (IFN-γ) as a defense mechanism against chlamydial infection, thereby effectively mediating the clearance of infection. However, the distinct roles of various immune cell populations in responding to chlamydial infection, as well as their functions during infection progression, remain poorly understood. Therefore, we will discuss the various roles of IFN-γ released by different immune cells in chlamydial infection, focusing primarily on experimental animal models and a review of available data from in vivo cellular immunological studies in humans.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/7c375743e3715f5e17dc641ecdc55eebdf06385f" target='_blank'>
              Role of IFN-γ from Different Immune Cells in Chlamydia Infection
              </a>
            </td>
          <td>
            Xuan Chen, Wenjing Yang, Yuchen Hu, Yang Zhou, Zhou Zhou
          </td>
          <td>2025-10-01</td>
          <td>Microorganisms</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="


 The effect of COV-19 infection or post-acute sequelae of SARS-CoV-2 (PASC) increases risk of thrombotic events. The mechanism underlying cardiovascular complications post-COV-19 infections remains incompletely understood. During severe COV-19 infection, viral antigens trigger , initiating and amplifying the immune response. This cytokine storm serves to eliminate the virus but inflicts significant collateral damage on the surrounding cellular environment, especially the vascular endothelium. In this study, we hypothesized that the antibody-mediated response to COV-19 infection activates the vascular endothelium and alters endothelial barrier integrity. We also investigated the mechanism driving endothelial activation and dysfunction which fosters a procoagulant state during COV-19 infection and PASC.
 To assess endothelial dysfunction and creation of a procoagulant state post-severe COV-19 infection, primary human umbilical vein endothelial cells (HUVEC) were isolated and incubated with 100 µg/mL IgG for 12 h. We compared the effects of IgG from 56 COV-19 patients with IgG from 12 healthy donors (HD IgG), as controls. Relative to HD-IgG, COV-19 IgG increased surface expression of vascular cell adhesion molecule-1, VCAM-1 (A450nm = 0.491±0.09 in case of COV-19 IgG compared to A450nm= 0.15±0.02 in HD IgG; P<0.05) used as a marker of endothelial cell activation. Using an assay of plasma clot formation in which HUVEC treated with HD or COV-19 IgG was exposed to normal human plasma and clot formation measured by turbidity (A405nm), we observed that 11 COV-19 IgG that induced increased VCAM-1 expression caused enhanced clot formation on HUVEC with maximal Vmax of 55±18 and decreased lag time of 18±5 min compared to HD-IgG (Vmax=35±5; lag time= 43±7 min). Increased clot formation was associated with increased expression of tissue factor mRNA (fold change increase = 4), plasminogen activator inhibitor type 1, PAI-1 (fold change increase =30), and TMEM-16F mRNA (fold change increase=2.5), though the relative contribution of each of these mediators to the prothrombotic phenotype is under investigation. We also observed delayed clot lysis after initial clot formation on HUVEC, possibly reflecting the effects of PAI-1, which was the highest upregulated HUVEC gene after exposure to COV-19 IgG.
 COV-19 infection is also associated with increased vascular permeability that contributed substantially to the clinical manifestations of the disease. To investigate the potential effects of COV-19 on endothelial cell barrier function we stained COV-19 treated HUVEC for VE-cadherin, an important adhesion molecule in endothelial cells. We observed that COV-19 IgG induced internalization and nuclear localization of VE-cadherin, in association with the formation of extensive contractile stress fibers leading to destabilization of cell-cell contacts.
 In preliminary analyses we observed that the correlation (r2) between levels of CL IgG and LBPA IgG in CoV -19 IgG fraction was 0.6545, whereas that between the EC activation markers, VCAM-1 or PAI-1 and CL IgG was 0.5479 and 0.6066 respectively. The correlation between VCAM-1 or PAI-1 and LBPA IgG were 0.2256 and 0.3791 respectively.
 The nature of the endothelial cell reactive antibodies contained in COV-19 IgG is uncertain at this point, but the effects observed occurred in the absence of added β2GPI. Analysis of proteins immunoprecipitated by COV-19 IgG is currently being undertaken.
 Previous studies have shown that IgG fractions from COV-19 patients are prothrombotic, but the mechanisms of these antibodies and the cellular antigens they recognize are uncertain. Our studies begin to address these concerns on a molecular mechanistic level and may lead to better understanding of the endotheliopathy that may underlie several viral syndromes.
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f6ebbe57cc1bb77e223e5d583feca3d2b468e47a" target='_blank'>
              COVID-19 IgG antibodies drive endothelial cell activation and dysfunction
              </a>
            </td>
          <td>
            Bhagwati Joshi, Charles Sukin, Wolfram Ruf, Keith R McCrae
          </td>
          <td>2025-11-03</td>
          <td>Blood</td>
          <td>0</td>
          <td>7</td>
        </tr>

        <tr id="Children with central nervous system malaria (CNS-M) have gene expression profiles and plasma biomarkers of malaria pathogenesis that differ from children with uncomplicated malaria (UM, malaria infection with fever and no systemic organ dysfunction) or acute febrile non-malaria illness (AFN). However, there is scant knowledge of the temporal dynamics of gene expression and plasma biomarkers during recovery from CNS-M. We compared serial changes of peripheral blood mononuclear cell transcriptomes at 6 weeks after recovery and plasma biomarkers of malaria pathogenesis at 6 weeks and 6 months after recovery in cohorts of Kenyan children who presented with CNS-M (n = 37), UM (n = 20) and AFN (n = 12). Upregulated genes and Reactome pathways of interleukin/cytokine signaling, neutrophil degranulation and innate immunity and downregulated pathways of protein biosynthesis of children presenting with CNS-M were partially reversed at hospital discharge 2–6 days later and 6 weeks. CNS-M and UM transcriptomes before treatment versus 6 weeks after recovery shared several pathways, but megakaryocyte/platelet production, IL-4/IL-13/IL-10 signaling and overexpression of LAG3, CCR5, PDGFRB and ICMT were specific to CNS-M. The Hemostasis Reactome pathway was uniquely downregulated in CNS-M at 6 weeks. Biomarkers of coagulation, fibrinolysis, neutrophil activation, endothelium integrity and cytokine signaling correlated with high plasma cell-free DNA in acute CNS-M and persisted for 6 weeks, whereas these values normalized at 6 weeks in UM and AFN. Recovery from pediatric CNS-M is associated with prolonged dysregulation of gene expression and biomarkers associated with coagulation, fibrinolysis and platelet activation. Future studies are needed to evaluate whether this dysregulation is associated with neurocognitive sequelae following recovery. Not applicable.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4942b63b4c5464413c8a8dbe8d60c3b063a47b28" target='_blank'>
              Prolonged dysregulation of gene expression and biomarkers of coagulation, fibrinolysis, and endothelium in pediatric central nervous system malaria
              </a>
            </td>
          <td>
            Arlene E. Dent, B. Rosa, K. Dobbs, Sidney Ogolla, D. Midem, P. Embury, Yelenna Skomorovska-Prokvolit, Emily R. Hannon, Emmily Koech, A. H. Schmaier, Walter Otieno, M. Mitreva, J. Kazura
          </td>
          <td>2025-11-05</td>
          <td>BMC Infectious Diseases</td>
          <td>0</td>
          <td>58</td>
        </tr>

        <tr id="Neuroinflammation, a pervasive hallmark in many neurological and neuropsychiatric diseases, is largely dictated by the functional phenotypic dynamics of microglia, the immune system of the brain. Recent data illustrate that these phenotypic changes, from neuroprotective scavenging to neurotoxic pro-inflammatory effects, are intrinsically regulated by microglial metabolic repolarization. This review synthesizes understanding of discrete microglial metabolic phenotypes like the glycolytic reliance of pro-inflammatory (M1-like) microglia and the oxidative phosphorylation/fatty acid oxidation bias of anti-inflammatory/resolving (M2-like) microglia. We discuss how central metabolic sensors like AMPK, mTOR, and HIF-1α oversee these metabolic shifts in response to disease-targeted pathologies in Alzheimer’s, Parkinson’s, Multiple Sclerosis, ischemic stroke, and traumatic brain injury. Moreover, we review innovative therapeutic strategies directed toward microglial metabolism, involving pharmacological modulators (e.g., metformin, rapamycin, and ketone bodies), nutritional interventions (e.g., ketogenic diets), and modulation of gut microbiota. By tightly specific re-tuning of microglial cells’ bioenergetics, these approaches enable unprecedented opportunities to counteract neuroinflammation, enhance pathological clearance, and induce neuroprotection, paving the way for a new generation of disease-modifying therapies of neurodegenerative disorders.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c8a37e2dcc6db354c333c276544357fb7b3b5ab0" target='_blank'>
              “Rewiring brain immunity: targeting microglial metabolism for neuroprotection in neurodegenerative disorders”
              </a>
            </td>
          <td>
            Mustafa M. Shokr
          </td>
          <td>2025-11-25</td>
          <td>Metabolic Brain Disease</td>
          <td>0</td>
          <td>6</td>
        </tr>

        <tr id="


 As the number of COVID-19 survivors continues to rise, the rates of post-acute sequalae of COVID19 (PASC) have also increased, emerging as a major public health concern. However, the role of monocytes on PASC development has not been fully explored. In this study, we aimed to determine whether monocyte dysregulation persists and contribute to driving inflammation and fibrosis after COVID-19 infection. RNA was isolated from purified monocytes from study participants who had pulmonary PASC (PPASC), had COVID-19 infection but no residual symptoms (Recovered), and had no COVID-19 infection (Healthy). We performed bulk RNA sequencing to profile monocytes to identify dysregulated genes and pathways associated with inflammation and fibrosis. In comparison to Recovered and Healthy, PPASC had an enrichment of immune activation signatures, such as neutrophil degranulation, IL8/IL-6 signaling, and macrophage response genes, while IL-10 pathway was down-regulated. Furthermore, disease prediction analysis showed that enriched genes in PPASC were linked to lung diseases such as pneumonia and lower respiratory tract disorder compared to those in Recovered. Transcriptomic analysis revealed that monocytes from PPASC individuals were continuously dysregulated with up regulation of pathways associated with immune activation, inflammation, and fibrosis. Our data demonstrate that monocyte dysregulation persists after viral resolution, impacting the pulmonary sequelae in PASC individuals.



 NIH/NIMHD (U54MD007601)



 Viral Immunology (VIR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/cc86198c15fa6664f1c94ceb5073217cc1f39b91" target='_blank'>
              Long-term consequence of SARS-CoV-2 on monocyte phenotype in COVID-19 survivors 3120
              </a>
            </td>
          <td>
            T. Awamura, Stefanos Giannakopoulos, N. Subia, V. Khadka, Domic Chow, Cecilia M. Shikuma, G. Devendra, Juwon Park
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>19</td>
        </tr>

        <tr id="Type 1 interferons (T1IFNs) are typically expressed in low concentrations under homeostatic conditions, but upon pathogenic insult or perturbation of the pathway, these critical immune signaling molecules can become either protectors from or drivers of pathology. While essential for initiating antiviral defense and modulating inflammation, dysregulation of T1IFN signaling can contribute to immunopathology, making it and its associated pathways prime targets for immune evasion and disruption by pathogens. This review focuses on the changes in T1IFN signaling across the lifespan, with particular emphasis on the role of the Stimulator of Interferon Genes (STING) pathway in autoimmune and infectious disease susceptibility, especially in the context of viral infections. Aging is associated with diminished T1IFN responsiveness, partially resulting from chronic stimulation of the STING pathway, which contributes to increased susceptibility and impaired viral clearance. Conversely, neonates and young children also show increased vulnerability to certain viral infections, but whether this is driven by T1IFN differences or another mechanism remains incompletely understood. Despite growing interest in T1IFN-based immunotherapies, pediatric and elderly populations remain underrepresented in clinical trials. Here, we advocate for a deeper molecular and systems understanding of how the interferon response evolves across the human lifespan, to inform age-tailored therapeutic approaches and more inclusive study designs, thereby improving outcomes in both the youngest and oldest patients.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/92fe0ce0558850fa46898881223207341f832632" target='_blank'>
              What goes up must come down: dynamics of type 1 interferon signaling across the lifespan
              </a>
            </td>
          <td>
            Lucy Hartnell, P. Agudelo-Romero, S. Montgomery, R. Ben-Othman, Valerie Verhasselt, Stephen M. Stick, Tobias R. Kollmann
          </td>
          <td>2025-10-16</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>15</td>
        </tr>

        <tr id="ABSTRACT OMICS analyses have the potential to greatly enhance our understanding of rejection and other processes in xenotransplantation. These approaches may therefore contribute to extending the survival time of xenotransplants. Initial OMICS studies in brain‐dead patients following transplantation of pig kidneys or hearts revealed increased expression of genes associated with humoral immune responses. This included activation of monocytes, macrophages, and natural killer (NK) cells, as well as endothelial activation, complement activation, and T cell development. Such multimodal deep phenotyping has been proposed as a potential game‐changer in the field of xenotransplantation. However, it is essential to consider that viral infections may significantly influence the results of these analyses. Viruses are known to alter gene expression patterns, not only within the immune system but also in endothelial cells and other tissue compartments. Depending on the type of virus, the immune response may either be stimulated—as the host reacts against the infection—or suppressed, in cases involving immunosuppressive viruses. Therefore, integration of comprehensive virus screening is essential in such studies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/adf01ebc0217855f1a122d115a28654f3a15583c" target='_blank'>
              OMICS Analyses in Xenotransplantation: Initial Findings, Key Precautions, and Virus Infections
              </a>
            </td>
          <td>
            Joachim Denner
          </td>
          <td>2025-11-01</td>
          <td>Xenotransplantation</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/695c274c959b0fd1b92ee86ff6aa4f6baf9e49bd" target='_blank'>
              A multicenter spatial transcriptomics atlas of human tuberculosis and non-tuberculous mycobacterial disease
              </a>
            </td>
          <td>
            Xun Jiang, Leonard Christian, Yuesi Xi, Liang Zhou, Ahmed Alaswad, Xiaoyi Zheng, N. V. Unen, L. Neubert, Jana Dietrich, Jan C. Kamp, Moritz Kayser, Mark Kühnel, J. Hohlfeld, Hortense Slevogt, Marius M. Hoeper, N. Kaminski, Tobias Welte, Jan Fuge, F. Ringshausen, R. Homer, D.D. Jonigk, Chengbin Xu, Jonas C. Schupp, Yang Li
          </td>
          <td>2025-10-17</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>32</td>
        </tr>

        <tr id="ABSTRACT Talaromyces marneffei (T. marneffei) is an opportunistic, dimorphic fungus that has been clinically reported to involve the central nervous system (CNS). However, its neuroinvasive capacity and the underlying pathogenic mechanisms remain poorly understood. In this study, T. marneffei infection was found to impair learning, memory, and motor balance in mice, as demonstrated by Morris water maze and accelerating rotarod assays. Viable T. marneffei was subsequently isolated from hippocampus and cortex through fungal cultures, confirming its ability to invade the CNS. Histopathological analysis revealed CNS damage following infection, characterized by neuronal pyknosis, neurofibrillary tangles, and an increased presence of glial cells in the cortex. To investigate the underlying mechanisms, transcriptomic profiling showed significant enrichment of neurodegeneration pathways, with elevated Tau and GSDMD expression in hippocampal and cortical regions as well as N2a cells. Additionally, neuronal damage was exacerbated by indirect neurotoxicity mediated by microglial M1 polarization, accompanied by increased levels of pro-inflammatory cytokines (TNF-α, IL-6, and IL-1β). In conclusion, our findings uncover for the first time a dual-pathogenic mechanism by which T. marneffei induces CNS injury: direct neuronal damage via Tau pathology and GSDMD-dependent pyroptosis and indirect inflammation-mediated injury via M1-polarized microglia. These insights not only advance our understanding of fungal neuroinvasion but also provide a foundation for the development of targeted therapies.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4d535583604940e83152cdf7b5514d60e076348a" target='_blank'>
              Mechanisms of Talaromyces marneffei induced CNS injury: Synergistic roles of tauopathy, pyroptosis, and microglial inflammation
              </a>
            </td>
          <td>
            Zongxiang Yuan, Fengyi Wang, Hailun Wei, Xuanrong Li, Wudi Wei, Shengrui Luo, Yukai Zhang, Xueqin Wei, Gang Wang, Hao Liang, Junjun Jiang, Li Ye
          </td>
          <td>2025-10-27</td>
          <td>Virulence</td>
          <td>0</td>
          <td>14</td>
        </tr>

        <tr id="


 SARS-CoV-2-induced excessive inflammation and cytokine storm cause acute lung injury and fatal pneumonia. We previously showed that an increased myeloid cell activity during coronavirus infections is highly inflammatory and causes severe lung pathology. However, the key myeloid cell factors that promote lethal inflammation are not well understood. Upon viral infection, myeloid cells elicit inflammatory response through TLR/TRAF6/NF-kB or MAPK pathway. Since TRAF6 is a common adapter molecule upstream of both MAPK and NF-kB, we examined the role of TRAF6 in SARS-CoV-2-induced lethal inflammation. Our preliminary work had showed that myeloid cell TRAF6 activity promotes robust SARS-CoV-2 structural protein induced inflammatory response. Therefore, we hypothesized that myeloid cell TLR-TRAF6 signaling is highly inflammatory and blocking TRAF6 suppresses inflammation while enhancing antiviral IFN response. We show that TRAF6 plays a critical role in viral RNA and protein induced dysregulated immunity and blocking TRAF6 activity specifically suppressed MAPK-ERK1/2 activity. Interestingly, decreased ERK1/2 activity upon blocking TRAF6 signaling correlated with significantly lower inflammatory cytokine and an improved antiviral IFN-I response in macrophages. In summary, our results show novel and contrasting role of TRAF6 activity in SARS-CoV-2-induced antiviral and inflammatory response and highlight therapeutic potential of blocking TRAF6 in host protection.



 NIH R21AI186028-01; NIH R01HL165423-01A1; NIH P30GM149368-02



 Innate Immune Responses and Host Defense: Cellular Mechanisms (INC)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a341e176bf297aee2aaec2915b5aa63c1ae31051" target='_blank'>
              Critical role of myeloid cell TRAF6 signaling in coronavirus-induced antiviral and inflammatory responses 3866
              </a>
            </td>
          <td>
            Roshan Ghimire, Cody Whitley, P. Johnson, Rudra Channappanavar
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>4</td>
        </tr>

        <tr id="Background: Cerebral malaria (CM) is a severe and often fatal complication of Plasmodium falciparum infection that causes devastating brain injury largely through immune-mediated mechanisms. Pathogenic brain-infiltrating CD8+ T cells are key drivers of CM pathology, yet the intracellular signals enabling their harmful autoimmune-like activity remain poorly defined. Here, we identify protein kinase C θ (PKCθ), a central antigen receptor-signalling mediator, as a critical contributor to experimental cerebral malaria (ECM). Methods/Results: Using a PKCθ null allele mouse strain on a C57BL/6N background, we demonstrate that PKCθ deficiency significantly improves survival in Plasmodium berghei ANKA (PbA)-infected mice without altering parasite burdens in the blood or brain. Mechanistically, loss of PKCθ skews T cell differentiation towards central memory (Tcm) rather than effector memory (Tem) phenotypes, thereby reducing effector differentiation and sequestration of CD8+ T cells in the cerebral microvasculature. This prevents extensive neurovascular damage, preserves neural tissue integrity, and alleviates neurological signs and symptoms. Our findings provide genetic evidence that PKCθ drives CD8+ T cell-mediated brain injury in ECM. Conclusions: These results underscore the potential for repurposing clinically PKCθ inhibitors as host-targeted interventions to protect against cerebral injury and improve outcomes in patients with CM.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f72ad9681b0a4fb1435cab237ed155e8996cc887" target='_blank'>
              Inhibition of PKCθ Abrogates CD8+ T Cell-Mediated Neurotoxicity in Murine Cerebral Malaria
              </a>
            </td>
          <td>
            Karin Albrecht-Schgör, Victoria E. Stefan, Martina Steinlechner, Dominik Humer, K. Siegmund, Sebastian Peer, Thomas Gruber, Maja Überegger, Stephanie zur Nedden, Gabriele Baier-Bitterlich, Peter Lackner, Erich Schmutzhard, Nikolaus Thuille, V. Klepsch, G. Baier
          </td>
          <td>2025-10-22</td>
          <td>Biomedicines</td>
          <td>0</td>
          <td>24</td>
        </tr>

        <tr id="Multiple sclerosis (MS) is a chronic, inflammatory condition characterized by neurodegeneration and lost myelin, or demyelination. This lost myelin may be regenerated in people with MS through a process called remyelination, that is prone to failure and is impaired with age. Remyelination is facilitated by microglia but our understanding of the microglial response during remyelination is incomplete. Here, we profile the microglial response during remyelination in the lysolecithin mouse model using single-cell RNA sequencing and find several distinct microglial states during the early stages of remyelination that coalesce into a resolved state defined by the presence of myelin transcripts, a state also present in MS brains. We also observe a delay in the appearance of several microglial states with age, in concordance with delayed remyelination. This multi-faceted microglial response during efficient remyelination provides the basis of multi-faceted microglia-specific targets for future MS therapies. Microglial states throughout remyelination are incompletely understood. Here, the authors show that microglia form several states during the early stages of remyelination that coalesce into a partially resolved state that is dysregulated with age.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/89f58ee42dc387c6b9d9bec82580a8d43e52f669" target='_blank'>
              Age-impaired remyelination is associated with dysregulated microglial transitions
              </a>
            </td>
          <td>
            Sameera Zia, Marianela E. Traetta, Charbel S. Baaklini, Brady P Hammond, Rebecca K. John, Katherine M. Souter, Niels Meijns, Larry K. A. Afun, Sharmistha P Panda, F. González Ibáñez, Mena K. Burr, Eva Dhupia, Abhisha M Rathod, Andre O. Faria, Dhruvish Zaveri, Sowmya Challa, Eugene Hahn, S. B. Manesh, Kelly V. Lee, Madelene F. S. Ho, Timothy N. Friedman, Aislinn D. Maguire, Arina Pang, Olivia Farkas, Bożena Szulc, Luiz Tenorio, Diya Vyas, Olivia R. La Caprara, Wolfram Tetzlaff, Sarthak Sinha, G. Duncan, Anastassia Voronova, Bradley J Kerr, Marie-Ève Tremblay, Jeff Biernaskie, G. Schenk, J. Plemel
          </td>
          <td>2025-11-12</td>
          <td>Nature Communications</td>
          <td>0</td>
          <td>21</td>
        </tr>

        <tr id="


 Many viral infections have been linked to the development of debilitating neurological disorders. However, the mechanism governing virus-induced neuropathology remains poorly understood, particularly when the virus is not directly neuropathic. Using a mouse model of Zika virus (ZIKV) infection, we find that brain ZIKV titers do not correlate with the severity of neurological disease. Instead, ZIKV-infected brains exhibit microglial activation and infiltration of ‘bystander activated’ CD8+ T cells expressing the NK cell receptor, NKG2D. To assess the role of these T cells in virus-induced neuropathology, we treated ZIKV-infected mice with antibodies to deplete CD8+ T cells or block NKG2D signaling. Both treatments completely prevented against the development of paralysis without altering the viral load in the serum or brain, suggesting that bystander activated T cells mediate virus-induced neurological disease. Interestingly, depletion of brain-resident microglia using the drug PLX3397 also prevented development of neurological disease. However, microglia depletion did not reduce bystander activated T cell numbers in the brain, suggesting that microglia influence bystander T cell function rather than recruitment. Overall, we have identified a novel mechanism where microglia promote bystander activation and function of CD8+ T cells neurological disease. Our findings reveal several strategies for further investigation of treatments for virus-induced neurological diseases.



 Canadian Institutes for Health Research



 Viral Immunology (VIR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/fab2ac785254407a4aa683cd871f705bd8afc9fa" target='_blank'>
              Microglia promote bystander activated T cell-mediated neurological disease during viral infection 3059
              </a>
            </td>
          <td>
            Elizabeth Balint, Emily Feng, Amelia Montemarano, Jonathan K Monteiro, Elizabeth C Giles, Tyrah M. Ritchie, Alexander S Qian, Fatemeh Vahedi, Ana L. Portillo, Veronique Miron, Bernardo L. Trigatti, A. Ashkar
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>56</td>
        </tr>

        <tr id="


 Investigations of human immune responses typically focus on adults, resulting in limited knowledge of the pediatric immune system and how it responds to distinct challenges early in life. To bridge this gap, we conducted a 3-year longitudinal multi-omic profiling study of 46 healthy children aged 11-13 as they received flu, HPV, DTaP, and COVID vaccines. This dataset includes scRNAseq of > 3.5 million PBMCs classified into 70 immune cell types based on our Immune Health Atlas, as well as plasma proteomics and high-dimensional flow cytometry. We are utilizing this dataset to characterize the pediatric immune system at baseline and in response to acute and chronic challenges as it compares to the adult immune system, with the ability to compare neoantigen and recall responses within the same children. This analysis revealed age-independent and age-dependent response patterns, with similar cellular compositions and gene-expression changes characterizing response to chronic CMV infection between children and adults but heightened activity in specific cell types responding to flu vaccination in children. We also identified increased activity in specific cell types in response to vaccines that elicit recall as opposed to neoantigen responses, providing a means to understand how immune memory is established and re-engaged in children. These initial findings lay the groundwork upon which we can build and deepen our understanding of immune dynamics in early adolescence.



 Vaccines and Immunotherapy (VAC)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/df59f6e43f958dcbaaa0bf7e9096332ed9f3c996" target='_blank'>
              Longitudinal multi-omic immune profiling of the healthy pediatric immune system and its response to vaccination 3300
              </a>
            </td>
          <td>
            Teminijesu Mary, Titus Adewunmi, Kathleen Abadie, Qiuyu Gong, Mehul Sharma, Upaasana Krishnan, Mansi Singh, Kathy Henderson, Mackenzie S. Kopp, Xiao-jun Li, Peter J. Skene, E. Wherry, Troy R. Torgerson, S. E. Henrickson, L. Vella, Claire E. Gustafson
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>38</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/f8602892f5a451d75b2917aa6aa3b1a249d99d98" target='_blank'>
              COVID-19-associated Autoimmune and Inflammatory Diseases: Molecular Mechanisms and the Role of IVIG Therapy
              </a>
            </td>
          <td>
            Sukanya Bordoloi, Suraj C. Singh, Jagadeesh Bayry
          </td>
          <td>2025-11-13</td>
          <td>Clinical Reviews in Allergy & Immunology</td>
          <td>0</td>
          <td>1</td>
        </tr>

        <tr id="Long COVID, also referred to as post-acute sequelae of SARS-CoV-2 infection (PASC), is characterized by persistent multi-systemic symptoms such as fatigue, cognitive impairment, and respiratory dysfunction. Accumulating evidence indicates that gut and oral microbiota play an important role in its pathogenesis. Patients with long COVID consistently exhibit reduced microbial diversity, depletion of beneficial short-chain fatty acid (SCFA)-producing species such as Faecalibacterium prausnitzii and Bifidobacterium spp. and enrichment of proinflammatory taxa including Ruminococcus gnavus, Bacteroides vulgatus, and Veillonella. These alterations may disrupt intestinal barrier integrity, sustain low-grade systemic inflammation, and influence host immune and neuroendocrine pathways through the gut–brain and gut–lung axes. Distinct microbial signatures have also been associated with symptom clusters, including neuropsychiatric, respiratory, and gastrointestinal manifestations. Proposed mechanisms linking dysbiosis to long COVID include impaired SCFA metabolism, tryptophan depletion, microbial translocation, and interactions with host immune and inflammatory responses, including autoantibody formation and viral antigen persistence. Preliminary interventional studies using probiotics, synbiotics, and fecal microbiota transplantation suggest that microbiome-targeted therapies may alleviate symptoms, although evidence remains limited and heterogeneous. This review synthesizes current literature on the role of gut and oral microbiota in long COVID, highlights emerging microbial biomarkers, and discusses therapeutic implications. While causality remains to be firmly established, restoring microbial balance represents a promising avenue for diagnosis, prevention, and management of long COVID.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/a462d11adc3888694fd7e83ee4854225cc318226" target='_blank'>
              Microbiome and Long COVID-19: Current Evidence and Insights
              </a>
            </td>
          <td>
            O. Caliman-Sturdza, S. Hamamah, Oana C Iatcu, Andrei Lobiuc, Anca Bosancu, M. Covașă
          </td>
          <td>2025-10-01</td>
          <td>International Journal of Molecular Sciences</td>
          <td>0</td>
          <td>12</td>
        </tr>

        <tr id="Accumulation of amyloid-β (Aβ) and neurofibrillary tangles (NFTs) are followed by the activation of glia cells and infiltration of peripheral immune cells that collectively accelerate neurodegeneration in preclinical AD models. Yet, the role of neuroinflammation for neuronal injury and disease progression in preclinical and early symptomatic AD remains elusive. Here, we combined multiplexed immunoassays and SomaScan proteomics of the cerebrospinal fluid (CSF) with MRI and PET brain imaging of people across the AD continuum to identify pathways that are associated with AD progression. Unbiased clustering revealed that glia-mediated inflammation, activation of cell death pathways (CDPs) and synaptic pathologies were among the earliest Aβ-induced changes, and were associated with disease progression in preclinical AD. Mediation analysis revealed that activation of CDPs were decisive drivers of inflammation in early symptomatic AD. The cycle of glia-mediated neuroinflammation and neuronal injury characterizes preclinical AD and has implications for novel treatment approaches. Glia activation, inflammation, cell death pathways and neuronal pathologies are associated with disease progression in preclinical AD. Activation of glia cells and cell death pathways maintain a vicious cycle of neuroinflammation that drives disease progression. Protein CSF signatures of neuroinflammation, glia activation, cell death pathways and neuronal pathologies are increased in early Alzheimer’s disease. Glia activation and cell death pathways are associated with disease progression in preclinical Alzheimer’s disease. Activation of cell death pathways is a mediator of neuroinflammation and disease progression in early Alzheimer’s disease. Disturbed synaptic signalling is a mediator of neuroinflammation and cell death pathways in early Alzheimer’s disease. Protein CSF signatures of neuroinflammation, glia activation, cell death pathways and neuronal pathologies are increased in early Alzheimer’s disease. Glia activation and cell death pathways are associated with disease progression in preclinical Alzheimer’s disease. Activation of cell death pathways is a mediator of neuroinflammation and disease progression in early Alzheimer’s disease. Disturbed synaptic signalling is a mediator of neuroinflammation and cell death pathways in early Alzheimer’s disease. Glia activation, inflammation, cell death pathways and neuronal pathologies are associated with disease progression in preclinical AD. Activation of glia cells and cell death pathways maintain a vicious cycle of neuroinflammation that drives disease progression.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/059a32370b4eead2f6b8e518d4468fb6c345d9f4" target='_blank'>
              Glia inflammation and cell death pathways drive disease progression in preclinical and early AD
              </a>
            </td>
          <td>
            Marcel S. Woo, J. Therriault, Seyyed Ali Hosseini, Y. Wang, A. Macedo, N. Rahmouni, É. Aumont, S. Servaes, C. Tissot, J. Fernandez-Arias, Lydia Trudel, Brandon J. Hall, G. Bezgin, Kely Quispialaya-Socualaya, Marina Goncalves, Tevy Chan, J. Stevenson, Yansheng Zheng, Stuart Mitchell, R. Hopewell, Ilaria Pola, Kübra Tan, Guglielmo di Molfetta, F. Lussier, G. Massarweh, P. Vitali, Jean-Paul Soucy, S. Gauthier, N. Ashton, K. Blennow, T. Pascoal, H. Zetterberg, A. Benedet, P. Rosa-Neto
          </td>
          <td>2025-10-10</td>
          <td>EMBO Molecular Medicine</td>
          <td>0</td>
          <td>69</td>
        </tr>

        <tr id="Sepsis remains a leading cause of critical illness worldwide. Despite advances in supportive care, durable benefit from immune-directed therapies is limited, reflecting heterogeneity with immune low-response states (‘immunoparalysis’) across innate and adaptive compartments. In this review we summarize advances from single-cell RNA and ATAC profiling, immune-repertoire assays and 3D spatial transcriptomics that resolve monocyte, dendritic-cell (cDC1, cDC2 and pDC), lymphocyte and NK-cell programs, and appraise translational opportunities spanning endotype-guided risk stratification, pharmacodynamic monitoring and spatial biomarkers. We also discuss enduring challenges—including assay standardization, harmonized thresholds for monocyte HLA-DR and whole-blood stimulation, and limited availability of clinically compatible spatial platforms—that temper implementation. By integrating bedside function (HLA-DR trajectories, LPS-induced cytokine capacity) with single-cell endotypes (MS1/HLA-DR^low S100A^high monocytes, dendritic-cell attrition, checkpoint-biased T cells) and host–pathogen topology from FFPE-ready spatial assays, emerging strategies aim to restore antigen presentation, reconstitute priming, disrupt inhibitory myeloid–lymphoid circuits and prevent secondary infection. Our synthesis provides an appraisal of the evolving landscape of immunoparalysis-informed precision medicine in sepsis and outlines pragmatic standards for composite biomarkers, patient selection and on-therapy decision rules. We hope these insights will assist investigators and clinicians as they endeavor to convert descriptive immune low-response states into tractable, reversible clinical entities.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/8bbe4c9833c37301d015a1fe8298eb3d5c890be7" target='_blank'>
              Decoding immune low-response states in sepsis: single-cell and 3D spatial transcriptomic insights into immunoparalysis
              </a>
            </td>
          <td>
            Yulian Yang, Yi Zhang, Jingjing Wu, Yi Liu, Xianying Lei
          </td>
          <td>2025-11-05</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>3</td>
        </tr>

        <tr id="Neurotropic viruses infect the central nervous system (CNS) and can cause severe neurological disorders. Theiler’s murine encephalomyelitis virus (TMEV) infection in C57BL/6 mice serves as a model for virus-induced encephalitis and hippocampal damage. C-type lectin domain family 12 member A (CLEC12A) is an inhibitory receptor, which modulates immune responses during inflammatory processes. However, the role of CLEC12A during neurotropic virus infections remains unclear. In this study, CLEC12A-deficient (CLEC12A−/−) and wild type C57BL/6 mice were infected with TMEV. Neuroinflammatory responses, viral load, and immune cell infiltration were analyzed using immunohistochemistry, RT-qPCR, and flow cytometry. CLEC12A−/− mice exhibited increased T cell sequestration in the brain, along with a higher expression of pro-inflammatory cytokine (TNF-α, IL-1β) and antigen presentation genes (CD11c, CD80, MHC-I) during acute infection. This led to an improved viral clearance in the hippocampus. CLEC12A deficiency also activates splenic CD4+ T cells and CD8+ cytotoxic T cells upon infection. Despite increased peripheral T cell activation and neuroinflammation, CLEC12A−/− mice displayed less hippocampal damage with improved neuronal and axonal integrity. In conclusion, CLEC12A signaling in C57BL/6 mice contributes to suppressive immune modulation, delaying viral elimination and exacerbating brain damage during acute neurotropic virus infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0c06a34914feb56293f8f56d9bcc2e6259a3943c" target='_blank'>
              CLEC12A signaling represses protective immune responses and contributes to hippocampal pathology in neurotropic picornavirus infection
              </a>
            </td>
          <td>
            M. K. Ameen, M. Stoff, S. Pavasutthipaisit, T. Ebbecke, M. Ciurkiewicz, T. Störk, J. Ruland, B. Lepenies, A. Beineke
          </td>
          <td>2025-11-10</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>8</td>
        </tr>

        <tr id="Neurocognitive impairment is a prevalent co-morbidity in virologically suppressed people living with HIV (PLWH), yet the underlying mechanisms remain elusive and treatments lacking. We explored use of participant-derived directly induced neurons (iNs) to model neuronal biology and injury in PLWH. iNs retain age- and disease-related donor features, providing unique opportunities to reveal important aspects of neurological disorders. We obtained primary dermal fibroblasts from six virologically suppressed PLWH (range: 27-64 years, median: 53; 83% Male) and seven matched people without HIV (PWOH) (range: 27-66, median: 55; 71% Male). iNs were generated using transcription factors NGN2 and ASCL1, and validated by immunocytochemistry, single-cell-RNAseq, and electrophysiological recordings. Transcriptomic aging analyses confirmed retention of donor age-related signatures. Bulk-RNAseq identified 29 significantly differentially expressed genes between PLWH and PWOH iNs. Of these, 16 were downregulated and 13 upregulated in PLWH iNs. Protein-protein interaction network mapping indicates iNs from PLWH exhibit differences in extracellular matrix organization and synaptic transmission. IFI27 was upregulated in PLWH iNs, complementing independent post-mortem studies demonstrating elevated IFI27 expression in PLWH-derived brain tissue. FOXL2NB-FOXL2-LINC01391 expression was reduced in PLWH iNs and negatively correlated with neurocognitive impairment. Thus, we identified an iN gene signature of HIV revealing mechanisms of neurocognitive impairment in PLWH.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/5ed7c586e77d0113c401ac4f4b8dda15f9a05841" target='_blank'>
              Transcriptional signature of induced neurons differentiates virologically suppressed people with HIV from people without HIV.
              </a>
            </td>
          <td>
            P. N. Ostermann, Youjun Wu, S. Bowler, Samuel Martínez-Meza, M. A. Siddiqui, David H Meyer, Alberto Herrera, Brandon A Sealy, Mega Sidharta, K. Ramnarine, Leslie St. Bernard, Desiree Byrd, R. Jones, Masahiro Yamashita, Douglas F. Nixon, L. Ndhlovu, Ting Zhou, Teresa H. Evering
          </td>
          <td>2025-11-25</td>
          <td>JCI insight</td>
          <td>0</td>
          <td>43</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/9463ca800a9fd687228ba6e8f05b6d34020cd3be" target='_blank'>
              Transcriptome Profiling Across Multiple Organs Unveils Potential Regulatory Effects of C-Fibers on Host in Mice
              </a>
            </td>
          <td>
            Yu He, Changgen Li, Jianhua Wei, Zhongying Yang, Luo Ren, Yu Deng, Na Zang, Enmei Liu
          </td>
          <td>2025-10-14</td>
          <td>Journal of Molecular Neuroscience</td>
          <td>0</td>
          <td>5</td>
        </tr>

        <tr id="


 Emerging evidence has suggested that primary infection and/or insult can “train” or “prime” long-term alterations in the transcriptional and epigenetic profiles of innate immune cells, particularly macrophages. Currently, it is unknown whether those “infection-experienced” macrophages can facilitate adaptive immune memory responses after infection resolution. Here, we show that influenza virus infection induces lasting transcriptional and epigenetic changes in lung alveolar macrophages (AMs) compartment following the resolution of primary infection. Further analysis showed that the IL-1b was persistently upregulated in the “infection-experienced” AMs at the memory phase compared to those of AMs from the naïve mice, and the “primed” AMs represent the major source of IL-1b in the infection-experienced lungs. Strikingly, blocking IL-1β or ablating it in myeloid cells during the memory phase led to decreased number of antigen-specific CD8 resident memory T cells (Trm) specifically in the airway but not the lung parenchyma. Consistently, IL-1b blockade caused diminished Trm-mediated protective immunity during heterologous influenza virus re-challenge. Our data suggest that infection-primed innate immune compartment facilitates protective local adaptive immune memory in the respiratory mucosa after the resolution of primary infection. Our findings may inform future vaccine design aiming to induce strong mucosal CD8 T cell immunity against respiratory viral infections.



 Immune Response Regulation: Cellular Mechanisms (IRC)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/c545200b85997582aa0e6b4cd460d5da7beff03a" target='_blank'>
              Infection-experienced alveolar macrophages sustain airway T cell memory 3555
              </a>
            </td>
          <td>
            I. Cheon, Y. Son, J. Im, Jie Sun
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>21</td>
        </tr>

        <tr id="The novel respiratory disease COVID-19 caused by the coronavirus SARS-CoV-2 continues to be a public health emergency worldwide, and there is a need for more effective therapy for patients. The relationship between the extracellular matrix and the host immune response to infection is severely understudied. Deposition of the polysaccharide hyaluronan (HA) into the lungs is associated with more severe COVID-19 disease outcomes. HA is a major component of the extracellular matrix in connective tissues and is abundant in many parts of the body, including cartilage, skin, brain, and vitreous body. CD44 is the primary receptor for HA and is found on almost all immune cells in the lung. Known functions of CD44 include mediation of immune cell migration, activation, and differentiation. We hypothesized that increased HA deposition during COVID-19 increases CD44-mediated immune cell infiltration into lungs and results in more severe pathology. Here, we report that in mice infected with a mouse-adapted strain of SARS-CoV-2, treatment with a combination of two anti-CD44 monoclonal antibodies confers a significant survival benefit and reduces weight loss and clinical score of the mice on Day 4 post infection. We show that anti-CD44 treatment decreases many key cytokines and chemokines in the bronchoalveolar lavage fluid on Day 4. With flow cytometry, we show that anti-CD44 reduces the numbers of neutrophils in infected lungs. We also show through immunofluorescence that treatment with anti-CD44 antibodies reduces colocalization of HA and CD45 in lung sections, indicating that HA’s interaction with immune cells contributes to pathology. Our findings demonstrate that disruption of HA-receptor interactions is a way to prevent inflammatory pathology in pulmonary infection.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/4da5b4b9505c812408a6d3c66eab78fd4c953bb1" target='_blank'>
              The hyaluronan receptor CD44 drives COVID-19 severity through its regulation of neutrophil migration
              </a>
            </td>
          <td>
            Duncan J. Hart, Md Jashim Uddin, R. Dodd, S. Brovero, Claire Fleming, G. B. Moreau, Nick R. Natale, Barbara J. Mann, T. Sutherland, J. Allen, Anthony J. Day, W. A. Petri
          </td>
          <td>2025-10-14</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>9</td>
        </tr>

        <tr id="Background Although an increase in neutrophil count has been observed in patients with coronavirus disease 2019 (COVID-19), the relationship between the systemic neutrophil transcriptome and clinical course of COVID-19 remains unclear. Hence, we examined the relationship between the clinical course and RNA sequencing analysis results in COVID-19 patients. Methods Peripheral blood samples were obtained from 28 patients with COVID-19-associated ARDS and 16 healthy controls. Bulk RNA sequencing was performed, and clustering analysis was used to explore relationships between gene expression and clinical characteristics. In a separate cohort, neutrophils were isolated from the peripheral blood of five COVID-19 patients with ARDS for single-cell RNA sequencing to further characterize the neutrophil subpopulations. Results In bulk RNA sequencing analysis, COVID-19 patients with ARDS had elevated gene expression associated with neutrophils compared with healthy controls.Clustering analysis revealed no differences in the clinical characteristics of COVID-19 patients with ARDS. In the single-cell RNA sequencing analysis, clustering analysis showed that the patients were divided into two groups: those who could be weaned from the ventilator within 28 days and those who could not be weaned. Conclusion These findings indicate that differences in neutrophil gene expression may have important clinical implications. This study may support the exploratory identification of genomic factors, such as neutrophil gene expression, that are relevant to clinical parameters.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/be169a2ec01392f5c6227748d161603c47c0cb32" target='_blank'>
              Neutrophil gene expression in COVID-19 patients with acute respiratory distress syndrome
              </a>
            </td>
          <td>
            Hiroshi Ito, Masakazu Ishikawa, J. Yoshimura, Yuchen Liu, Shuhei Sakakibara, Fuminori Sugihara, Hisatake Matsumoto, H. Hirata, Hiroshi Ogura, Jun Oda, Daisuke Okuzaki
          </td>
          <td>2025-11-06</td>
          <td>Frontiers in Immunology</td>
          <td>0</td>
          <td>25</td>
        </tr>

        <tr id="To date, COVID-19 continues to pose a global health challenge, with substantial morbidity, mortality, and long-term post-COVID-19 complications threatening public health resilience. During the early pandemic, the IL-6 inhibitor (tocilizumab) was the widely used approved immunotherapy for critically ill patients; however, a subset of ICU cases exhibited normal interleukin-6 (IL-6) levels and failed to respond. We hypothesized that interleukin-17 (IL-17), which acts synergistically with IL-6, contributes to cytokine storm progression and severe inflammation. Our study uniquely integrates a clinical cross-sectional analysis with advanced in-silico modelling, directly linking patient-derived biomarker, radiological, and statistical data to molecular-level mechanisms of COVID-19 severity. Serum IL-17 was significantly elevated in critical versus moderate COVID-19 cases, with a threshold of 187.9 ng/mL predicting poor outcomes by ROC analysis. Logistic regression identified age and monocytes as independent predictors of severity, supporting a combined biomarker approach for improving the prognosis and clinical outcomes. Radiological findings, including ground-glass opacities and consolidations, alongside hematological abnormalities, were more frequent in critical cases. Computational docking revealed key amino acid residues—particularly asparagine (Asn) and cysteine (Cys)—as structural determinants shared by SARS-CoV-2 spike protein and human inflammatory mediators (IL-17R, IL-6R, CD41/CD61, CD47/SIRP). Asparaginase (ASNase) targeted critical residues such as the invariant gate residue “Asn343” and Cys213 of spike protein, Asn240 of IL-17R, and Asn136 of IL-6R. Several phytochemicals, including phytic acid and amygdalin, as well as synthetic agents such as candesartan, remdesivir, and enalapril, were found to preferentially bind to cysteine (Cys) residues—and, to a lesser extent, asparagine (Asn) residues—within key binding interfaces, in addition to targeting B-cell epitopes. This conserved residue preference supports the rationale for a dual-action therapeutic strategy in which asparaginase (ASNase) is combined with selected plant-derived ligands to simultaneously disrupt viral entry mechanisms and attenuate the inflammatory signalling. This dual-perspective approach not only identified IL-17 and IL-6 as independent severity predictors but also revealed conserved Asn and Cys motifs as critical therapeutic targets, leading to novel strategies—such as ASNase, synthetic agents and phytochemical combinations—for simultaneously blocking viral entry and modulating hyperinflammatory pathways. These findings warrant rigorous experimental and clinical validation to facilitate translation into effective therapeutic interventions.">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/0c39de9842650cb3d4bcee32541dbefd2af7f692" target='_blank'>
              Targeting asparagine and cysteine in SARS-CoV-2 variants and human pro-inflammatory mediators to alleviate COVID-19 severity; a cross-section and in-silico study
              </a>
            </td>
          <td>
            Hewida H. Fadel, Hadeer Adel EL-Esseily, Mohammad Abd El-Rahman Ahmed, Mohammed Ahmed Khamis Mohamed, M. N. Roushdy, Amr ElSherif, K. M. Gharbeya, H. Abdelsalam
          </td>
          <td>2025-11-03</td>
          <td>Scientific Reports</td>
          <td>0</td>
          <td>2</td>
        </tr>

        <tr id="None">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/62a7046e53aa7828325fcbe7a57e5422fd94bc21" target='_blank'>
              Cytokines of the Interleukin-1 superfamily and Interleukin-6 are associated with neuroinflammation and brain injury in Herpes Simplex Virus Encephalitis
              </a>
            </td>
          <td>
            F. N. Egbe, C. Dunai, Claire Hetherington, S. Boardman, Laura Bricio Moreno, B. Facer, Cory Hooper, David Haw, A-C. Villani, Luca Lenzi, Sam Haldenby, Steve Patterson, Evelyn Kurt-Jones, A.D. Luster, Tom Solomon, M. Ellul, B. Michael
          </td>
          <td>2025-10-12</td>
          <td>bioRxiv</td>
          <td>0</td>
          <td>22</td>
        </tr>

        <tr id="


 Severe COVID-19 is associated with excessive lung inflammation and impaired antiviral response. SARS-CoV-2 structural spike (S), nucleocapsid (N), and envelope (E) proteins are key mediators of excessive inflammation. The immune sensors and signaling pathways for S-, N-, and E-proteins are well described. However, the role of M-protein in SARS-CoV-2-induced immunity, and the immune sensor and downstream pathways promoting M protein-induced immunity are not well defined. Here, we stimulated murine bone marrow derived macrophages (BMDMs) with M-protein and examined host response, identified immune sensor, and defined key adapter molecules that facilitated excessive inflammation and impaired antiviral response. We show that M-protein elicits robust inflammation and suppresses antiviral immunity. Using wild-type and knock-out BMDMs, we identified TLR4 as primary immune sensor, while Myd88 and TRIF facilitated M-protein-induced inflammation via both NFkB and MAPK activation. Interestingly, M-protein suppressed antiviral interferon (IFN) response via ERK1/2 activation, while blocking M-protein-induced ERK1/2 activity reduced inflammation while improving IFN-I response. Collectively, we defined the role of M-protein in SARS-CoV-2-induced inflammation and identified TLR4 and Myd88/TRIF as key molecules orchestrating dysregulated immunity largely via the ERK1/2 pathway; specifically targeting these pathways may mitigate SARS-CoV-2-mediated dysregulated immunity and severe disease.



 Supported by NIH R21AI186028; NIH P20GM103648; P30GM149368; SRTP OSU-CVM; FFAR Veterinary Student Research Fellowship.



 Viral Immunology (VIR)
">
          <td id="tag"><i class="material-icons">visibility_off</i></td>
          <td><a href="https://www.semanticscholar.org/paper/6dad1a93bbd5352c9219bcf5ca58ca76a8cc63e4" target='_blank'>
              TLR4 and Myd88/TRIF signaling serve as novel immune sensor and adapters of SARS-CoV-2-membrane (M) protein induced immune response 2730
              </a>
            </td>
          <td>
            P. Johnson, Rakshya Shrestha, Cody Whitley, Rudra Channappanavar
          </td>
          <td>2025-11-01</td>
          <td>The Journal of Immunology</td>
          <td>0</td>
          <td>3</td>
        </tr>

    </tbody>
    <tfoot>
      <tr>
          <th>Abstract</th>
          <th>Title</th>
          <th>Authors</th>
          <th>Publication Date</th>
          <th>Journal/Conference</th>
          <th>Citation count</th>
          <th>Highest h-index</th>
      </tr>
    </tfoot>
    </table>
    </p>
  </div>

</body>

<script>

  function create_author_list(author_list) {
    let td_author_element = document.getElementById();
    for (let i = 0; i < author_list.length; i++) {
          // tdElements[i].innerHTML = greet(tdElements[i].innerHTML);
          alert (author_list[i]);
      }
  }

  var trace1 = {
    x: ['2024', '2025'],
    y: [2, 5],
    name: 'Num of citations',
    yaxis: 'y1',
    type: 'scatter'
  };

  var data = [trace1];

  var layout = {
    yaxis: {
      title: 'Num of citations',
      }
  };
  Plotly.newPlot('myDiv1', data, layout);
</script>
<script>
var dataTableOptions = {
        initComplete: function () {
        this.api()
            .columns()
            .every(function () {
                let column = this;

                // Create select element
                let select = document.createElement('select');
                select.add(new Option(''));
                column.footer().replaceChildren(select);

                // Apply listener for user change in value
                select.addEventListener('change', function () {
                    column
                        .search(select.value, {exact: true})
                        .draw();
                });

                // keep the width of the select element same as the column
                select.style.width = '100%';

                // Add list of options
                column
                    .data()
                    .unique()
                    .sort()
                    .each(function (d, j) {
                        select.add(new Option(d));
                    });
            });
    },
    scrollX: true,
    scrollCollapse: true,
    paging: true,
    fixedColumns: true,
    columnDefs: [
        {"className": "dt-center", "targets": "_all"},
        // set width for both columns 0 and 1 as 25%
        { width: '7%', targets: 0 },
        { width: '30%', targets: 1 },
        { width: '25%', targets: 2 },
        { width: '15%', targets: 4 }

      ],
    pageLength: 10,
    layout: {
        topStart: {
            buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
        }
    }
  }
  new DataTable('#table1', dataTableOptions);
  new DataTable('#table2', dataTableOptions);

  var table1 = $('#table1').DataTable();
  $('#table1 tbody').on('click', 'td:first-child', function () {
    var tr = $(this).closest('tr');
    var row = table1.row( tr );

    var rowId = tr.attr('id');
    // alert(rowId);

    if (row.child.isShown()) {
      // This row is already open - close it.
      row.child.hide();
      tr.removeClass('shown');
      tr.find('td:first-child').html('<i class="material-icons">visibility_off</i>');
    } else {
      // Open row.
      // row.child('foo').show();
      tr.find('td:first-child').html('<i class="material-icons">visibility</i>');
      var content = '<div class="child-row-content"><strong>Abstract:</strong> ' + rowId + '</div>';
      row.child(content).show();
      tr.addClass('shown');
    }
  });
  var table2 = $('#table2').DataTable();
  $('#table2 tbody').on('click', 'td:first-child', function () {
    var tr = $(this).closest('tr');
    var row = table2.row( tr );

    var rowId = tr.attr('id');
    // alert(rowId);

    if (row.child.isShown()) {
      // This row is already open - close it.
      row.child.hide();
      tr.removeClass('shown');
      tr.find('td:first-child').html('<i class="material-icons">visibility_off</i>');
    } else {
      // Open row.
      // row.child('foo').show();
      var content = '<div class="child-row-content"><strong>Abstract:</strong> ' + rowId + '</div>';
      row.child(content).show();
      tr.addClass('shown');
      tr.find('td:first-child').html('<i class="material-icons">visibility</i>');
    }
  });
</script>
<style>
  .child-row-content {
    text-align: justify;
    text-justify: inter-word;
    word-wrap: break-word; /* Ensure long words are broken */
    white-space: normal; /* Ensure text wraps to the next line */
    max-width: 100%; /* Ensure content does not exceed the table width */
    padding: 10px; /* Optional: add some padding for better readability */
    /* font size */
    font-size: small;
  }
</style>
</html>







  
  




  



                
              </article>
            </div>
          
          
<script>var target=document.getElementById(location.hash.slice(1));target&&target.name&&(target.checked=target.name.startsWith("__tabbed_"))</script>
        </div>
        
          <button type="button" class="md-top md-icon" data-md-component="top" hidden>
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M13 20h-2V8l-5.5 5.5-1.42-1.42L12 4.16l7.92 7.92-1.42 1.42L13 8v12Z"/></svg>
  Back to top
</button>
        
      </main>
      
        <footer class="md-footer">
  
  <div class="md-footer-meta md-typeset">
    <div class="md-footer-meta__inner md-grid">
      <div class="md-copyright">
  
  
    Made with
    <a href="https://squidfunk.github.io/mkdocs-material/" target="_blank" rel="noopener">
      Material for MkDocs
    </a>
  
</div>
      
    </div>
  </div>
</footer>
      
    </div>
    <div class="md-dialog" data-md-component="dialog">
      <div class="md-dialog__inner md-typeset"></div>
    </div>
    
    
    <script id="__config" type="application/json">{"base": "..", "features": ["navigation.top", "navigation.tabs"], "search": "../assets/javascripts/workers/search.b8dbb3d2.min.js", "translations": {"clipboard.copied": "Copied to clipboard", "clipboard.copy": "Copy to clipboard", "search.result.more.one": "1 more on this page", "search.result.more.other": "# more on this page", "search.result.none": "No matching documents", "search.result.one": "1 matching document", "search.result.other": "# matching documents", "search.result.placeholder": "Type to start searching", "search.result.term.missing": "Missing", "select.version": "Select version"}}</script>
    
    

      <script src="../assets/javascripts/bundle.c8d2eff1.min.js"></script>
      
    
<script>
  // Execute intro.js when a button with id 'intro' is clicked
  function startIntro(){
      introJs().setOptions({
          tooltipClass: 'customTooltip'
      }).start();
  }
</script>
<script>
  

  // new DataTable('#table1', {
  //   order: [[5, 'desc']],
  //   "columnDefs": [
  //       {"className": "dt-center", "targets": "_all"},
  //       { width: '30%', targets: 0 }
  //     ],
  //   pageLength: 10,
  //   layout: {
  //       topStart: {
  //           buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
  //       }
  //   }
  // });

  // new DataTable('#table2', {
  //   order: [[3, 'desc']],
  //   "columnDefs": [
  //       {"className": "dt-center", "targets": "_all"},
  //       { width: '30%', targets: 0 }
  //     ],
  //   pageLength: 10,
  //   layout: {
  //       topStart: {
  //           buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
  //       }
  //   }
  // });
  new DataTable('#table3', {
    initComplete: function () {
        this.api()
            .columns()
            .every(function () {
                let column = this;
 
                // Create select element
                let select = document.createElement('select');
                select.add(new Option(''));
                column.footer().replaceChildren(select);
 
                // Apply listener for user change in value
                select.addEventListener('change', function () {
                    column
                        .search(select.value, {exact: true})
                        .draw();
                });

                // keep the width of the select element same as the column
                select.style.width = '100%';
 
                // Add list of options
                column
                    .data()
                    .unique()
                    .sort()
                    .each(function (d, j) {
                        select.add(new Option(d));
                    });
            });
    },
    // order: [[3, 'desc']],
    "columnDefs": [
        {"className": "dt-center", "targets": "_all"},
        { width: '30%', targets: 0 }
      ],
    pageLength: 10,
    layout: {
        topStart: {
            buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
        }
    }
  });
  new DataTable('#table4', {
    initComplete: function () {
        this.api()
            .columns()
            .every(function () {
                let column = this;
 
                // Create select element
                let select = document.createElement('select');
                select.add(new Option(''));
                column.footer().replaceChildren(select);
 
                // Apply listener for user change in value
                select.addEventListener('change', function () {
                    column
                        .search(select.value, {exact: true})
                        .draw();
                });

                // keep the width of the select element same as the column
                select.style.width = '100%';
 
                // Add list of options
                column
                    .data()
                    .unique()
                    .sort()
                    .each(function (d, j) {
                        select.add(new Option(d));
                    });
            });
    },
    // order: [[3, 'desc']],
    "columnDefs": [
        {"className": "dt-center", "targets": "_all"},
        { width: '30%', targets: 0 }
      ],
    pageLength: 10,
    layout: {
        topStart: {
            buttons: ['copy', 'csv', 'excel', 'pdf', 'print']
        }
    }
  });
</script>


  </body>
</html>